Processing 00000000.tx.1: Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3 Anna J. 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "protects"

Phrase: "cells from ER stress-induced lipid accumulation"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0229606:Reticulum cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "apoptosis by inhibiting glycogen synthase kinase-3 Anna J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.2: Kim1, Yuanyuan Shi2, Richard C. 

Phrase: "Kim1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425141:KIM1 [Gene or Genome]
  1000   C2681921:KIM1 [Laboratory Procedure]

Phrase: "Yuanyuan Shi2,"

Phrase: "Richard C."
Processing 00000000.tx.3: Austin2,3 and Geoff H. 

Phrase: "Austin2,"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Geoff H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Werstuck1,2,4,* 1 Department of Biochemistry, McMaster University, Hamilton, Ontario, L8S 4LB, Canada 2 Henderson Research Centre, Hamilton, Ontario, L8V 1C3, Canada 3 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, L8S 4LB, Canada 4 Department of Medicine, McMaster University, Hamilton, Ontario, L8S 4LB, Canada * Author for correspondence (e-mail: gwerstuck{at}thrombosis.hhscr.org ) Accepted 24 September 2004  Summary Top Summary Introduction Materials and Methods Results Discussion References  A wide range of agents and conditions are known to disrupt the ability of the endoplasmic reticulum (ER) to fold proteins properly, resulting in the onset of ER dysfunction/stress. 

Phrase: "Werstuck1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "* 1 Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "McMaster University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Hamilton,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "L8S 4LB,"

Phrase: "Canada 2 Henderson Research Centre,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0683939:research center [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "Hamilton,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "L8V 1C3,"

Phrase: "Canada 3 Department of Pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587487:Pathology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Molecular Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1513397:Molecular Medicine [Biomedical Occupation or Discipline]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "McMaster University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Hamilton,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "L8S 4LB,"

Phrase: "Canada 4 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "McMaster University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Hamilton,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "L8S 4LB,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "* Author for correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0221193:Author [Professional or Occupational Group]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gwerstuck{at}thrombosis.hhscr.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1522486:ORG [Professional or Occupational Group]

Phrase: ")"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "24 September 2004  Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A wide range of agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the ability of the endoplasmic reticulum (ER)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "to fold proteins properly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulting in the onset of ER dysfunction/stress."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   784   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   764   C0014239:Endoplasmic Reticulum [Cell Component]
   764   C0332294:Resulting in [Functional Concept]
   742   C0031847:dysfunction [Functional Concept]
   742   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   742   C0038435:Stress [Finding]
   742   C0277785:Dysfunction, NOS [Qualitative Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C0678226:resulting [Functional Concept]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]
Processing 00000000.tx.5: We and others have shown that ER stress can induce intracellular lipid accumulation through the activation of the sterol responsive element binding proteins (SREBPs) and initiate programmed cell death by activation of caspases. 

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "intracellular lipid accumulation through the activation of the sterol responsive element binding proteins (SREBPs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   750   C0333574:Lipid accumulation [Finding]

Phrase: "and"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "programmed cell death by activation of caspases."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   870   C2248385:activation of programmed cell death [Cell Function]
   814   C0162638:Programmed Cell Death [Cell Function]
   778   C0007587:Cell Death [Cell Function]
   774   C1326120:cell activation [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: It has been suggested that ER stress-induced lipid accumulation and cell death play a role in the pathogenesis of disorders including Alzheimer's disease, Parkinson's disease, type-1 diabetes mellitus and hepatic steatosis. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that ER stress-induced lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333574:Lipid accumulation [Finding]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "type-1 diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Type 1 diabetes
  1000   C2984334:Type I diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441729:Type 1 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "hepatic steatosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015695:hepatic steatosis [Disease or Syndrome]
  1000   C2711227:Hepatic steatosis [Disease or Syndrome]
   861   C0152254:Steatosis [Pathologic Function]
   861   C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.7: Here we show that exposure of HepG2 cells to the branch chain fatty acid, valproate, increases cellular resistance to ER stress-induced dysfunction. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that exposure of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]

Phrase: "to the branch"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1253959:Branch [Body Part, Organ, or Organ Component]
  1000   C1881507:Branch [Chemical Viewed Structurally]
  1000   C2700383:Branch [Plant]
  1000   C2826234:BRANCH [Intellectual Product]

Phrase: "chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337112:Chain [Manufactured Object]
  1000   C1524075:Chain [Idea or Concept]

Phrase: "fatty acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015684:Fatty acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "valproate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cellular resistance to ER stress-induced dysfunction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0237834:Resistance [Mental Process]
   744   C1514892:Resistance [Physiologic Function]
   735   C0332325:Resistant to [Functional Concept]
Processing 00000000.tx.8: Two distinctly different potential mechanisms for this protective effect were investigated. 

Phrase: "Two distinctly different potential mechanisms for this protective effect"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0441712:Mechanisms [Functional Concept]
   708 E C1706376:Mechanism [Manufactured Object]

Phrase: "were"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.9: We show that exposure to valproate increases the expression of chaperones that assist in the folding of proteins in the ER including GRP78/BiP, GRP94, PDI and calreticulin as well as the cytosolic chaperone, HSP70. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that exposure to valproate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of chaperones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "assist in the folding of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0162847:folding protein [Molecular Function]
   753   C0018896:assist [Social Behavior]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185026:Folding [Therapeutic or Preventive Procedure]
   753   C0557034:assist [Health Care Activity]

Phrase: "in the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GRP78/BiP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "GRP94,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0120372:GRP94 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1825546:GRP94 [Gene or Genome]

Phrase: "PDI"

Phrase: "and"

Phrase: "calreticulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "as well as"

Phrase: "the cytosolic chaperone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "HSP70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.10: However, exposure of HepG2 cells to valproate does not decrease the apparent ER stress response in cells challenged with tunicamycin, A23187 or glucosamine, suggesting that valproate-conferred protection occurs downstream of ER dysfunction. 

Phrase: "However,"

Phrase: "exposure of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the apparent ER stress response in cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0149784:stress response [Physiologic Function]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "challenged with tunicamycin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "or"

Phrase: "glucosamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate-conferred protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1545588:Protection [Finding]

Phrase: "occurs downstream of ER dysfunction."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0031847:dysfunction [Functional Concept]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]
   753   C0522506:Downstream [Spatial Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.11: Finally, we demonstrate that valproate directly inhibits the glycogen synthase kinases (GSK)-3/. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that valproate directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the glycogen synthase kinases (GSK)-3/."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.12: The ability of lithium, another inhibitor of GSK3/ to protect cells from ER stress-induced lipid accumulation suggests that GSK3 plays a central role in signaling downstream effects of ER stress. 

Phrase: "The ability of lithium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "another inhibitor of GSK3/ to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   767   C3537023:kinase inhibitor [Molecular Function]
   767   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "protect"

Phrase: "cells from ER stress-induced lipid accumulation"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0229606:Reticulum cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in signaling downstream effects of ER stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.13: Strategies to protect cells from agents/conditions that induce ER stress may have potential in the treatment of the growing number of diseases and disorders linked to ER dysfunction. 

Phrase: "Strategies to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "protect"

Phrase: "cells from agents/"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "may"

Phrase: "have"

Phrase: "potential in the treatment of the growing number of diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "linked to ER dysfunction."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0031847:dysfunction [Functional Concept]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.14: Key words: Valproate, Endoplasmic reticulum stress, Apoptosis, Lipid accumulation, Glycogen synthase kinase  Introduction Top Summary Introduction Materials and Methods Results Discussion References  In eukaryotic cells, the endoplasmic reticulum (ER) provides a contained environment for the synthesis and modification of membrane proteins and proteins destined to be secreted. 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Valproate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "Endoplasmic reticulum stress,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "Apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "Lipid accumulation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333574:Lipid accumulation [Finding]

Phrase: "Glycogen synthase kinase  Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In eukaryotic cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0015161:Eukaryotic Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "(ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a contained environment for the synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014406:Environment [Spatial Concept]

Phrase: "and"

Phrase: "modification of membrane proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0033666:Protein Modification [Molecular Function]
   802   C2263112:protein modification [Molecular Function]
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "destined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "secreted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]
Processing 00000000.tx.15: These co- and post-translational modifications, including disulfide bond formation and N-linked glycosylation, play an important role in the subsequent folding and oligomeric assembly of proteins (Helenius, 1994). 

Phrase: "These co-"

Phrase: "and"

Phrase: "post-translational modifications,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1704687:Post [Manufactured Object]
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "disulfide bond formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150347:disulphide bond formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C1511997:Disulfide Bond [Amino Acid Sequence]

Phrase: "and"

Phrase: "N-linked glycosylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017982:glycosylation [Natural Phenomenon or Process]
   827   C0376322:Glycosylation [Molecular Function]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the subsequent folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "oligomeric assembly of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   847   C1523273:protein oligomer assembly [Molecular Function]
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]

Phrase: "(Helenius,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.16: To assist in the folding of nascent polypeptides and to prevent aggregation of folding intermediates, the ER contains a high concentration of protein chaperones including the glucose-regulated proteins (GRPs), calnexin, calreticulin, protein disulphide isomerase and Erp72 (Gething and Sambrook, 1992; Ruddon and Bedows, 1997). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assist in the folding of nascent polypeptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0018896:assist [Social Behavior]
   748   C0185026:Folding [Therapeutic or Preventive Procedure]
   748   C0557034:assist [Health Care Activity]
   748   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "aggregation of folding intermediates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a high concentration of protein chaperones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0427716:Protein concentration [Laboratory Procedure]
   783   C1304757:Protein concentration [Laboratory or Test Result]
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the glucose-regulated proteins (GRPs),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0061421:glucose-regulated proteins [Amino Acid, Peptide, or Protein,Receptor]
   896   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "calnexin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]

Phrase: "calreticulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "protein disulphide isomerase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0072354:Protein Disulfide Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
           Disulfide Isomerase
  1000   C1150347:protein disulfide-isomerase [Molecular Function]
   901   C1418224:DISULFIDE ISOMERASE [Gene or Genome]
   827   C0012771:disulfide [Chemical Viewed Structurally]
   827   C0022202:Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Erp72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0059258:ERp72 [Amino Acid, Peptide, or Protein]
  1000   C1538609:ERP72 [Gene or Genome]

Phrase: "(Gething"

Phrase: "and"

Phrase: "Sambrook,"

Phrase: "1992"

Phrase: "; Ruddon"

Phrase: "and"

Phrase: "Bedows,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.17: In addition to their role in folding, some of these chaperones are postulated to act as a quality control system to ensure that only correctly folded proteins proceed to the Golgi for further processing and secretion (Kuznetsov et al., 1997). 

Phrase: "In addition to their role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "in folding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "some of these chaperones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]
   737   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as a quality control system to"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0034378:quality control [Functional Concept]
   778   C0680582:control system [Regulation or Law]
   778   C1561524:Quality Control [Intellectual Product]
   778   C1610034:Quality Control [Intellectual Product]
   774   C1554191:control act [Idea or Concept]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0243148:control [Qualitative Concept]
   748   C0332306:Quality [Qualitative Concept]
   748   C0449913:System [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that only correctly folded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "proceed to the Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018042:Golgi [Cell Component]

Phrase: "for further processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(Kuznetsov et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.18: Misfolded polypeptides are retained in the ER and subsequently targeted for degradation (Travers et al., 2000; Friedlander et al., 2000). 

Phrase: "Misfolded polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "retained in the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0333118:Retained [Functional Concept]

Phrase: "and"

Phrase: "subsequently"

Phrase: "targeted for degradation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "(Travers et al.,"

Phrase: "2000"

Phrase: "; Friedlander et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.19: Disruption of the ER protein processing system by pathogens, mutations or specific deficiencies in the protein folding machinery have been implicated in the progression of several human diseases including Alzheimer's, Huntington's, Parkinson's and type-1 diabetes (Katayama et al., 2001; Nishitoh et al., 2002; Ryu et al., 2002; Oyadomari et al., 2002a) (reviewed by Aridor and Balch, 1999). 

Phrase: "Disruption of the ER protein processing system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332453:Disruption [Functional Concept]

Phrase: "by pathogens,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C0450254:Pathogen [Organism]
   893 E C0030657:pathogenicity [Qualitative Concept]
   893 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "specific deficiencies in the protein folding machinery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0033626:Protein Deficiencies [Disease or Syndrome]
   714   C0011155:Deficiency [Functional Concept]
   714   C0162429:Deficiency [Disease or Syndrome]
   714   C1623416:deficiency [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the progression of several human diseases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C0242656:Disease Progression [Pathologic Function]
           progression
   750   C1947900:Disease progression NOS [Finding]
   744   C0012634:Diseases [Disease or Syndrome]
   744   C0086418:Human [Human]
   744   C0449258:Progression [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer's,"

Phrase: "Huntington's,"

Phrase: "Parkinson's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "type-1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(Katayama et al.,"

Phrase: "2001"

Phrase: "; Nishitoh et al.,"

Phrase: "2002"

Phrase: "; Ryu et al.,"

Phrase: "2002"

Phrase: "; Oyadomari et al.,"

Phrase: "2002a"

Phrase: ")"

Phrase: "("

Phrase: "reviewed by Aridor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Balch,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.20: Agents or conditions that adversely affect ER protein folding cause the accumulation of unfolded or misfolded proteins in the ER, a condition defined as ER stress. 

Phrase: "Agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "or"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that adversely"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "ER protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162847:protein folding [Molecular Function]
   812   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the accumulation of unfolded"

Phrase: "or"

Phrase: "misfolded proteins in the ER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "defined as ER stress."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.21: ER stress can be induced by agents that interfere with protein glycosylation (i.e. glucose starvation, tunicamycin, glucosamine), disulfide bond formation (i.e. DTT, homocysteine), Ca2+ balance (A23187, thapsigargin, EGTA) and/or the general overloading of the ER with proteins (i.e. viral and non-viral oncogenesis) (reviewed by Pahl, 1999; Kaufman, 1999; Lee, 2001). 

Phrase: "ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "can"

Phrase: "be"

Phrase: "induced by agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205263:Induced [Functional Concept]
   756   C0450442:Agent [Chemical Viewed Functionally]
   756   C1254351:Agent [Pharmacologic Substance]
   756   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "interfere with protein glycosylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0376322:Protein Glycosylation [Molecular Function]
           Glycosylation
   770   C0017982:glycosylation [Natural Phenomenon or Process]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0521102:Interfere [Qualitative Concept]

Phrase: "(i.e. glucose starvation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038187:Starvation [Finding]

Phrase: "tunicamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "disulfide bond formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150347:disulphide bond formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C1511997:Disulfide Bond [Amino Acid Sequence]

Phrase: "(i.e. DTT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "homocysteine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019878:homocysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0019879:Homocystine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "Ca2+ balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014653:Balance [Organism Function]
   861   C0205415:Balance [Functional Concept]
   861   C0560184:Balance [Finding]

Phrase: "(A23187,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "thapsigargin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "and/or"

Phrase: "the general overloading of the ER"

Phrase: "with proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(i.e. viral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0521026:Viral [Functional Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "non-viral oncogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007621:Oncogenesis [Neoplastic Process]
   827   C0596263:Oncogenesis [Neoplastic Process]

Phrase: ")"

Phrase: "("

Phrase: "reviewed by Pahl,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "1999"

Phrase: "; Kaufman,"

Phrase: "1999"

Phrase: "; Lee,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.22: Conditions of ER stress trigger the cellular unfolded protein response (UPR). 

Phrase: "Conditions of ER stress"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the cellular unfolded protein response (UPR)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1155342:Unfolded Protein Response [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
Processing 00000000.tx.23: In mammals the UPR is activated through three distinct signaling pathways. 

Phrase: "In mammals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]

Phrase: "the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "activated through three distinct signaling pathways."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
           Signaling
   773 E C0086982:Signaling Pathway [Molecular Function]
   753   C0205449:Three [Quantitative Concept]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   753   C1879547:Activated [Activity]
   753   C3537152:signaling [Biologic Function]
   719 E C1515877:Activate [Functional Concept]
   719 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.24: Activation of the ER-resident PKR-ER-related kinase (PERK) promotes the phosphorylation/inhibition of the translation initiation factor, eIF2 (Harding et al., 2000). 

Phrase: "Activation of the ER-resident PKR-ER-related kinase (PERK)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1879547:Activation [Activity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the phosphorylation/inhibition of the translation initiation factor,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   801   C2249872:inhibition of translational initiation [Cell Function]
   793   C1519062:inhibition of phosphorylation [Molecular Function]
           Phosphorylation Inhibition
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
   731   C1519619:Translational Inhibition [Genetic Function]

Phrase: "eIF2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439095:Alpha [Intellectual Product]
   804   C0589507:Initiation [Mental Process]
   804   C1158830:Initiation [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1704686:Initiation [Functional Concept]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "(Harding et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.25: The resulting attenuation of general protein synthesis prevents further overloading of the ER folding machinery. 

Phrase: "The resulting attenuation of general protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0599946:Attenuation [Activity]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "further overloading of the ER folding machinery."
Processing 00000000.tx.26: Activation of ER resident proteins IRE1 and ATF6 promote the expression of the ER chaperones thereby increasing the capacity of the ER to fold the accumulated polypeptides (Wang et al., 1998; Haze et al., 1999). 

Phrase: "Activation of ER resident proteins IRE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "ATF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412622:ATF6 [Gene or Genome]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the expression of the ER chaperones thereby"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the capacity of the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "to fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]

Phrase: "the accumulated polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "(Wang et al.,"

Phrase: "1998"

Phrase: "; Haze et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.27: These ER chaperones also function as part of the quality control system that targets irrevocably misfolded proteins for ER-associated protein degradation (ERAD) (Travers et al., 2000). 

Phrase: "These ER chaperones also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "function as part of the quality control system"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   770   C0034378:quality control [Functional Concept]
   770   C0680582:control system [Regulation or Law]
   770   C1292711:Part of [Spatial Concept]
   770   C1561524:Quality Control [Intellectual Product]
   770   C1610034:Quality Control [Intellectual Product]
   767   C2587213:Control function [Functional Concept]
           Control
   744   C0031843:function [Physiologic Function]
   744   C0243148:control [Qualitative Concept]
   744   C0332306:Quality [Qualitative Concept]
   744   C0449719:Part [Spatial Concept]
   744   C0449913:System [Functional Concept]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1550141:Control [Substance]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1705273:Function [Intellectual Product]
   744   C1709471:Part [Quantitative Concept]
   744   C1882979:Control [Conceptual Entity]
   744   C3274648:Control [Qualitative Concept]

Phrase: "that"

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "irrevocably misfolded proteins for ER-associated protein degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C0597297:Protein Degradation [Molecular Function]
   745   C0597304:Protein Degradation [Molecular Function]
   745   C1623036:Protein Degradation [Molecular Function]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(ERAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1157980:ERAD [Molecular Function]

Phrase: ")"

Phrase: "(Travers et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.28: Thus, the UPR acts to alleviate ER stress by increasing folding capacity, inhibiting general protein translation and promoting the degradation of misfolded proteins. 

Phrase: "Thus,"

Phrase: "the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alleviate"

Phrase: "ER stress by increasing folding capacity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0038435:Stress [Finding]
   728   C0231298:Increased stress [Functional Concept]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "general protein translation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597295:Protein Translation [Molecular Function]
           translation
   827   C0040712:Translation [Intellectual Product]
   827   C1519614:Translation [Genetic Function]

Phrase: "and"

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "the degradation of misfolded proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0597297:Protein Degradation [Molecular Function]
   781   C0597304:Protein Degradation [Molecular Function]
   781   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.29: Under conditions of severe ER stress, or when the UPR has been compromised, the cell may be incapable of maintaining ER homeostasis. 

Phrase: "Under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of severe ER stress,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   861   C0014239:Endoplasmic Reticulum [Cell Component]
   812   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   812   C0038435:Stress [Finding]
   741 E C0231297:Stressful [Functional Concept]
   741   C0598268:Endoplasm [Cell Component]

Phrase: "or"

Phrase: "when"

Phrase: "the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: ","

Phrase: "the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "incapable of maintaining ER homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1550518:incapable [Idea or Concept]
Processing 00000000.tx.30: In this case the detrimental effects of ER disruption can activate intracellular pathways that lead to programmed cell death (Nakagawa et al., 2000; Oyadomari et al., 2002b). 

Phrase: "In this case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the detrimental effects of ER disruption"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "intracellular pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "lead to programmed cell death"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0162638:Programmed Cell Death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Nakagawa et al.,"

Phrase: "2000"

Phrase: "; Oyadomari et al.,"

Phrase: "2002b"

Phrase: ")."
Processing 00000000.tx.31: ER stress has been shown to promote apoptosis in pancreatic  cells (Oyadomari et al., 2002a), neurons, (Nishitoh et al., 2002) and endothelial cells (Hossain et al., 2003). 

Phrase: "ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "apoptosis in pancreatic  cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(Oyadomari et al.,"

Phrase: "2002a"

Phrase: ")"

Phrase: ","

Phrase: "neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Nishitoh et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: "and"

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Hossain et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.32: Although the molecular mechanisms by which ER stress activates the apoptosis are not clear, several proteins have been implicated in this pathway including the transcription factor GADD153/CHOP (growth arrest and DNA damage, also called CHOP) (Zinszner et al., 1998; Oyadomari et al., 2002a), the ER-resident cysteine protease, caspase 12 (Nakagawa et al., 2000), and the T-cell death-associated gene TDAG51 (Hossain et al., 2003; Scheuner et al., 2001). 

Phrase: "Although"

Phrase: "the molecular mechanisms by which ER stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the transcription factor GADD153/CHOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0287750:Transcription Factor CHOP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2945739:chop [Activity]

Phrase: "(growth arrest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333951:Growth arrest [Pathologic Function]
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "also called CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2945739:chop [Activity]

Phrase: ")"

Phrase: "(Zinszner et al.,"

Phrase: "1998"

Phrase: "; Oyadomari et al.,"

Phrase: "2002a"

Phrase: ")"

Phrase: ","

Phrase: "the ER-resident cysteine protease,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]

Phrase: "caspase 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0911469:Caspase 12 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Nakagawa et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the T-cell death-associated gene TDAG51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1418540:TDAG51 [Gene or Genome]

Phrase: "(Hossain et al.,"

Phrase: "2003"

Phrase: "; Scheuner et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.33: In recent years additional cellular responses to ER stress have been identified. 

Phrase: "In recent years additional cellular responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0871261:responses [Organism Attribute]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]

Phrase: "to ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.34: We have shown that homocysteine-induced ER stress can affect lipid metabolism through the activation and dysregulation of the sterol regulatory element binding proteins (SREBPs) (Werstuck et al., 2001). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that homocysteine-induced ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   840   C0014239:Endoplasmic Reticulum [Cell Component]
   804   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   804   C0038435:Stress [Finding]
   733 E C0231297:Stressful [Functional Concept]
   733   C0598268:Endoplasm [Cell Component]

Phrase: "can"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "lipid metabolism through the activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0598783:Lipid Metabolism [Molecular Function]
   806   C1517898:Lipid Metabolism [Molecular Function]
   760   C0023779:Lipid [Lipid]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "dysregulation of the sterol regulatory element binding proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C1566548:Sterol Regulatory Element Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SREBPs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C2246292:sterol binding [Molecular Function]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.35: SREBPs promote cholesterol and fatty acid biosynthesis and also induce LDL receptor expression and activity (Brown and Goldstein, 1999; Horton and Shimomura, 1999). 

Phrase: "SREBPs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C2246292:sterol binding [Molecular Function]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "fatty acid biosynthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596562:fatty acid biosynthesis [Molecular Function]
  1000   C2981166:Fatty acid biosynthesis [Functional Concept]
   827   C0005572:biosynthesis [Functional Concept]
   827   C0220781:Biosynthesis [Biologic Function]
   734   C0015684:Fatty acid [Lipid]

Phrase: "and"

Phrase: "also"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "LDL receptor expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597360:receptor expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0034821:LDL Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1149327:LDL receptor [Molecular Function]

Phrase: "and"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(Brown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Goldstein,"

Phrase: "1999"

Phrase: "; Horton"

Phrase: "and"

Phrase: "Shimomura,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.36: Thus, ER stress-induced SREBPs promote lipid accumulation in human aortic smooth muscle cells and hepatocytes (Werstuck et al., 2001). 

Phrase: "Thus,"

Phrase: "ER stress-induced SREBPs"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   866   C0018850:Stress Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   854   C0969348:Stress-Induced Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   854   C1336511:Stress-Induced Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   829   C2246292:sterol binding [Molecular Function]
   807   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0243122:binding [Functional Concept]
   791   C1145667:Binding [Activity]
   791   C1167622:Binding [Molecular Function]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "lipid accumulation in human aortic smooth muscle cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333574:Lipid accumulation [Finding]

Phrase: "and"

Phrase: "hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.37: The specific cellular response elicited by an ER stress-inducing agent appears to be dependent upon cell type and the severity of the stress. 

Phrase: "The specific cellular response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "elicited by an ER stress-inducing agent"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0449265:Elicited by [Qualitative Concept]
           elicited
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0038435:Stress [Finding]
   744   C0205263:Inducing [Functional Concept]
   744   C0450442:Agent [Chemical Viewed Functionally]
   744   C1254351:Agent [Pharmacologic Substance]
   744   C1521826:Agent [Intellectual Product]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "dependent upon cell type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "the severity of the stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439793:Severity [Qualitative Concept]
   760   C2983285:Severity [Intellectual Product]
Processing 00000000.tx.38: The signaling mechanisms that link ER stress to the apoptotic and lipid biosynthetic pathways have yet to be delineated. 

Phrase: "The signaling mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "ER stress to the apoptotic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0038435:Stress [Finding]

Phrase: "and"

Phrase: "lipid biosynthetic pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1721101:Biosynthetic Pathways [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "delineated."
Processing 00000000.tx.39: The potential role of ER stress-induced cellular dysfunction in the development and/or progression of human disease make this pathway a plausible therapeutic target. 

Phrase: "The potential role of ER stress-induced cellular dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and/or"

Phrase: "progression of human disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0242656:Disease Progression [Pathologic Function]
           progression
   819   C1947900:Disease progression NOS [Finding]
   770   C0449258:Progression [Functional Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "a plausible therapeutic target."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.40: In this paper we demonstrate the ability of a small molecule drug, valproate (2-propylpentanoic acid), to increase the resistance of HepG2 cells to ER stress-induced lipid accumulation and apoptosis. 

Phrase: "In this paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "the ability of a small molecule drug,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "(2-propylpentanoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042291:2-Propylpentanoic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the resistance of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]

Phrase: "to ER stress-induced lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333574:Lipid accumulation [Finding]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.41: Valproate is a widely prescribed drug in the treatment of epilepsy and bipolar disorder although the mechanisms by which valproate alleviate convulsions and modify behavior remain controversial (Penry et al., 1989; Bowden et al., 1994). 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "is"

Phrase: "a widely prescribed drug in the treatment of epilepsy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0013227:Drug [Pharmacologic Substance]
   742   C1254351:Drug [Pharmacologic Substance]

Phrase: "and"

Phrase: "bipolar disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005586:Bipolar Disorder [Mental or Behavioral Dysfunction]
   861   C0012634:Disorder [Disease or Syndrome]
   861   C0443156:Bipolar [Spatial Concept]

Phrase: "although"

Phrase: "the mechanisms by which valproate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "alleviate"

Phrase: "convulsions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036572:Convulsions [Sign or Symptom]

Phrase: "and"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "remain"

Phrase: "controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "(Penry et al.,"

Phrase: "1989"

Phrase: "; Bowden et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.42: To determine the molecular mechanisms by which valproate protects cells from ER stress-induced dysfunction we have investigated the previously reported capacity of this molecule to (1) increase intracellular ER chaperone levels (Wang et al., 1999; Brown et al., 2000), and (2) inhibit the serine-threonine kinase, glycogen synthase kinase 3/ (GSK3/) (Chen et al., 1999a; Tatebayashi et al., 2004). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the molecular mechanisms by which valproate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "protects"

Phrase: "cells from ER stress-induced dysfunction"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0229606:Reticulum cell [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the previously reported capacity of this molecule to (1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1516240:Capacity [Quantitative Concept]

Phrase: ")"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular ER chaperone levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Wang et al.,"

Phrase: "1999"

Phrase: "; Brown et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "and ("

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the serine-threonine kinase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
  1000   C1414387:serine/threonine kinase [Gene or Genome]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase 3/ (GSK3/)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Chen et al.,"

Phrase: "1999a"

Phrase: "; Tatebayashi et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.43: Our results clearly show that, although valproate can increase intracellular protein levels of ER chaperones in HepG2 cells, the protection against ER stress-induced cellular dysfunction occurs as a result of GSK3 inhibition. 

Phrase: "Our results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "although"

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular protein levels of ER chaperones"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   745   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in HepG2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the protection against ER stress-induced cellular dysfunction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1545588:Protection [Finding]

Phrase: "occurs as a result of GSK3 inhibition."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   748   C2825142:Result [Finding]
   748   C3463820:Inhibition [Activity]
Processing 00000000.tx.44: We propose that the strategy of protecting cells from ER stress-associated complications with small molecule drugs may be useful in the treatment of disorders associated with ER dysfunction.  

Phrase: "We"

Phrase: "propose"

Phrase: "that"

Phrase: "the strategy of protecting cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679199:strategy [Mental Process]

Phrase: "from ER stress-associated complications"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0009566:Complications [Pathologic Function]
   804   C1171258:complications [Pathologic Function]
   771 E C2362589:Complication [Idea or Concept]
   721 E C0231242:Complicated [Functional Concept]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "with small molecule drugs"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734   C1328819:Small Molecule [Organic Chemical]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "useful in the treatment of disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1524063:Use of [Functional Concept]

Phrase: "associated with ER dysfunction."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0031847:dysfunction [Functional Concept]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.45: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion References  Cell culture and treatment conditions The human hepatocarcinoma cell line, HepG2, was obtained from the American Type Culture Collection (ATCC; Rockville, Maryland, USA) and cultured in DMEM (Life Technologies, Burlington, Ontario) containing 10% fetal bovine serum. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "The human hepatocarcinoma cell line,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "HepG2,"

Phrase: "was"

Phrase: "obtained from the American Type Culture Collection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   853   C0598079:American Type Culture Collection [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0596070:American [Population Group]
   748   C1301820:Obtained [Functional Concept]
   748   C1516698:Collection [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704814:Collection [Idea or Concept]
   748   C2242979:Culture [Laboratory Procedure]
   714 E C1706701:Obtain [Activity]

Phrase: "(ATCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]

Phrase: "; Rockville,"

Phrase: "Maryland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024858:Maryland [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "cultured in DMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Burlington,"

Phrase: "Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
Processing 00000000.tx.46: Cells were maintained in a humidified incubator at 37C with 5% CO2. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in a humidified incubator"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0021178:Incubator [Manufactured Object]
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "at 37C"

Phrase: "with 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.47: Sodium valproate, A23187, tunicamycin, glucosamine, H2O2 and filipin were purchased from Sigma (Oakville, Ontario). 

Phrase: "Sodium valproate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0037567:Sodium Valproate [Lipid,Pharmacologic Substance]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "A23187,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "tunicamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "glucosamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "filipin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016095:Filipin [Antibiotic,Organic Chemical]

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(Oakville,"

Phrase: "Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: ")."
Processing 00000000.tx.48: GSK inhibitor II, 3-(3-carboxy-4-chloroanilino)-4-(3-nitrophenyl) maleimide, was purchased from CalBiochem (La Jolla, California, USA). 

Phrase: "GSK inhibitor II,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0206354:Glycogen Synthase Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(3-carboxy-4-chloroanilino"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0442757:3 4 [Finding]

Phrase: ")-"

Phrase: "4-"

Phrase: "(3-nitrophenyl"

Phrase: ")"

Phrase: "maleimide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024579:maleimide [Organic Chemical]
  1000   C0065573:Maleimide [Organic Chemical]

Phrase: "was"

Phrase: "purchased from CalBiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "California,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006754:California [Geographic Area]
  1000   C3146274:California [Plant]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.49: All compounds were prepared fresh in culture medium, sterilized by filtration and added to the cell cultures. 

Phrase: "All compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "fresh in culture medium,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443224:Fresh [Qualitative Concept]
   770   C2827486:Fresh [Body Substance]

Phrase: "sterilized by filtration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016107:filtration [Laboratory Procedure]
   756   C0038280:Sterilize [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "added to the cell cultures."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0007585:Cell Cultures [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0010453:Cultures [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1524062:Added [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C1883712:Add [Functional Concept]
   726 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.50: Cell death assays HepG2 cells were pretreated with 0 or 0.5 mM valproate for 18 hours after which cells were washed and cultured in DMEM without serum. 

Phrase: "Cell death assays HepG2 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C2717940:HepG2 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "pretreated with 0"

Phrase: "or"

Phrase: "0.5 mM valproate for 18 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "after which cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "cultured in DMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "without serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.51: Cells were then challenged with 0 to 10 M A23187 or 0 to 10 g/ml tunicamycin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "to 10 M A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "or"

Phrase: "0 to 10 g/ml tunicamycin."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.52: After 6 hours, media were removed from each well and lactate dehydrogenase (LDH) activity was determined using a cytotoxicity assay kit (Roche Diagnostic, Laval, Quebec). 

Phrase: "After 6 hours,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "removed from each well"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C0849355:Removed [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "lactate dehydrogenase (LDH) activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151154:lactate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cytotoxicity assay kit (Roche Diagnostic, Laval,"

Phrase: "Quebec"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034390:Quebec [Geographic Area]

Phrase: ")."
Processing 00000000.tx.53: Total LDH activity was determined by lysing cells with 0.5% Triton X-100 prior to media sampling. 

Phrase: "Total LDH activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1151154:lactate dehydrogenase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by lysing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0024348:lysing [Pathologic Function]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with 0.5% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "prior to media sampling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441621:Sampling [Diagnostic Procedure]
   861   C0870078:Sampling [Idea or Concept]
Processing 00000000.tx.54: To monitor caspase 3 activation, HepG2 cells were cultured and challenged with ER stress agents as described above. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "caspase 3 activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "challenged with ER stress agents"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0038435:Stress [Finding]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C0798503:Challenge [Clinical Attribute]
   719   C0805586:Challenge [Health Care Activity]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]
   719   C3274764:Challenge [Conceptual Entity]

Phrase: "as described above."
Processing 00000000.tx.55: After 6 hours, cells were harvested, lysed and cell lysates were assayed for caspase 3 activity using the colorimetric CaspACE Assay System (Promega, Madison, Wisconsin). 

Phrase: "After 6 hours,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "assayed for caspase 3 activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C1150132:caspase-3 activity [Molecular Function]
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   797   C1150130:caspase activity [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the colorimetric CaspACE Assay System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "Wisconsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:Wisconsin [Geographic Area]

Phrase: ")."
Processing 00000000.tx.56: Free-cholesterol staining The accumulation of free cholesterol was determined by filipin staining (Kruth, 1984). 

Phrase: "Free-cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0368909:Free cholesterol [Biologically Active Substance,Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "The accumulation of free cholesterol"

Phrase: "was"

Phrase: "determined by filipin staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016095:Filipin [Antibiotic,Organic Chemical]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "(Kruth,"

Phrase: "1984"

Phrase: ")."
Processing 00000000.tx.57: HepG2 cells, grown on coverslips, were treated with 0.5 mM valproate, 5 mM lithium or 20 M GSK3 inhibitor II for 2 hours and then challenged with A23187 (5 M), tunicamycin (2 g/ml) or glucosamine (5 mM) for an additional 18-24 hours. 

Phrase: "HepG2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "grown on coverslips,"

Phrase: "were"

Phrase: "treated with 0.5 mM valproate,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0444499:0/5 [Quantitative Concept]
   753   C0080356:Valproate [Lipid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "5 mM lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "20 M GSK3 inhibitor II for 2 hours"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with A23187"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0878412:A23187 [Antibiotic,Organic Chemical]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(2 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "(5 mM) for an additional 18-24 hours."
Processing 00000000.tx.58: Cells were washed three times with Medium 1 (150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 20 mM HEPES pH 7.4, 2 g/l glucose), fixed with 3% paraformaldehyde and then incubated for 2 hours at room temperature with 50 g/ml filipin in Medium 1. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with Medium 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "(150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM KCl,"

Phrase: "1 mM CaCl2,"

Phrase: "20 mM HEPES pH 7.4,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C2678549:PH-4 [Gene or Genome]
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]

Phrase: "2 g/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "fixed with 3% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 2 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439227:hours [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with 50 g/ml filipin in Medium 1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   877   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   818   C1300565:g/mL [Quantitative Concept]
   795   C0009458:Medium [Intellectual Product]
   795   C0016095:Filipin [Antibiotic,Organic Chemical]
   795   C0439267:g% [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   795   C0439536:Medium [Quantitative Concept]
   795   C1705217:Medium [Substance]
   795   C3244283:medium [Intellectual Product]
Processing 00000000.tx.59: Cells were again washed three times with Medium 1 and then filipin-free cholesterol complexes were visualized by fluorescence microscopy with excitation at 335-385 nm (emission at 420 nm). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "again"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with Medium 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "then filipin-free cholesterol complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "visualized by fluorescence microscopy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]

Phrase: "with excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "at 335-385 nm (emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0233929:Emission [Body Substance]
   812   C2349995:Emission [Substance]

Phrase: "at 420 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.60: Relative fluorescence was quantified using Sigma Scan Pro software and results were normalized to total cell area. 

Phrase: "Relative fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sigma Scan Pro software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "normalized to total cell area."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0007634:Cell [Cell]
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1882115:Normalized [Research Activity]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.61: Analysis of protein synthesis HepG2 cells were pretreated with 0.5 mM valproate for 48 hours and then challenged with 0-10 g/ml tunicamycin or 0-10 M A23187. 

Phrase: "Analysis of protein synthesis HepG2 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1514534:Protein Analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "pretreated with 0.5 mM valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "for 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with 0-10 g/ml tunicamycin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0439267:g% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   714   C0798503:Challenge [Clinical Attribute]
   714   C0805586:Challenge [Health Care Activity]
   714   C3274764:Challenge [Conceptual Entity]

Phrase: "or"

Phrase: "0-10 M A23187."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.62: Cells were washed in 1xPBS, transferred into methionine/cysteine-free DMEM for 30 minutes then labeled with Express Mix [35S]Met/Cys (100 Ci/ml; 1000 Ci/mmol; Perkin Elmer, Boston, Massachusetts) for 30 minutes. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed in 1xPBS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "transferred into methionine/cysteine-free DMEM"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   783   C2927891:Cysteine / Methionine [Pharmacologic Substance]
   753   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0332296:free [Functional Concept]
   753   C0348011:transferred [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "for 30 minutes then"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0456693:/30 minutes [Temporal Concept]
   901   C1442458:30 Minutes [Temporal Concept]
   827   C0439232:minute [Temporal Concept]
   827   C0700321:minute [Quantitative Concept]
   827   C0702093:/minute [Temporal Concept]
   827   C1282918:Minute [Quantitative Concept]
   827   C2347166:Minute [Quantitative Concept]

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "Express"

Phrase: "Mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205430:Mix [Functional Concept]
  1000   C1421951:MIX [Gene or Genome]
  1000   C1720722:Mix [Qualitative Concept]

Phrase: "[35S"

Phrase: "]Met/Cys (100 Ci/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2348025:Ci/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "; 1000 Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "; Perkin Elmer,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024874:Massachusetts [Geographic Area]

Phrase: ")"

Phrase: "for 30 minutes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0456693:/30 minutes [Temporal Concept]
  1000   C1442458:30 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.63: After washing with PBS, cell extracts were prepared and analyzed by SDS-PAGE. 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "with PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "analyzed by SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.64: Northern blot analysis Total RNA was isolated from cultured cells using the RNeasy total RNA kit (Qiagen, Mississauga, Ontario) and resuspended in diethyl pyrocarbonate-treated water. 

Phrase: "Northern blot analysis Total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0005861:Northern blot analysis [Molecular Biology Research Technique]

Phrase: "was"

Phrase: "isolated from cultured cells"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0370215:Isolate [Substance]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the RNeasy total RNA kit (Qiagen,"

Phrase: "Mississauga,"

Phrase: "Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "resuspended in diethyl pyrocarbonate-treated water."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0012186:Diethyl Pyrocarbonate [Organic Chemical,Pharmacologic Substance]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0212509:pyrocarbonate [Organic Chemical]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C1522326:Treated [Functional Concept]
   753   C1550678:Water [Inorganic Chemical]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.65: Quantification and purity of the RNA was assessed by A260/A280 absorption, and RNA samples with ratios above 1.6 were stored at 70C for further analysis. 

Phrase: "Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "purity of the RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882508:Purity [Quantitative Concept]

Phrase: "was"

Phrase: "assessed by A260/A280 absorption,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0000854:Absorption [Natural Phenomenon or Process]
   760   C0220777:absorption [Functional Concept]
   760   C1516048:Assessed [Activity]
   760   C1706688:A260 [Molecular Biology Research Technique]
   760   C1706689:A280 [Molecular Biology Research Technique]
   760   C2347023:Absorption [Phenomenon or Process]
   760   C2347080:Absorption [Phenomenon or Process]
   760   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   760   C2825050:Absorption [Phenomenon or Process]

Phrase: "and"

Phrase: "RNA samples with ratios"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "above 1.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "were"

Phrase: "stored at 70C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "for further analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.66: Total RNA (10 g/lane) was size-fractionated on 2.2 M formaldehyde/1.2% agarose gels, transferred to Zeta-Probe GT nylon membranes (BioRad Laboratories, Toronto, Ontario) and hybridized using radiolabeled cDNA probes as described previously (Outinen et al., 1999). 

Phrase: "Total RNA (10 g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "size-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "on 2.2 M formaldehyde/1.2% agarose gels,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   795   C1706746:Agarose Gel [Research Device]
   793   C0017243:Gels [Biomedical or Dental Material]
   760 E C1382104:Gel [Substance]

Phrase: "transferred to Zeta-Probe GT nylon membranes"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   748   C0025255:Membranes [Tissue]
   748   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   748   C0182400:Probe [Medical Device]
   748   C0348011:transferred [Functional Concept]
   748   C0740034:Nylon [Biomedical or Dental Material]
   748   C1704681:Probe [Gene or Genome]
   748   C1719914:Zeta [Intellectual Product]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C2828406:Zeta [Eukaryote]
   748   C3536729:Probe [Manufactured Object]
   714 E C0040671:Transfer [Mental Process]
   714 E C0596901:Membrane [Cell Component]
   714 E C1705822:Transfer [Activity]
   714 E C1706182:Membrane [Manufactured Object]

Phrase: "(BioRad Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Toronto,"

Phrase: "Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "hybridized"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "radiolabeled cDNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Outinen et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.67: Signal intensities were quantified by densitometric scanning of the autoradiograms using the ImageMaster VDS and Analysis Software (Amersham Pharmacia Biotech, Baie d'Urf, Qubec) or using a Typhoon 9410 phosphoimaging system. 

Phrase: "Signal intensities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0871362:signal intensity [Quantitative Concept]
   861   C0522510:intensities [Qualitative Concept]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantified by densitometric scanning of the autoradiograms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0011321:densitometric scanning [Laboratory Procedure]
   748   C0034606:Scanning [Diagnostic Procedure]
   748   C0441633:Scanning [Diagnostic Procedure]
   714   C1709793:Quantify [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ImageMaster VDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036916:vds [Disease or Syndrome]
   861   C0042682:VDS [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Analysis Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Baie"

Phrase: "d'"

Phrase: "Urf,"

Phrase: "Qubec"

Phrase: ")"

Phrase: "or"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Typhoon 9410 phosphoimaging system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.68: To correct for differences in gel loading, integrated optical densities were normalized to human glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 

Phrase: "To correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for differences in gel loading,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708715:Loading [Activity]

Phrase: "integrated optical densities"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   867   C0439164:Optical density [Quantitative Concept]
   867   C1268822:Optical density [Clinical Attribute]
   827   C0178587:densities [Quantitative Concept]
   771   C0042789:Vision [Organism Function]
   771   C2707266:Vision [Clinical Attribute]
   755   C1158478:Integration [Genetic Function]
   755   C1705422:Integration [Machine Activity]
   743 E C0439794:Dense [Qualitative Concept]

Phrase: "were"

Phrase: "normalized to human glyceraldehyde 3-phosphate dehydrogenase (GAPDH)."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   853   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   804   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   748   C0017854:Glyceraldehyde [Carbohydrate]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0086418:Human [Human]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C1882115:Normalized [Research Activity]
Processing 00000000.tx.69: The ERdj4 cDNA probe was purchased from ATCC (IMAGE 1920927). 

Phrase: "The ERdj4 cDNA probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "purchased from ATCC (IMAGE 1920927"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0598079:ATCC [Intellectual Product]
   760   C0869011:purchased [Activity]
   760   C1704254:Image [Intellectual Product]
   760   C1704922:Image [Entity]
   760   C3542466:Image [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.70: The cDNA probes encoding GRP78/BiP or GADD153/CHOP have been described previously (Outinen et al., 1999). 

Phrase: "The cDNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "GRP78/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "or"

Phrase: "GADD153/CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945739:chop [Activity]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Outinen et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.71: Immunoblot analysis Antibodies to calreticulin (SPA-600) and the anti-KDEL monoclonal antibody (SPA-827), which recognizes GRP78/BiP, HSP47 and GRP94, were purchased from StressGen Biotechnologies (Victoria, British Columbia). 

Phrase: "Immunoblot analysis Antibodies to calreticulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(SPA-600"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420002:SPA [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "the anti-KDEL monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(SPA-827"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420002:SPA [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "recognizes"

Phrase: "GRP78/BiP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "HSP47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413153:HSP47 [Gene or Genome]

Phrase: "and"

Phrase: "GRP94,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0120372:GRP94 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1825546:GRP94 [Gene or Genome]

Phrase: "were"

Phrase: "purchased from StressGen Biotechnologies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005574:Biotechnologies [Biomedical Occupation or Discipline]
   770   C0869011:purchased [Activity]

Phrase: "(Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "British Columbia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0006193:British Columbia [Geographic Area]
   861   C1551442:Columbia [Population Group]
   861   C3245499:Columbia [Health Care Related Organization]
   789 E C1551955:Columbian [Language]

Phrase: ")."
Processing 00000000.tx.72: Anti-GADD153/CHOP (sc-575), anti-eIF2 (sc-7629) and anti-ATF4 (sc-200) polyclonal antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, California). 

Phrase: "Anti-GADD153/CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2945739:chop [Activity]

Phrase: "(sc-575"

Phrase: ")"

Phrase: ","

Phrase: "anti-eIF2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439095:Alpha [Intellectual Product]
   799   C0589507:Initiation [Mental Process]
   799   C1158830:Initiation [Genetic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1704686:Initiation [Functional Concept]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "(sc-7629"

Phrase: ")"

Phrase: "and"

Phrase: "anti-ATF4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412617:ATF4 [Gene or Genome]

Phrase: "(sc-200"

Phrase: ")"

Phrase: "polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Santa Cruz Biotechnology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "(Santa Cruz,"

Phrase: "California"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006754:California [Geographic Area]
  1000   C3146274:California [Plant]

Phrase: ")."
Processing 00000000.tx.73: Antibodies against the phosphorylated form of eIF2 (RG0001) were purchased from ResGen (Huntsville, Alabama). 

Phrase: "Antibodies against the phosphorylated form of eIF2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   704 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(RG0001"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from ResGen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Huntsville,"

Phrase: "Alabama"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001895:Alabama [Geographic Area]
  1000   C1551894:Alabama [Language]
  1000   C2825084:Alabama [Eukaryote]

Phrase: ")."
Processing 00000000.tx.74: Anti- actin (AC-15) antibodies were purchased from Sigma. 

Phrase: "Anti- actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "(AC-15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.75: Total protein lysates (40 g/ml) from cultured cells were solubilized in SDS-PAGE sample buffer and separated on SDS-polyacrylamide gels under reducing conditions. 

Phrase: "Total protein lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1881488:Lysate [Physical Object]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "(40 g/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1955160:40 g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) from cultured cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C2699156:Cells/mL [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "solubilized in SDS-PAGE sample buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0370003:Sample [Substance]
   753   C1704732:Page [Intellectual Product]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "separated on SDS-polyacrylamide gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726 E C1382104:Gel [Substance]

Phrase: "under reducing conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.76: After incubation with the appropriate primary and horseradish peroxidase (HRP)-conjugated secondary antibodies (Life Technologies, Burlington, Ontario), the membranes were developed using the SuperSignal chemiluminescent substrate (Pierce, Rockford, Illinois). 

Phrase: "After incubation"

Phrase: "with the appropriate primary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "horseradish peroxidase (HRP)-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Burlington,"

Phrase: "Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SuperSignal chemiluminescent substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "Illinois"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020898:Illinois [Geographic Area]

Phrase: ")."
Processing 00000000.tx.77: GSK3 Activity GSK3 was immunoprecipitated from freshly prepared HepG2 lysates with antibodies directed against the alpha (5 g, Upstate Biotech, Charlottesville, Virginia) or beta (2 g, BD Bioscience, Mississauga, Ontario) using a Catch and Release IP Kit (UpState). 

Phrase: "GSK3 Activity GSK3"

Phrase: "was"

Phrase: "immunoprecipitated from freshly prepared HepG2 lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719   C1881488:Lysate [Physical Object]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the alpha"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439095:Alpha [Intellectual Product]
   770   C2003941:Alpha [Intellectual Product]
   770   C2350010:Alpha [Qualitative Concept]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "(5 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Upstate Biotech,"

Phrase: "Charlottesville,"

Phrase: "Virginia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042753:Virginia [Geographic Area]
  1000   C1256310:Virginia [Reptile]

Phrase: ")"

Phrase: "or"

Phrase: "beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0330390:Beta [Plant]
  1000   C0439096:Beta [Intellectual Product]
  1000   C2004068:Beta [Qualitative Concept]

Phrase: "(2 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "BD Bioscience,"

Phrase: "Mississauga,"

Phrase: "Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Catch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231617:Catch [Sign or Symptom]

Phrase: "and"

Phrase: "Release IP Kit (UpState"

Phrase: ")."
Processing 00000000.tx.78: The immobilized immune complexes were washed twice with lysis buffer (1% NP40, 0.25% deoxycholic acid, pH 7.4) and once with 4x kinase buffer (8 mM MOPS, 0.2 mM EDTA, 10 mM Magnesium acetate, pH 7.4) before elution. 

Phrase: "The immobilized immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439662:Immune [Functional Concept]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with lysis buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "(1% NP40,"

Phrase: "0.25% deoxycholic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011479:Deoxycholic Acid [Biologically Active Substance,Pharmacologic Substance,Steroid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "once with 4x kinase buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1720092:Once [Intellectual Product]
   760   C1948045:Once [Temporal Concept]

Phrase: "(8 mM MOPS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0740123:8-MOP [Organic Chemical,Pharmacologic Substance]
   827   C0066823:MOPS [Organic Chemical]
   827   C1271466:Mops [Mammal]

Phrase: "0.2 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "10 mM Magnesium acetate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0982266:magnesium acetate [Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "before"

Phrase: "elution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]
Processing 00000000.tx.79: Kinase activity was measured by adding 15 M substrate (phosphoglycogen synthase peptide-2, pGS-2; Upstate) and 0.5 Ci/l [-32P]ATP to recombinant or immunoprecipitated GSK3/ (New England Biolabs and UpState Biotech) in a reaction mixture containing 20 mM MOPS, 50 M EDTA, 0.25 mM Mg acetate, 5 mM MgCl2, 5 mM -glycerol phosphate, 1 mM EGTA, 0.25 mM Na3VO4, 0.25 mM DTT and 35 M ATP in a total volume of 40 l. 

Phrase: "Kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by adding 15 M substrate"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   783   C0168944:M 15 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0444706:Measured [Qualitative Concept]
   753   C1710236:Substrate [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1883712:Add [Functional Concept]

Phrase: "(phosphoglycogen synthase peptide-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "pGS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031619:PGS [Lipid]
   861   C0796254:PGS [Disease or Syndrome]

Phrase: "; Upstate"

Phrase: ")"

Phrase: "and"

Phrase: "0.5 Ci/l [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1553631:32p [Medical Device]

Phrase: "]ATP to recombinant"

Phrase: "or"

Phrase: "immunoprecipitated GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: "and"

Phrase: "UpState Biotech"

Phrase: ")"

Phrase: "in a reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mM MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0066823:MOPS [Organic Chemical]
   827   C1271466:Mops [Mammal]

Phrase: "50 M EDTA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1831960:M-EDTA [Organic Chemical,Pharmacologic Substance]
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.25 mM Mg acetate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5 mM -glycerol phosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.25 mM Na3VO4,"

Phrase: "0.25 mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "35 M ATP in a total volume of 40 l."
Processing 00000000.tx.80: Lithium (0-20 mM) or valproate (0-5 mM) was added to GSK3 before the substrate and ATP were added. 

Phrase: "Lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(0-20 mM)"

Phrase: "or"

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "(0-5 mM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "was"

Phrase: "added to GSK3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "before the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "ATP"

Phrase: "were"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.81: After 30 minutes at 30C samples were placed on ice, then spotted onto Whatman P81 phosphocellulose paper and washed three times with 0.75% o-phosphoric acid and once with acetone. 

Phrase: "After 30 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0456693:/30 minutes [Temporal Concept]
  1000   C1442458:30 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at 30C samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "placed on ice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "spotted onto Whatman P81 phosphocellulose paper"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0030351:Paper [Manufactured Object]
   753   C0059973:p81 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0070824:phosphocellulose [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1547566:Paper [Idea or Concept]
   719   C0329155:Spot [Fish]
   719   C1427618:SPOT [Gene or Genome]
   719   C1705203:Spot [Conceptual Entity]

Phrase: "and"

Phrase: "washed three times with 0.75% o-phosphoric acid"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0040223:times [Temporal Concept]
   742   C1632851:Times [Quantitative Concept]
   708 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "once with acetone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   790   C1720092:Once [Intellectual Product]
   790   C1948045:Once [Temporal Concept]
Processing 00000000.tx.82: 32P incorporation onto the substrate was determined by scintillation counting and total counts minus background were normalized to the total protein concentration of each cell lysates before immunoprecipitation. 

Phrase: "32P incorporation onto the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "determined by scintillation counting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "total counts minus background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]

Phrase: "were"

Phrase: "normalized to the total protein concentration of each cell lysates"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   760   C0427716:Protein concentration [Laboratory Procedure]
   760   C0555903:Total protein [Laboratory Procedure]
   760   C1261360:total protein [Laboratory or Test Result]
   760   C1304757:Protein concentration [Laboratory or Test Result]
   757 E C0439177:Protein.total [Quantitative Concept]
   743   C1881488:Cell Lysate [Physical Object]
           Lysate
   739   C0007634:Cell [Cell]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086045:Concentration [Mental Process]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C1269647:Cell [Cell]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1704653:Cell [Medical Device]
   739   C1882115:Normalized [Research Activity]
   739   C1948049:Cell [Spatial Concept]

Phrase: "before immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.83: Statistical analysis Results are presented as the means.d. 

Phrase: "Statistical analysis Results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "are"

Phrase: "presented as the means.d."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.84: Significant differences in treatment groups were determined using the unpaired Student's t-test. 

Phrase: "Significant differences in treatment groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the unpaired Student's t-test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1710574:Unpaired t-Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0038492:student [Professional or Occupational Group]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C1551041:student [Idea or Concept]
   812   C1552573:student [Intellectual Product]
Processing 00000000.tx.85: For all analyses, P<0.05 was considered statistically significant.  

Phrase: "For all analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.86: Results Top Summary Introduction Materials and Methods Results Discussion References  Exposure to valproate can protect HepG2 cells from ER stress-induced apoptosis The use of valproate as an anti-convulsant or anti-epileptic drug has been associated with hepatotoxicity in humans (Suchy et al., 1979). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Exposure to valproate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "can"

Phrase: "protect"

Phrase: "HepG2 cells from ER stress-induced apoptosis"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C2717940:HepG2 Cells [Cell]
   750   C0229606:Reticulum cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   703   C2610698:endoplasmic reticulum stress-induced apoptosis [Cell Function]

Phrase: "The use of valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "as an anti-convulsant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009950:convulsant [Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "anti-epileptic drug"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C3537002:Anti-epileptic Drug [Pharmacologic Substance]
           Anti-epileptic
   901   C0003299:Anti-epileptic [Pharmacologic Substance]
   827   C0013227:Drug [Pharmacologic Substance]
   827   C0014544:Epileptic [Disease or Syndrome]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "associated with hepatotoxicity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0235378:Hepatotoxicity [Injury or Poisoning]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(Suchy et al.,"

Phrase: "1979"

Phrase: ")."
Processing 00000000.tx.87: The mood-stabilizing effects of valproate occur at plasma concentrations over 0.35 mM and toxicity is observed at concentrations over 1.4 mM (Bowden et al., 1994; McElroy and Keck, 1995). 

Phrase: "The mood-stabilizing effects of valproate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0026516:Mood [Mental Process]
   753   C0184512:stabilizing [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   753   C2713234:Mood [Clinical Attribute]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "occur at plasma concentrations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0683150:concentrations plasma [Quantitative Concept]
   770   C0032105:Plasma [Body Substance]
   770   C0086045:Concentrations [Mental Process]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "over 0.35 mM"

Phrase: "and"

Phrase: "toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "is"

Phrase: "observed at concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0086045:Concentrations [Mental Process]
   790   C1441672:Observed [Functional Concept]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "over 1.4 mM (Bowden et al.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C0556650:mm Al [Quantitative Concept]

Phrase: "1994"

Phrase: "; McElroy"

Phrase: "and"

Phrase: "Keck,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.88: We first investigated the cytotoxic properties of valproate in HepG2 cells (Fig. 1A). 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the cytotoxic properties of valproate"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.89: Concentrations of valproate between 0.25-2.0 mM had no cytotoxic effect on HepG2. 

Phrase: "Concentrations of valproate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "between 0.25-2.0 mM"

Phrase: "had"

Phrase: "no cytotoxic effect on HepG2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1301751:No effect [Qualitative Concept]
   760   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   760   C1280500:Effect [Qualitative Concept]
   760   C1511636:cytotoxic [Functional Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.90: Growth and proliferation of HepG2 cells were not significantly affected by concentrations of valproate below 2 mM (data not shown). 

Phrase: "Growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "proliferation of HepG2 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0596290:Cell Proliferation [Cell Function]
   770   C0334094:Proliferation [Pathologic Function]
   770   C1514485:Proliferation [Functional Concept]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affected by concentrations of valproate"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0080356:Valproate [Lipid,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "below 2 mM (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.93: Pretreatment with low concentrations of valproate increases resistance to ER stress-induced cell death. 

Phrase: "Pretreatment with low concentrations of valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "resistance to ER stress-induced cell death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0237834:Resistance [Mental Process]
   744   C1514892:Resistance [Physiologic Function]
   735   C0332325:Resistant to [Functional Concept]
Processing 00000000.tx.94: (A) HepG2 cells were cultured in the presence of various concentrations of valproate as indicated. 

Phrase: "(A) HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2717940:HepG2 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in the presence of various concentrations of valproate"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0080356:Valproate [Lipid,Pharmacologic Substance]
   742   C0086045:Concentrations [Mental Process]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   708   C0010453:Culture [Idea or Concept]
   708   C0220814:culture [Functional Concept]
   708   C0430400:Culture [Laboratory Procedure]
   708 E C1446561:Concentration [Quantitative Concept]
   708   C2242979:Culture [Laboratory Procedure]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.95: Lactate dehydrogenase (LDH) activity was determined in media after 48 hours. 

Phrase: "Lactate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "(LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "after 48 hours."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.96: The plot represents LDH released after exposure to valproate as a percentage of the total LDH activity recovered from control cells lysed with 0.5% Triton X-100. 

Phrase: "The plot"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "released after exposure"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "to valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "as a percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "of the total LDH activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1151154:lactate dehydrogenase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "recovered from control cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C0521108:recovered [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2004454:recover [Organism Function]

Phrase: "lysed with 0.5% Triton X-100."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   778   C0444499:0/5 [Quantitative Concept]
   748   C0024348:lysed [Pathologic Function]
   748   C0242759:Triton [Geographic Area]
Processing 00000000.tx.97: Data are presented as the means.d. of three separate experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the means.d. of three separate experiments."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   742   C0205449:Three [Quantitative Concept]
   742   C0443299:Separate [Spatial Concept]
   742   C0449450:Presented [Idea or Concept]
   742   C0681814:Experiments [Research Activity]
   742   C1704970:Means [Conceptual Entity]
   708 E C0150312:Present [Quantitative Concept]
   708 E C0444504:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
   708 E C2347634:Mean [Quantitative Concept]
   708 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.98: (B) LDH release assay measuring cell death in HepG2 cells pretreated with 0 mM () or 0.5 mM () valproate for 18 hours and then exposed for 6 hours to the calcium ionophore, A23187 (0-10 M), tunicamycin (0-40 g/ml) or H2O2 (0-0.5%) as indicated. 

Phrase: "(B) LDH release assay measuring cell death in HepG2 cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0007587:Cell Death [Cell Function]
           cells death
   754   C0004561:B-cell [Cell]
   754   C2717940:HepG2 Cell [Cell]
   738   C0007634:Cell [Cell]
   738   C0011065:Death [Organism Function]
   738   C1269647:Cell [Cell]
   738   C1306577:Death, NOS [Finding]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]

Phrase: "pretreated with 0 mM ()"

Phrase: "or"

Phrase: "0.5 mM () valproate for 18 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed for 6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332157:Exposed [Clinical Attribute]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "to the calcium ionophore,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0022022:Ionophore [Pharmacologic Substance]
   861   C1517596:ionophore [Molecular Function]

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "(0-10"

Phrase: "M)"

Phrase: ","

Phrase: "tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(0-40 g/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1955160:40 g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(0-0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.99: Results are expressed as the percentage of the total LDH present in untreated cells and depicted as means.d. from three separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the percentage of the total LDH present"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   777   C1441401:Lactate dehydrogenase.total [Laboratory or Test Result]
   760   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0022924:lactate [Organic Chemical]
   739   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0150312:Present [Quantitative Concept]
   739   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   739   C0439165:Percentage [Quantitative Concept]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0449450:Present [Idea or Concept]
   739   C1549488:Percentage [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]

Phrase: "in untreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "depicted as means.d."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "from three separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.100: *P<0.01 when compared to levels in the corresponding controls. 

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared to levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0441889:Levels [Qualitative Concept]
   790   C1707455:Compared [Activity]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the corresponding controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.101: (C) Determination of caspase 3 activation in HepG2 cells pretreated for 18 hours in the absence or presence of 0.5 mM valproate and then exposed to 0 or 20 mg/ml tunicamycin for 6 hours as indicated. 

Phrase: "(C) Determination of caspase 3 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated for 18 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1442448:18 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 0.5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to 0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed

Phrase: "or"

Phrase: "20 mg/ml tunicamycin for 6 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.102: Hatched bars represent cells that were treated with the caspase 3 inhibitor, Z-VAD, in addition to tunicamycin. 

Phrase: "Hatched bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "treated with the caspase 3 inhibitor,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   753   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1522326:Treated [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "Z-VAD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0077973:VAD [Therapeutic or Preventive Procedure]

Phrase: "in addition to tunicamycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.103: Caspase 3 activity was determined in the cell lysates and normalized to total protein concentrations. 

Phrase: "Caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "determined in the cell lysates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "normalized to total protein concentrations."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0555903:Total protein [Laboratory Procedure]
   806   C1261360:total protein [Laboratory or Test Result]
   797 E C0439177:Protein.total [Quantitative Concept]
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1882115:Normalized [Research Activity]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.104: Data are presented as the means.d. of three separate experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the means.d. of three separate experiments."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   742   C0205449:Three [Quantitative Concept]
   742   C0443299:Separate [Spatial Concept]
   742   C0449450:Presented [Idea or Concept]
   742   C0681814:Experiments [Research Activity]
   742   C1704970:Means [Conceptual Entity]
   708 E C0150312:Present [Quantitative Concept]
   708 E C0444504:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
   708 E C2347634:Mean [Quantitative Concept]
   708 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.105: *P<0.01 when compared to the activity in the corresponding control.  

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared to the activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   770   C1707455:Compared [Activity]

Phrase: "in the corresponding control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.106: Our previous studies, and those of other labs, have demonstrated that ER stress-inducing agents can cause cellular dysfunction including apoptosis and disrupted lipid metabolism (Ng et al., 2000; Shank et al., 2001; Werstuck et al., 2001; Hossain et al., 2003). 

Phrase: "Our previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "those of other labs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0587081:Labs [Finding]
   737 E C0022877:Lab [Manufactured Object,Organization]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that ER stress-inducing agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   771   C0450442:Agent [Chemical Viewed Functionally]
   771   C1254351:Agent [Pharmacologic Substance]
   771   C1521826:Agent [Intellectual Product]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cellular dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "disrupted lipid metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0598783:Lipid Metabolism [Molecular Function]
   901   C1517898:Lipid Metabolism [Molecular Function]
   827   C0023779:Lipid [Lipid]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "(Ng et al.,"

Phrase: "2000"

Phrase: "; Shank et al.,"

Phrase: "2001"

Phrase: "; Werstuck et al.,"

Phrase: "2001"

Phrase: "; Hossain et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.107: It has been suggested that the physiological benefits of valproate in individuals with bipolar disease and epilepsy may result from neural protective properties of this drug. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the physiological benefits of valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814225:Benefits [Quantitative Concept]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with bipolar disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "epilepsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014544:Epilepsy [Disease or Syndrome]

Phrase: "may"

Phrase: "result from neural protective properties of this drug."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   767   C0033613:Protective drug [Pharmacologic Substance]
   744   C0013227:Drug [Pharmacologic Substance]
   744   C0599851:Neural [Functional Concept]
   744   C0871161:properties [Qualitative Concept]
   744   C1254351:Drug [Pharmacologic Substance]
   744   C1274040:Result [Functional Concept]
   744   C1292721:properties [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]
Processing 00000000.tx.108: Previous reports have suggested that valproate can have pro- or anti-apoptotic characteristics (Mora et al., 1999; Bittigau et al., 2002). 

Phrase: "Previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "can"

Phrase: "have"

Phrase: "pro-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2987124:PRO [Intellectual Product]

Phrase: "or"

Phrase: "anti-apoptotic characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521970:Characteristics [Qualitative Concept]

Phrase: "(Mora et al.,"

Phrase: "1999"

Phrase: "; Bittigau et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.109: We examined the effect of valproate treatment on cell survival in HepG2 cells exposed to agents that cause ER stress including tunicamycin and the calcium ionophore A23187. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of valproate treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   756   C0450442:Agent [Chemical Viewed Functionally]
   756   C1254351:Agent [Pharmacologic Substance]
   756   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the calcium ionophore A23187."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.110: Results show that exposure of HepG2 cells to tunicamycin or A23187 for 6 hours resulted in the dose-dependent release of lactate dehydrogenase (LDH) activity into the culture media, an indication of cytotoxicity. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that exposure of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]

Phrase: "to tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "A23187 for 6 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "resulted in the dose-dependent release of lactate dehydrogenase"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   764   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1512045:Dose-dependent [Quantitative Concept]
   742   C0022924:lactate [Organic Chemical]
   742   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0030685:Release [Health Care Activity]
   742   C0178602:Dose [Quantitative Concept]
   742   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C0851827:Dependent [Qualitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]
   742   C1283071:Release [Functional Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]
   742   C3244310:dependent [Functional Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "(LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "activity into the culture media,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "an indication of cytotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392360:indication [Idea or Concept]
   770   C3146298:Indication [Functional Concept]
Processing 00000000.tx.111: Pretreatment with 0.5 mM valproate significantly decreased the release of LDH after exposure to either ER stress agent (Fig. 1B). 

Phrase: "Pretreatment with 0.5 mM valproate significantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1550147:Pretreatment [Substance]
   748   C2709094:pre treatment [Temporal Concept]
   748   C3539075:Pretreatment [Temporal Concept]
   748   C3539076:Pretreatment [Activity]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the release of LDH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to either ER stress agent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0450442:Agent [Chemical Viewed Functionally]
   804   C1254351:Agent [Pharmacologic Substance]
   804   C1521826:Agent [Intellectual Product]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.112: The protective effect conferred by valproate appeared to be specific for ER dysfunction because pretreatment with valproate did not alter the sensitivity of HepG2 cells to oxidative stress-inducing agents such as hydrogen peroxide (H2O2) that do not cause ER stress. 

Phrase: "The protective effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "conferred by valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specific for ER dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "pretreatment with valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the sensitivity of HepG2 cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to oxidative stress-inducing agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "such as hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "ER stress."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.113: We conclude that exposure to valproate decreases the sensitivity of HepG2 cells to ER stress-induced cell death. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that exposure to valproate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the sensitivity of HepG2 cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to ER stress-induced cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   858   C0229606:Reticulum cell [Cell]
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.114: To determine if valproate specifically protects cells from ER stress-induced apoptosis we measured the activity of the pro-apoptotic cysteine protease, caspase 3, in cells challenged with tunicamycin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "valproate specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "protects"

Phrase: "cells from ER stress-induced apoptosis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   757   C0229606:Reticulum cell [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   731   C2610698:endoplasmic reticulum stress-induced apoptosis [Cell Function]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the activity of the pro-apoptotic cysteine protease,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1150124:cysteine protease activity [Molecular Function]
   767   C1150095:protease activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "caspase 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "challenged with tunicamycin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.115: HepG2 cells were incubated in the presence or absence of 0.5 mM valproate, challenged with tunicamycin (20 g/ml) for 6 hours and caspase 3 activity was determined in cell lysates. 

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of 0.5 mM valproate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "challenged with tunicamycin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "(20 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) for 6 hours"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0439391:mL/hour [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "determined"

Phrase: "in cell lysates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.116: Data indicate that valproate pretreatment had no significant effect on caspase 3 activity in unstressed HepG2 cells (Fig. 1C), a result consistent with previous findings showing that 0.5 mM valproate has no detrimental effect on HepG2 cell growth and viability (Fig. 1A,B). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that valproate pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "had"

Phrase: "no significant effect on caspase 3 activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in unstressed HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2717940:HepG2 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: ","

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "consistent with previous findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that 0.5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "has"

Phrase: "no detrimental effect on HepG2 cell growth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.117: Exposure to tunicamycin elevated the level of caspase 3 activity in control cells, indicative of an early stage of ER stress-induced apoptosis. 

Phrase: "Exposure to tunicamycin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "the level of caspase 3 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0456949:Level 3 [Intellectual Product]
   783   C0683317:Activity level [Finding]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in control cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "indicative of an early stage of ER stress-induced apoptosis."
Processing 00000000.tx.118: Caspase 3 activity was significantly attenuated in cell lysates containing the general caspase inhibitor, Z-VAD as well as in cells pretreated for up to 48 hours with 0.5 mM valproate (Fig. 1C). 

Phrase: "Caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "in cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the general caspase inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "Z-VAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0077973:VAD [Therapeutic or Preventive Procedure]

Phrase: "as well as in cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C2347578:Cells/well [Quantitative Concept]
   760   C0007634:Cells [Cell]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated for"

Phrase: "up to 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "with 0.5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.119: These findings are consistent with the results from the LDH assay and further support our hypothesis that valproate treatment increases the resistance of HepG2 cells to ER stress-induced cell death. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "from the LDH assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that valproate treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the resistance of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]

Phrase: "to ER stress-induced cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   858   C0229606:Reticulum cell [Cell]
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.120: Valproate pretreatment blocks ER stress-induced lipid accumulation We and others have demonstrated that ER stress can cause cellular dysfunction through the dysregulation of cholesterol and fatty acid metabolism in HepG2 cells (Werstuck et al., 2001; Shank et al., 2001). 

Phrase: "Valproate pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "ER stress-induced lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333574:Lipid accumulation [Finding]

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cellular dysfunction through the dysregulation of cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031847:dysfunction [Functional Concept]
   748   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "and"

Phrase: "fatty acid metabolism in HepG2 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0596563:Fatty Acid Metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: "; Shank et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.121: Specifically, we have shown that ER stress agents can activate SREBPs, and thereby increase endogenous lipid biosynthesis as well as lipid uptake resulting in the accumulation of lipids in specific cell types including HepG2s (Werstuck et al., 2001). 

Phrase: "Specifically,"

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ER stress agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "SREBPs,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C2246292:sterol binding [Molecular Function]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "thereby"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "endogenous lipid biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1563744:lipid biosynthesis [Organism Function]
   827   C0005572:biosynthesis [Functional Concept]
   827   C0220781:Biosynthesis [Biologic Function]

Phrase: "as well as"

Phrase: "lipid uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "resulting in the accumulation of lipids"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0332294:Resulting in [Functional Concept]
   767   C0333574:Lipid accumulation [Finding]
   753   C0023779:Lipids [Lipid]
   753   C0678226:resulting [Functional Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "in specific cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "HepG2s"

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.122: To determine if valproate can attenuate ER stress-induced lipid accumulation we monitored intracellular free cholesterol by staining cells with filipin (Kruth, 1984). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "can"

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "ER stress-induced lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333574:Lipid accumulation [Finding]

Phrase: "we"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "intracellular free cholesterol by staining cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0368909:Free cholesterol [Biologically Active Substance,Steroid]
   767   C1183428:Free cell [Cell]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]

Phrase: "with filipin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016095:Filipin [Antibiotic,Organic Chemical]

Phrase: "(Kruth,"

Phrase: "1984"

Phrase: ")."
Processing 00000000.tx.123: Treatment of cells with ER stress agents tunicamycin (2 g/ml), A23187 (5 M) or glucosamine (5 mM) for 24 hours significantly increased the free cholesterol content of HepG2 cells (1.9-, 1.7- and 2.6-fold, respectively; Fig. 2A,B), a result consistent with our previous findings (Werstuck et al., 2001). 

Phrase: "Treatment of cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with ER stress agents tunicamycin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "(2 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "M)"

Phrase: "or"

Phrase: "glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "(5 mM) for 24 hours significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the free cholesterol content of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "(1.9-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1.7-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2.6-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "respectively"

Phrase: "; Fig. 2A,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "consistent with our previous findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   745   C0332529:Consistency finding [Qualitative Concept]

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.124: Free cholesterol accumulation was especially evident around the nuclei of the stressed cells in what appears to be the ER membrane. 

Phrase: "Free cholesterol accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0368909:Free cholesterol [Biologically Active Substance,Steroid]

Phrase: "was"

Phrase: "especially evident around the nuclei of the stressed cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332120:Evidence of [Functional Concept]

Phrase: "in what"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the ER membrane."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]
Processing 00000000.tx.125: This observation is consistent with the increased endogenous cholesterol biosynthesis that occurs in the smooth ER. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "consistent with the increased endogenous cholesterol biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "occurs in the smooth ER."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0230789:Smooth Endoplasmic Reticulum [Cell Component]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.126: Pretreatment of HepG2 cells with valproate significantly decreased free cholesterol accumulation associated with exposure to tunicamycin and glucosamine (Fig. 2B). 

Phrase: "Pretreatment of HepG2 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with valproate significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "free cholesterol accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0368909:Free cholesterol [Biologically Active Substance,Steroid]

Phrase: "associated with exposure"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.127: Treatment with the HMG-CoA reductase inhibitor, mevastatin, also reduced ER stress-induced intracellular cholesterol accumulation. 

Phrase: "Treatment with the HMG-CoA reductase inhibitor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "mevastatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0056170:mevastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "also"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "ER stress-induced intracellular cholesterol accumulation."
Processing 00000000.tx.128: View larger version (58K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(58K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.130: Valproate blocks ER stress-induced activation of SREBP and accumulation of free cholesterol in HepG2 cells. 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "ER stress-induced activation of SREBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "accumulation of free cholesterol"

Phrase: "in HepG2 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.131: (A) Filipin staining of HepG2 cells pre-cultured for 2 hours in the presence or absence of 0.5 mM valproate and then exposed to 5 M A23187, 2 g/ml tunicamycin or 5 mM glucosamine as indicated. 

Phrase: "(A) Filipin staining of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "pre-cultured for 2 hours"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0332152:Pre [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C2257086:PRE [Genetic Function]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C0564385:/hour [Quantitative Concept]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 0.5 mM valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to 5 M A23187,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   797   C1440942:M-5 [Immunologic Factor]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "2 g/ml tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "5 mM glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.132: As a control, HepG2 cells were exposed to the HMG CoA reductase inhibitor, mevastatin (50 M) and 5 mM glucosamine as described above. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to the HMG CoA reductase inhibitor,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0360714:HMG-CoA reductase inhibitor [Organic Chemical,Pharmacologic Substance]
   853   C2756999:HMG-CoA Reductase Inhibitor [Molecular Function]
   853   C3536932:HMG-CoA Reductase Inhibitor [Pharmacologic Substance]
   814   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   778   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "mevastatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0056170:mevastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "(50"

Phrase: "M)"

Phrase: "and"

Phrase: "5 mM glucosamine as described above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.133: After 24 hours, cells were washed, fixed in paraformaldehyde and stained with filipin. 

Phrase: "After 24 hours,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "fixed in paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "stained with filipin."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0016095:Filipin [Antibiotic,Organic Chemical]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.134: Intracellular filipin-cholesterol complexes were visualized by fluorescence microscopy and images were captured with a digital camera. 

Phrase: "Intracellular filipin-cholesterol complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "visualized by fluorescence microscopy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]

Phrase: "and"

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured with a digital camera."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0179533:Camera [Medical Device]
   760   C0442015:Digital [Intellectual Product]
   760   C1654607:Camera [Eukaryote]
   760   C1706254:CAMERA [Medical Device]
   760   C1883674:Digital [Qualitative Concept]
   704 E C0016129:Finger [Body Location or Region]
   704 E C0549188:fingers [Quantitative Concept]
   704 E C1281584:Finger [Body Part, Organ, or Organ Component]
Processing 00000000.tx.135: Representative images are shown. 

Phrase: "Representative images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.136: (B) Median fluorescence of filipin-stained cells treated as described in A. 

Phrase: "(B) Median fluorescence of filipin-stained cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   721   C0303920:Fluorescent stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.137: *P<0.01 when compared with the fluorescence in the corresponding control. 

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with the fluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C1707455:Compared [Activity]

Phrase: "in the corresponding control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.138: **P<0.05 compared to the relative fluorescence under the same conditions without valproate. 

Phrase: "*"

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared to the relative fluorescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "under the same conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "without valproate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]
Processing 00000000.tx.139: (C) Immunoblot analysis of mature SREBP-2 protein levels in HepG2 cells pretreated with 0.5 mM valproate for 2 hours and then exposed to 0, 1 or 5 mM glucosamine for 24 hours as indicated. 

Phrase: "(C) Immunoblot analysis of mature SREBP-2 protein levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated with 0.5 mM valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "for 2 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292425:2 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to 0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "5 mM glucosamine for 24 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.140: Total protein lysates were resolved by SDS-PAGE, transferred to nitrocellulose membranes and immunostained with antibodies against SREBP-2.  

Phrase: "Total protein lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1881488:Lysate [Physical Object]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "were"

Phrase: "resolved by SDS-PAGE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "immunostained with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against SREBP-2."
Processing 00000000.tx.141: Immunoblot analysis shows that HepG2 cells exposed to 5 mM glucosamine have increased levels of the mature/active form of SREBP-2 (68 kDa) (Fig. 2C). 

Phrase: "Immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to 5 mM glucosamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "have"

Phrase: "increased levels of the mature/active form of SREBP-2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0456948:Level 2 [Intellectual Product]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(68 kDa) (Fig. 2C"

Phrase: ")."
Processing 00000000.tx.142: In cells pretreated with valproate, the active form of SREBP-2 is barely detectable. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated with valproate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "the active form of SREBP-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "barely detectable."
Processing 00000000.tx.143: These results suggest that valproate blocks lipid accumulation by inhibiting ER stress-induced activation of SREBPs. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "lipid accumulation by inhibiting ER stress-induced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C0333574:Lipid accumulation [Finding]

Phrase: "of SREBPs."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C2246292:sterol binding [Molecular Function]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
Processing 00000000.tx.144: Valproate induces ER chaperone expression independent of the PERK pathway We have demonstrated that overexpression of the ER-resident chaperone GRP78/ BiP can protect HepG2 cells from ER stress-induced lipid accumulation and cell death (Werstuck et al., 2001). 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "ER chaperone expression independent of the PERK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "We"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that overexpression of the ER-resident chaperone GRP78/ BiP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1514559:Overexpression [Genetic Function]

Phrase: "can"

Phrase: "protect"

Phrase: "HepG2 cells from ER stress-induced lipid accumulation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   764   C2717940:HepG2 Cells [Cell]
   745   C0229606:Reticulum cell [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.145: It has been shown that valproate can induce the expression of the ER chaperones GRP78/BiP and calreticulin in the cerebral cortex and hippocampus of the rats injected with valproate as well as in cultured rat brain glioma cells (Wang et al., 1999; Brown et al., 2000). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of the ER chaperones GRP78/BiP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "calreticulin in the cerebral cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "and"

Phrase: "hippocampus of the rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "injected with valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]
   756   C1720154:Inject [Functional Concept]

Phrase: "as well as in cultured rat brain glioma cells"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   764   C0349661:brain glioma [Neoplastic Process]
   764   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   762   C0007600:cultured cells [Cell]
   762   C0007635:Cultured Cells [Cell]
   762   C0596208:brain cells [Cell]
   762   C2347578:Cells/well [Quantitative Concept]
   762   C3282338:Cells, Cultured [Cell]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0007634:Cells [Cell]
   742   C0017638:Glioma [Neoplastic Process]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0205170:Well [Qualitative Concept]
   742   C0555198:[M]Glioma NOS [Neoplastic Process]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C2984291:Glioma [Functional Concept]
   742   C3146287:Well [Manufactured Object]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(Wang et al.,"

Phrase: "1999"

Phrase: "; Brown et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.146: To determine if valproate protects HepG2 cells from ER stress-induced apoptosis and lipid accumulation by promoting GRP78/BiP expression, we examined the ability of valproate to affect ER chaperone expression levels in these cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "protects"

Phrase: "HepG2 cells from ER stress-induced apoptosis"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C2717940:HepG2 Cells [Cell]
   750   C0229606:Reticulum cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   703   C2610698:endoplasmic reticulum stress-induced apoptosis [Cell Function]

Phrase: "and"

Phrase: "lipid accumulation by promoting GRP78/BiP expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0333574:Lipid accumulation [Finding]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ability of valproate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "ER chaperone expression levels in these cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.147: Our results indicate that exposure to 0.5 mM valproate for 48 hours induces the steady state mRNA levels of GRP78/BiP but not the ER stress-inducible transcription factor, GADD153/CHOP relative to the mRNA transcript level of the `housekeeping' gene GAPDH (Fig. 3A). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that exposure to 0.5 mM valproate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "for 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the steady state mRNA levels of GRP78/BiP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0683927:state level [Spatial Concept]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the ER stress-inducible transcription factor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0040649:Transcription [Genetic Function]
   799   C0205263:Inducible [Functional Concept]
   799   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "GADD153/CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945739:chop [Activity]

Phrase: "relative to the mRNA transcript level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "of the `housekeeping' gene GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   901   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   867   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   861   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   799   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.148: Furthermore, exposure of HepG2 cells to 0.5 mM valproate for 48 hours results in increased protein levels of the ER chaperones, GRP78/BiP, HSP47, calreticulin and PDI as well as the cytosolic chaperone, HSP70 (Fig. 3B). 

Phrase: "Furthermore,"

Phrase: "exposure of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to 0.5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "for 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "results in increased protein levels of the ER chaperones,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0205217:Increased [Quantitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]
   726   C0428479:Protein level [Laboratory or Test Result]
   706   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "GRP78/BiP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "HSP47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413153:HSP47 [Gene or Genome]

Phrase: "calreticulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "and"

Phrase: "PDI"

Phrase: "as well as"

Phrase: "the cytosolic chaperone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "HSP70 (Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450365:3b [Intellectual Product]
   827   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.149: Typically, ER chaperones are induced as a response to the accumulation of unfolded or misfolded proteins in the ER, a condition known as ER stress. 

Phrase: "Typically,"

Phrase: "ER chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "are"

Phrase: "induced as a response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205263:Induced [Functional Concept]
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "to the accumulation"

Phrase: "of unfolded"

Phrase: "or"

Phrase: "misfolded proteins in the ER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "known as ER stress."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.150: However, the observation that valproate does not induce the expression of the ER stress-response gene, GADD153/CHOP, indicates that the valproate-dependent induction of ER chaperone expression may occur in the absence of ER stress. 

Phrase: "However,"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of the ER stress-response gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "GADD153/CHOP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945739:chop [Activity]

Phrase: "indicates"

Phrase: "that"

Phrase: "the valproate-dependent induction of ER chaperone expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "occur in the absence of ER stress."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   793   C0231300:Absence of stress [Finding]
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0038435:Stress [Finding]
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.151: To investigate this possibility further we examined diagnostic markers of ER stress in valproate-treated cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this possibility further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "diagnostic markers of ER stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1511876:Diagnostic Marker [Clinical Attribute]
   719   C0005516:Marker [Clinical Attribute]

Phrase: "in valproate-treated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.152: View larger version (30K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.153: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.154: Valproate induces the expression of ER-resident chaperones. 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of ER-resident chaperones."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.155: (A) Relative levels of GRP78/BiP and GADD153/CHOP mRNA normalized to GAPDH mRNA as determined by northern blot analysis. 

Phrase: "(A) Relative levels of GRP78/BiP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GADD153/CHOP mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to GAPDH mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   734   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   700   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]

Phrase: "as"

Phrase: "determined by northern blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C1621557:Northern Blot [Research Device]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.156: HepG2 cells were cultured for the indicated times in the presence of 0.5 mM valproate. 

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for the indicated times"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0040223:times [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.5 mM valproate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]
Processing 00000000.tx.157: Total RNA was resolved by agarose gel electrophoresis, transferred to nylon membranes and subjected to blot hybridization with 32P-radiolabeled cDNA probes encoding human GRP78/BiP and GADD153/CHOP. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "resolved by agarose gel electrophoresis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred to nylon membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025255:Membranes [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0740034:Nylon [Biomedical or Dental Material]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "subjected to blot hybridization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0020202:Hybridisation [Genetic Function]
   770   C1300517:Hybridization [Laboratory Procedure]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with 32P-radiolabeled cDNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human GRP78/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415761:BIP [Gene or Genome]

Phrase: "and"

Phrase: "GADD153/CHOP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945739:chop [Activity]
Processing 00000000.tx.158: Relative mRNA levels were quantified using a Typhoon 9410 phosphoimaging system and normalized to GAPDH (loading control) RNA levels. 

Phrase: "Relative mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Typhoon 9410 phosphoimaging system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   937   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   888   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   884   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(loading control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "RNA levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.159: (B) Immunoblot analysis of protein chaperone levels in HepG2 cells cultured for the indicated time in the presence of 0.5 mM valproate. 

Phrase: "(B) Immunoblot analysis of protein chaperone levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   774   C1514534:Protein Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured for the indicated time"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0040223:Time [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C3541383:Time [Temporal Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.5 mM valproate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]
Processing 00000000.tx.160: Total protein lysates were resolved by SDS-PAGE, transferred to nitrocellulose membranes and immunostained with antibodies against GRP78/BiP, HSP47, calreticulin, PDI or HSP70 as indicated. 

Phrase: "Total protein lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1881488:Lysate [Physical Object]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "were"

Phrase: "resolved by SDS-PAGE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "immunostained with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against GRP78/BiP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "HSP47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413153:HSP47 [Gene or Genome]

Phrase: "calreticulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "PDI"

Phrase: "or"

Phrase: "HSP70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.161: As a loading control, an identical blot was immunostained with an antibody against -actin.  

Phrase: "As a loading control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "an identical blot"

Phrase: "was"

Phrase: "immunostained with an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against -actin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]
Processing 00000000.tx.162: A well-characterized pathway of the ER stress response involves the activation of PERK, an ER-resident kinase that phosphorylates eukaryotic initiation factor 2 alpha (eIF2) on serine52 thereby blocking translation initiation and relieving the burden of de novo protein synthesis on the ER (Harding et al., 2000). 

Phrase: "A well-characterized pathway of the ER stress response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]

Phrase: "involves"

Phrase: "the activation of PERK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "an ER-resident kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "phosphorylates"

Phrase: "eukaryotic initiation factor 2 alpha (eIF2) on serine52 thereby"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1979845:Alpha 2 [Qualitative Concept]
   744   C0439095:Alpha [Intellectual Product]
   744   C0589507:Initiation [Mental Process]
   744   C1158830:Initiation [Genetic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1704686:Initiation [Functional Concept]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519613:Translation Initiation [Genetic Function]
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "relieving"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332303:relieving [Functional Concept]
  1000   C1301676:Relieving [Functional Concept]
  1000   C1301771:relieving [Qualitative Concept]

Phrase: "the burden of de novo protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2828008:Burden [Idea or Concept]

Phrase: "on the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "(Harding et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.163: By monitoring [35S]methionine/cysteine incorporation into newly expressed proteins, we have demonstrated that exposure of HepG2 cells to 10 M A23187 for 1 hour results in an 80% decrease in the rate of general protein synthesis but 0.5 mM valproate for 0-48 hours has no significant effect (Fig. 4A). 

Phrase: "By monitoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150369:Monitoring [Health Care Activity]
  1000   C1516647:monitoring [Research Activity]

Phrase: "[35S"

Phrase: "]methionine/cysteine incorporation into newly expressed proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that exposure of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]

Phrase: "to 10 M A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "for 1 hour"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442450:1 Hour [Temporal Concept]
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "results in an 80% decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of general protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "but"

Phrase: "0.5 mM valproate for 0-48 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "has"

Phrase: "no significant effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.164: Using antibodies directed against eIF2 and specifically against the phosphorylated form, eIF2-P (ser52), we have shown that neither the total cellular concentration nor the phosphorylation status of eIF2 are affected in HepG2 cells exposed to 0.5 mM valproate for up to 48 hours (Fig. 4B). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against eIF2"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1979845:Alpha 2 [Qualitative Concept]
   748   C0439095:Alpha [Intellectual Product]
   748   C0589507:Initiation [Mental Process]
   748   C1158830:Initiation [Genetic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1704686:Initiation [Functional Concept]
   748   C2003941:Alpha [Intellectual Product]
   748   C2350010:Alpha [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "specifically against the phosphorylated form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "eIF2-P (ser52"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "neither the total cellular concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "nor"

Phrase: "the phosphorylation status of eIF2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449438:Status [Qualitative Concept]

Phrase: "are"

Phrase: "affected in HepG2 cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C2717940:HepG2 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C0001721:Affect [Mental Process]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to 0.5 mM valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0444499:0/5 [Quantitative Concept]
   753   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "for"

Phrase: "up to 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.165: We further examined the expression of ER stress-response proteins, GADD153/CHOP and ATF4, which lie downstream of PERK/eIF2 (Harding et al., 2000). 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the expression of ER stress-response proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "GADD153/CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945739:chop [Activity]

Phrase: "and"

Phrase: "ATF4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412617:ATF4 [Gene or Genome]

Phrase: "which"

Phrase: "lie"

Phrase: "downstream of PERK/eIF2"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   879   C1521863:ER-Alpha [Amino Acid, Peptide, or Protein,Receptor]
   858   C1823210:ER-related factor [Gene or Genome]
   849   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0439095:Alpha [Intellectual Product]
   791   C0589507:Initiation [Mental Process]
   791   C1158830:Initiation [Genetic Function]
   791   C1521761:Factor [Functional Concept]
   791   C1704686:Initiation [Functional Concept]
   791   C2003941:Alpha [Intellectual Product]
   791   C2350010:Alpha [Qualitative Concept]
   791   C2827422:Factor [Conceptual Entity]

Phrase: "(Harding et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.166: Although tunicamycin and A23187 promote the expression of GADD153/CHOP and ATF4, valproate had no effect on protein levels after 24 hours and may cause a decrease in GADD153/CHOP after 72 hours (Fig. 4C), a result consistent with mRNA levels (Fig. 3A). 

Phrase: "Although"

Phrase: "tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the expression of GADD153/CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ATF4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412617:ATF4 [Gene or Genome]

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect on protein levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "after 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a decrease in GADD153/CHOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "after 72 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292423:72 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "consistent with mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.167: To investigate effects on other ER stress pathways we examined the IRE-1 dependent ERdj4 transcript (Lee et al., 2003). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "effects on other ER stress pathways"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the IRE-1 dependent ERdj4 transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Lee et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.168: In contrast to tunicamycin, valproate treatment has no effect on ERdj4 expression (Fig. 4D). 

Phrase: "In contrast to tunicamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "valproate treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "has"

Phrase: "no effect on ERdj4 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.169: ATF6 expression and activation were also unaffected in valproate-treated cells (not shown). 

Phrase: "ATF6 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "were"

Phrase: "also unaffected in valproate-treated cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986417:Unaffected [Conceptual Entity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: Together, these results show that valproate does not activate the ER stress-induced PERK pathway and therefore, contrary to previous reports (Lee, 2001), valproate does not appear to cause ER stress. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the ER stress-induced PERK pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1704259:Pathway [Molecular Function]
   791   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "therefore,"

Phrase: "contrary to previous reports"

Phrase: "(Lee,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "ER stress."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.171: Furthermore, the induction of ER-resident chaperone expression by valproate appears to be independent of ER stress. 

Phrase: "Furthermore,"

Phrase: "the induction of ER-resident chaperone expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205263:Induction [Functional Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be independent of ER stress."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   790   C0332291:Independent of [Functional Concept]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0038435:Stress [Finding]
   753   C0085862:Independent [Idea or Concept]
   753   C1299583:Independent [Finding]
   753   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.172: View larger version (66K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(66K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.173: 4. 

Phrase: "4."
Processing 00000000.tx.174: Valproate does not induce an ER stress response in HepG2 cells. 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an ER stress response in HepG2 cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0149784:stress response [Physiologic Function]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.175: (A) Protein synthesis rates measured by the incorporation of [35S]methionine/cysteine into proteins during a 15-minute pulse of labeling of HepG2 cells that were pre-exposed to 10 M A23187 or 0.5 mM valproate for the indicated times. 

Phrase: "(A) Protein synthesis rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "measured by the incorporation of [35S"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0243126:incorporation [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "]methionine/cysteine into proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C2927891:Cysteine / Methionine [Pharmacologic Substance]
   770   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "during a 15-minute pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0391850:Pulse [Physiologic Function]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: "of labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "of HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "pre-exposed to 10 M A23187"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0332152:Pre [Temporal Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0740175:Pre [Qualitative Concept]
   753   C0878412:A23187 [Antibiotic,Organic Chemical]
   753   C2257086:PRE [Genetic Function]

Phrase: "or"

Phrase: "0.5 mM valproate for the indicated times."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0080356:Valproate [Lipid,Pharmacologic Substance]
Processing 00000000.tx.176: Total protein extracts were resolved by SDS-PAGE and visualized by Coomassie Blue staining (top panel) or autoradiography (middle panel). 

Phrase: "Total protein extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2828366:Extract [Substance]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "visualized by Coomassie Blue staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   760   C0234621:Visualized [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1704680:Staining [Finding]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "autoradiography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.177: Total 35S incorporation in each of the tested conditions was determined by scintillation counting and plotted as a percentage of the control count (bottom panel). 

Phrase: "Total 35S incorporation in each of the tested conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "determined by scintillation counting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "plotted as a percentage of the control count"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0243148:control [Qualitative Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0750480:Count [Activity]
   744   C1549488:Percentage [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1561533:Percentage [Idea or Concept]
   744   C1705566:Count [Quantitative Concept]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.178: (B) Immunoblot analysis of protein extracts treated as described in A. 

Phrase: "(B) Immunoblot analysis of protein extracts"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   783   C1514534:Protein Analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.179: Total protein lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes. 

Phrase: "Total protein lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1881488:Lysate [Physical Object]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.180: Membranes were immunostained with antibodies against total eIF2 or the ser-52 phosphorylated form of eIF2. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunostained with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against total eIF2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439095:Alpha [Intellectual Product]
   799   C0589507:Initiation [Mental Process]
   799   C1158830:Initiation [Genetic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1704686:Initiation [Functional Concept]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "the ser-52 phosphorylated form of eIF2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C1522492:Form [Functional Concept]
Processing 00000000.tx.181: (C) Immunoblot analysis of HepG2 cells cultured for the indicated times in the presence of 0.5 mM valproate or in the presence of 10 g/ml tunicamycin or 10 M A23187 for 8 hours. 

Phrase: "(C) Immunoblot analysis of HepG2 cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "cultured for the indicated times"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0040223:times [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "or in the presence of 10 g/ml tunicamycin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   764   C1300565:g/mL [Quantitative Concept]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "10 M A23187 for 8 hours."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.182: Total protein lysates were resolved and transferred to nitrocellulose membranes. 

Phrase: "Total protein lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1881488:Lysate [Physical Object]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "were"

Phrase: "resolved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.183: Membranes were immunostained with antibodies against total GADD153/CHOP, ATF4 or -actin (loading control). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunostained with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against total GADD153/CHOP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2945739:chop [Activity]

Phrase: "ATF4 or -actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "(loading control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.184: (D) Analysis of ERdj4 mRNA levels in HepG2 cells cultured for the indicated times in presence of 0.5 mM valproate or for 8 hours with 10 g/ml tunicamycin. 

Phrase: "("

Phrase: "D)"

Phrase: "Analysis of ERdj4 mRNA levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured for the indicated times"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0040223:times [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "or for 8 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1292429:8 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "with 10 g/ml tunicamycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.185: Total RNA was resolved by agarose gel electrophoresis, transferred to nylon membranes and subjected to blot hybridization with 32P-radiolabeled cDNA probes encoding ERdj4 and GAPDH (loading control).  

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "resolved by agarose gel electrophoresis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred to nylon membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025255:Membranes [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0740034:Nylon [Biomedical or Dental Material]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "subjected to blot hybridization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0020202:Hybridisation [Genetic Function]
   770   C1300517:Hybridization [Laboratory Procedure]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with 32P-radiolabeled cDNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "ERdj4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417086:ERDJ4 [Gene or Genome]

Phrase: "and"

Phrase: "GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(loading control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.186: ER stress agents activate the UPR in valproate-treated cells We and others have shown, using transgene systems, that overexpression of specific ER-resident chaperones can protect cells from ER stress and ER stress-related cellular dysfunction (Liu et al., 1997; Johnson et al., 1998; Werstuck et al., 2001). 

Phrase: "ER stress agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the UPR in valproate-treated cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1155342:Unfolded Protein Response [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transgene systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "that overexpression of specific ER-resident chaperones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514559:Overexpression [Genetic Function]

Phrase: "can"

Phrase: "protect"

Phrase: "cells from ER stress"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0229606:Reticulum cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "ER stress-related cellular dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0031847:dysfunction [Functional Concept]
   799   C0277785:Dysfunction, NOS [Qualitative Concept]
   743 E C0231174:Malfunction [Functional Concept]
   743 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(Liu et al.,"

Phrase: "1997"

Phrase: "; Johnson et al.,"

Phrase: "1998"

Phrase: "; Werstuck et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.187: The ability of valproate to induce the expression of several ER chaperones, including GRP78/BiP, HSP47, calreticulin and PDI independent of ER dysfunction (Figs 3 and 4) suggests that pretreatment of cells with valproate may confer resistance to ER stress agents. 

Phrase: "The ability of valproate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of several ER chaperones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GRP78/BiP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "HSP47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413153:HSP47 [Gene or Genome]

Phrase: "calreticulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "and"

Phrase: "PDI independent of ER dysfunction"

Phrase: "(Figs 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that pretreatment of cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "may"

Phrase: "confer"

Phrase: "resistance to ER stress agents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0332325:Resistant to [Functional Concept]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
Processing 00000000.tx.188: To test this possibility we challenged control and valproate-pretreated cells with the ER stress agents tunicamycin and A23187. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "challenged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0798503:Challenge [Clinical Attribute]
   966   C0805586:Challenge [Health Care Activity]
   966   C3274764:Challenge [Conceptual Entity]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "valproate-pretreated cells with the ER stress agents tunicamycin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   741   C0229606:Reticulum cell [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "A23187."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.189: As previously observed (Fig. 3), exposure of HepG2 cells to 0.5 mM valproate increases the steady-state levels of mRNAs encoding GRP78/BiP but not GADD153/CHOP (Fig. 5A). 

Phrase: "As"

Phrase: "previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "exposure of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to 0.5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the steady-state levels of mRNAs"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0678587:steady state [Natural Phenomenon or Process]
   773   C0683927:state level [Spatial Concept]
   753   C0205361:Steady [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "GRP78/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "but"

Phrase: "not GADD153/CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2945739:chop [Activity]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.190: As expected, in the absence of valproate, HepG2 cells exposed to an ER stress agent exhibited a typical ER stress response with an increase in both GRP78/BiP and GADD153/CHOP mRNA levels. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of valproate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to an ER stress agent"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0038435:Stress [Finding]
   748   C0450442:Agent [Chemical Viewed Functionally]
   748   C1254351:Agent [Pharmacologic Substance]
   748   C1521826:Agent [Intellectual Product]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a typical ER stress response with an increase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0149784:stress response [Physiologic Function]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "in both GRP78/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "and"

Phrase: "GADD153/CHOP mRNA levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.191: Pretreatment with valproate for 48 hours before challenge with 2 and 10 g/ml tunicamycin or 2 and 10 M A23187 did not diminish the ER stress response as measured by the level of induction of GADD153/CHOP mRNA. 

Phrase: "Pretreatment with valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "for 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "before challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0798503:Challenge [Clinical Attribute]
  1000   C0805586:Challenge [Health Care Activity]
  1000   C3274764:Challenge [Conceptual Entity]

Phrase: "with 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "10 g/ml tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "10 M A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "the ER stress response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0149784:stress response [Physiologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "as"

Phrase: "measured by the level of induction of GADD153/CHOP mRNA."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205263:Induction [Functional Concept]
   739   C0441889:Level [Qualitative Concept]
   739   C0444706:Measured [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C0857127:induction [Therapeutic or Preventive Procedure]
   739   C1413947:GADD153 [Gene or Genome]
   739   C1547707:Level [Geographic Area]
   739   C2945739:chop [Activity]
   739   C2946261:Level [Pharmacologic Substance]
   739   C2985165:GADD153 [Gene or Genome]
   739   C3541902:MEASURED [Diagnostic Procedure]
   706 E C0079809:Measure [Quantitative Concept]
   706 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.192: In support of this observation, the pretreatment of cells with valproate did not attenuate the ER stress-induced expression of GADD153/CHOP protein or the increased phosphorylation of eIF2 (Fig. 5B). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this observation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "the pretreatment of cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the ER stress-induced expression of GADD153/CHOP protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "the increased phosphorylation of eIF2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.193: Furthermore, pretreatment with valproate did not alleviate the A23187-induced translation block that results from eIF2a phosphorylation (data not shown). 

Phrase: "Furthermore,"

Phrase: "pretreatment with valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alleviate"

Phrase: "the A23187-induced translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040712:Translation [Intellectual Product]
   827   C0597295:translation [Molecular Function]
   827   C1519614:Translation [Genetic Function]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "that results from eIF2a phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.194: Together these results indicate that conditions of valproate exposure that confer significant protection from ER stress-induced apoptosis and lipid accumulation do not affect the ability of ER stress agents to elicit an ER stress response. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that conditions of valproate exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "that"

Phrase: "confer"

Phrase: "significant protection from ER stress-induced apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1545588:Protection [Finding]
   703   C2610698:endoplasmic reticulum stress-induced apoptosis [Cell Function]

Phrase: "and"

Phrase: "lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333574:Lipid accumulation [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the ability of ER stress agents to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "an ER stress response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0149784:stress response [Physiologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
Processing 00000000.tx.195: This finding suggests that valproate does not alleviate the ER stress levels in HepG2 cells but rather acts at some point subsequent to ER stress to block pathways associated with apoptosis and lipid metabolism. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alleviate"

Phrase: "the ER stress levels in HepG2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C1319127:levels stress [Finding]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "rather"

Phrase: "acts at some point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "subsequent to ER stress to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   861   C0014239:Endoplasmic Reticulum [Cell Component]
   812   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   812   C0038435:Stress [Finding]
   741 E C0231297:Stressful [Functional Concept]
   741   C0598268:Endoplasm [Cell Component]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "associated with apoptosis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0162638:Apoptosis [Cell Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "lipid metabolism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.196: View larger version (44K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.197: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.198: Valproate pretreatment does not abrogate an ER stress response. 

Phrase: "Valproate pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "abrogate"

Phrase: "an ER stress response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0149784:stress response [Physiologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
Processing 00000000.tx.199: (A) Northern blot analysis of HepG2 cells pretreated for 0, 24 or 48 hours with 0.5 mM valproate and then challenged with 0, 2 or 10 g/ml tunicamycin (left panel) or 0, 2, 10 M A23187 (right panel) for 4 hours as indicated. 

Phrase: "(A) Northern blot analysis of HepG2 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0005861:Northern blot analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "pretreated for 0,"

Phrase: "24"

Phrase: "or"

Phrase: "48 hours with 0.5 mM valproate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0439586:48 hours [Temporal Concept]
   778   C1442464:48 Hours [Temporal Concept]
   748   C0439227:hours [Temporal Concept]
   714 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with 0,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "10 g/ml tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "0,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "10 M A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "for 4 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292426:4 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.200: Total RNA was resolved by agarose gel electrophoresis, transferred to nylon membranes and hybridized to radiolabeled cDNA probes encoding human GRP78/BiP or GADD153/CHOP. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "resolved by agarose gel electrophoresis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred to nylon membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025255:Membranes [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0740034:Nylon [Biomedical or Dental Material]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "hybridized to radiolabeled cDNA probes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0182400:Probes [Medical Device]
   760   C1527121:Radiolabeled [Qualitative Concept]
   726 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   726 E C1704681:Probe [Gene or Genome]
   726 E C2347609:Probe [Chemical Viewed Functionally]
   726 E C3536729:Probe [Manufactured Object]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human GRP78/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415761:BIP [Gene or Genome]

Phrase: "or"

Phrase: "GADD153/CHOP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945739:chop [Activity]
Processing 00000000.tx.201: Control for equivalent RNA loading was assessed using a radiolabeled GAPDH cDNA probe. 

Phrase: "Control for equivalent RNA loading"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a radiolabeled GAPDH cDNA probe."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0182400:Probe [Medical Device]
   795   C1704681:Probe [Gene or Genome]
   795   C2347609:Probe [Chemical Viewed Functionally]
   795   C3536729:Probe [Manufactured Object]
   710   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   710   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.202: (B) Immunoblot analysis of HepG2 cells treated with valproate, tunicamycin and A23187 as described above. 

Phrase: "(B) Immunoblot analysis of HepG2 cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "treated with valproate,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "A23187 as described above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.203: Total protein lysates were resolved and transferred to nitrocellulose membranes. 

Phrase: "Total protein lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1881488:Lysate [Physical Object]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "were"

Phrase: "resolved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.204: Membranes were immunostained with antibodies against GADD153/CHOP, the ser9-phosphorylated form of eIF2 (eIF2-P) or total eIF2 as indicated.  

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunostained with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against GADD153/CHOP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945739:chop [Activity]

Phrase: "the ser9-phosphorylated form of eIF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "(eIF2-P)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0033452:Factor P [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1418482:FACTOR P [Gene or Genome]
   734   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "total eIF2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439095:Alpha [Intellectual Product]
   799   C0589507:Initiation [Mental Process]
   799   C1158830:Initiation [Genetic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1704686:Initiation [Functional Concept]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.205: Valproate protects cells from ER stress-induced dysfunction by inhibiting GSK3 Possible downstream targets of valproate include GSK3 and -. 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "protects"

Phrase: "cells from ER stress-induced dysfunction"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0229606:Reticulum cell [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "by inhibiting GSK3 Possible downstream targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1521840:Target [Functional Concept]
   771   C2986546:TARGET [Diagnostic Procedure]

Phrase: "of valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "."
Processing 00000000.tx.206: Valproate has been reported to inhibit GSK3 (Chen et al., 1999a; Tatebayashi et al., 2004) although conflicting data have been published (Phiel et al., 2001). 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Chen et al.,"

Phrase: "1999a"

Phrase: "; Tatebayashi et al.,"

Phrase: "2004"

Phrase: ")"

Phrase: "although"

Phrase: "conflicting data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "have"

Phrase: "been"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(Phiel et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.207: To the best of our knowledge, the effects of ER stress and valproate on GSK3 have not been determined. 

Phrase: "To the best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]

Phrase: "of our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "the effects of ER stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "valproate on GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined."
Processing 00000000.tx.208: It has previously been reported that the ER stress agent thapsigargin induces apoptosis by enhancing GSK3 activity in human neuroblastoma SH-SY5Y cells (Song et al., 2002). 

Phrase: "It"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the ER stress agent thapsigargin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis by enhancing GSK3 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "in human neuroblastoma SH-SY5Y cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Song et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.209: We directly assayed GSK3 and - activity by immunoprecipitating each kinase from lysates of HepG2 cells and measuring its activity in vitro. 

Phrase: "We directly assayed GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "activity by immunoprecipitating"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "each kinase from lysates of HepG2 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.210: In HepG2 cells we observed no increase in GSK3 or - activity upon treatment with tunicamycin or A23187 (Fig. 6A). 

Phrase: "In HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no increase in GSK3 or - activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "upon treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.211: These findings are consistent with our observation that the phosphorylation status of Akt (ser473) and GSK3 (ser9), sites important in the regulation of kinase activity (Song et al., 2002), were not affected in cells exposed to ER stress in the presence or absence of valproate (not shown). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with our observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the phosphorylation status of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449438:Status [Qualitative Concept]

Phrase: "(ser473"

Phrase: ")"

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(ser9"

Phrase: ")"

Phrase: ","

Phrase: "sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "important in the regulation of kinase activity"

Phrase: "(Song et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected in cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C0001721:Affect [Mental Process]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to ER stress"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of valproate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.212: To determine if valproate directly inhibits GSK3 and/or GSK3, 0-5 mM valproate or 0-50 mM lithium, a selective inhibitor of GSK3/ (Stambolic et al., 1996) were added to purified recombinant GSK3 or - and kinase activity was determined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "valproate directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and/or"

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "0-5 mM valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "or"

Phrase: "0-50 mM lithium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "a selective inhibitor of GSK3/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   767   C3537023:kinase inhibitor [Molecular Function]
   767   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Stambolic et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "were"

Phrase: "added to purified recombinant GSK3"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1514798:recombinant [Organism]
   760   C1524062:Added [Functional Concept]
   760   C1998793:Purified [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "or -"

Phrase: "and"

Phrase: "kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.213: Results show that 20 mM lithium significantly inhibited both isoforms whereas valproate preferentially inhibited the  form of the kinase (Fig. 6B). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that 20 mM lithium significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "both isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "whereas"

Phrase: "valproate preferentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the  form of the kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.214: Next, the ability of valproate to inhibit intracellular GSK3 was compared to inhibition in vitro. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "the ability of valproate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "intracellular GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "compared to inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C1707455:Compared [Activity]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.215: GSK3 and - were immunoprecipitated from HepG2 cells that had been pretreated for 2 hours in the presence or absence of 0.5 mM valproate. 

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "were"

Phrase: "immunoprecipitated from HepG2 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C2717940:HepG2 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "pretreated for 2 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 0.5 mM valproate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.216: As observed with the recombinant enzymes, valproate was a more effective inhibitor of GSK3 (Fig. 6C). 

Phrase: "As"

Phrase: "observed with the recombinant enzymes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1514798:recombinant [Organism]

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "was"

Phrase: "a more effective inhibitor of GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.217: However, significant inhibition of GSK3 was observed in vivo suggesting that valproate indirectly affects GSK3 activity in addition to its ability to inhibit kinase activity directly. 

Phrase: "However,"

Phrase: "significant inhibition of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate indirectly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "GSK3 activity in addition to its ability to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "kinase activity directly."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.218: Similar patterns of inhibition were observed for GSK3 immunoprecipitated from cells exposed to ER stress-inducing agents (not shown). 

Phrase: "Similar patterns of inhibition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "observed for GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1441672:Observed [Functional Concept]

Phrase: "immunoprecipitated from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756   C0301871:Immunoprecipitate [Immunologic Factor]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to ER stress-inducing agents"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0038435:Stress [Finding]
   748   C0205263:Inducing [Functional Concept]
   714   C0450442:Agent [Chemical Viewed Functionally]
   714   C1254351:Agent [Pharmacologic Substance]
   714   C1521826:Agent [Intellectual Product]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.219: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.220: 6. 

Phrase: "6."
Processing 00000000.tx.221: Effects of ER stress-inducing agents and valproate on GSK3/ activity. 

Phrase: "Effects of ER stress-inducing agents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "valproate on GSK3/ activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0080356:Valproate [Lipid,Pharmacologic Substance]
   731   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
Processing 00000000.tx.222: (A) GSK3 and - activity immunoprecipitated from cells exposed to 10 g/ml tunicamycin or 10 M A23187 for 2 hours. 

Phrase: "(A) GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "immunoprecipitated from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756   C0301871:Immunoprecipitate [Immunologic Factor]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to 10 g/ml tunicamycin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "10 M A23187 for 2 hours."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.223: Quantitative values are expressed as a percentage of GSK3 or - activity in untreated cells. 

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as a percentage of GSK3 or - activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205177:Activity [Functional Concept]
   744   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "in untreated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.224: Data are expressed as the means.d. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the means.d."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.225: (n=3). 

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.226: (B) Recombinant GSK3 and - activity in the presence of 0-5 mM valproate or 0-50 mM lithium. 

Phrase: "(B) Recombinant GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "activity in the presence of 0-5 mM valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "0-50 mM lithium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.227: Quantitative values are expressed as a percentage of recombinant GSK3 or - activity in the absence of inhibitor. 

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as a percentage of recombinant GSK3 or - activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0205177:Activity [Functional Concept]
   742   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1514798:recombinant [Organism]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.228: Data are expressed as the means.d. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the means.d."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.229: (n=3). 

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.230: *P<0.05 relative to activity in the corresponding control. 

Phrase: "*P<0.05 relative to activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in the corresponding control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.231: (C) GSK and - activity immunoprecipitated from HepG2 cells. 

Phrase: "(C) GSK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0206354:Glycogen Synthase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "immunoprecipitated from HepG2 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C2717940:HepG2 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.232: Valproate (0.5 mM) was added in vivo to the cells 2 hours prior to harvesting and immunoprecipitation or to the immunopurified GSK3 during the kinase assay as indicated. 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "(0.5 mM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "in vivo to the cells 2 hours"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "prior to harvesting"

Phrase: "and"

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "or to the immunopurified GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "during the kinase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.233: Quantitative values are expressed as a percentage of GSK3 or  activity in untreated cells. 

Phrase: "Quantitative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as a percentage of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "or"

Phrase: "activity in untreated cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.234: Data are expressed as the means.d. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the means.d."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.235: (n=3). 

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.236: *P<0.05 relative to levels in the corresponding control.  

Phrase: "*P<0.05 relative to levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in the corresponding control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.237: If valproate protects HepG2 cells from ER stress-induced cellular dysfunctions including lipid accumulation and apoptosis by virtue of its ability to inhibit GSK3, then other inhibitors of this kinase should confer similar protection. 

Phrase: "If"

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "protects"

Phrase: "HepG2 cells from ER stress-induced cellular dysfunctions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   764   C2717940:HepG2 Cells [Cell]
   745   C0229606:Reticulum cell [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333574:Lipid accumulation [Finding]

Phrase: "and"

Phrase: "apoptosis by virtue of its ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162638:Apoptosis [Cell Function]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "other inhibitors of this kinase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C1152564:Kinase Inhibitors [Molecular Function]
   797   C3537035:inhibitors kinase [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   781 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   781 E C3537023:kinase inhibitor [Molecular Function]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "should"

Phrase: "confer"

Phrase: "similar protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.238: We investigated the ability of lithium to inhibit caspase 3 activation by tunicamycin in HepG2 cells. 

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the ability of lithium to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "caspase 3 activation by tunicamycin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "in HepG2 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.239: We found that 20 mM lithium attenuates the ER stress-induced caspase 3 activity in HepG2 cells in a manner similar to valproate (Fig. 7A). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that 20 mM lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the ER stress-induced caspase 3 activity in HepG2 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1150132:caspase-3 activity [Molecular Function]
   754   C1150130:caspase activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "in a manner"

Phrase: "similar to valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.240: To investigate the potential role of GSK3 in ER stress-induced lipid accumulation, HepG2 cells were pretreated with lithium or GSK inhibitor II (CalBiochem) and then challenged with 5 mM glucosamine for 24 hours. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the potential role of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in ER stress-induced lipid accumulation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333574:Lipid accumulation [Finding]

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "GSK inhibitor II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0206354:Glycogen Synthase Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(CalBiochem"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with 5 mM glucosamine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
   726   C0798503:Challenge [Clinical Attribute]
   726   C0805586:Challenge [Health Care Activity]
   726   C3274764:Challenge [Conceptual Entity]

Phrase: "for 24 hours."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.241: Both GSK inhibitors significantly decreased free cholesterol levels in HepG2 cells as determined by filipin staining (Fig. 7B,C). 

Phrase: "Both GSK inhibitors significantly"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   823   C1152564:Kinase Inhibitors [Molecular Function]
   806 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   806 E C3537023:kinase inhibitor [Molecular Function]
   806 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "free cholesterol levels in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0201950:cholesterol levels [Laboratory Procedure]
   790   C0428466:cholesterol levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "determined by filipin staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016095:Filipin [Antibiotic,Organic Chemical]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "(Fig. 7B,"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.242: To the best of our knowledge, these are the first experiments that link GSK3 activity to lipid metabolism. 

Phrase: "To the best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]

Phrase: "of our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "these"

Phrase: "are"

Phrase: "the first experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "that"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "GSK3 activity to lipid metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.243: Together these results suggest that valproate protects cells from ER stress-induced lipid accumulation and apoptosis by blocking the activation of GSK3 by conditions of ER stress. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "protects"

Phrase: "cells from ER stress-induced lipid accumulation"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0229606:Reticulum cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "apoptosis by blocking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "the activation of GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of ER stress."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.244: At the present time we cannot rule out the possibility that HDAC inhibition or other effects contribute to the observed cytoprotective role of valproate. 

Phrase: "At the present time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that HDAC inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "or"

Phrase: "other effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "contribute to the observed cytoprotective role of valproate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0035820:Role [Social Behavior]
   744   C0080356:Valproate [Lipid,Pharmacologic Substance]
   744   C1441672:Observed [Functional Concept]
   744   C1705810:Role [Conceptual Entity]
   744   C1880177:Contribute [Activity]
Processing 00000000.tx.245: View larger version (38K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.246: 7. 

Phrase: "7."
Processing 00000000.tx.247: Agents that inhibit GSK3 activity also block ER stress-induced lipid accumulation and apoptosis. 

Phrase: "Agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3 activity also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "ER stress-induced lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333574:Lipid accumulation [Finding]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.248: (A) Determination of caspase 3 activity in HepG2 cells pretreated for 1 hour in the presence or absence of 20 mM LiCl and then exposed to 0 or 20 g/ml tunicamycin for 6 hours as indicated. 

Phrase: "(A) Determination of caspase 3 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated for 1 hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 20 mM LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to 0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed

Phrase: "or"

Phrase: "20 g/ml tunicamycin for 6 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.249: Caspase 3 activity was determined in cell lysates and normalized to total protein concentrations. 

Phrase: "Caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "determined"

Phrase: "in cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "and"

Phrase: "normalized to total protein concentrations."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0555903:Total protein [Laboratory Procedure]
   806   C1261360:total protein [Laboratory or Test Result]
   797 E C0439177:Protein.total [Quantitative Concept]
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1882115:Normalized [Research Activity]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.250: Data are presented as the means.d. of three independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the means.d. of three independent experiments."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   762   C0332291:Independent of [Functional Concept]
   742   C0085862:Independent [Idea or Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0449450:Presented [Idea or Concept]
   742   C0681814:Experiments [Research Activity]
   742   C1299583:Independent [Finding]
   742   C1704970:Means [Conceptual Entity]
   708 E C0150312:Present [Quantitative Concept]
   708 E C0444504:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
   708 E C2347634:Mean [Quantitative Concept]
   708 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.251: *P<0.01 when compared to the corresponding control. 

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared to the corresponding control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.252: (B) Filipin staining of HepG2 cells pretreated for 1 hour in the presence of 0.5 mM valproate, 20 mM LiCl or 20 M GSK inhibitor II (GSKin) and then challenged with 0 or 5 mM glucosamine as indicated. 

Phrase: "(B) Filipin staining of HepG2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "pretreated for 1 hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.5 mM valproate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "20 mM LiCl"

Phrase: "or"

Phrase: "20 M GSK inhibitor II"

Phrase: "(GSKin"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "or"

Phrase: "5 mM glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.253: After 24 hours, cells were washed, fixed in paraformaldehyde and stained with filipin. 

Phrase: "After 24 hours,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "fixed in paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "stained with filipin."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0016095:Filipin [Antibiotic,Organic Chemical]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.254: Intracellular filipin-cholesterol complexes were visualized by fluorescence microscopy. 

Phrase: "Intracellular filipin-cholesterol complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "visualized by fluorescence microscopy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.255: (C) Median fluorescence of filipin-stained cells treated as described in B. 

Phrase: "(C) Median fluorescence of filipin-stained cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   721   C0303920:Fluorescent stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "described in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.256: *P<0.01 when compared to the corresponding control. 

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared to the corresponding control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.257: **P<0.01 compared to relative fluorescence in the absence of GSK3 inhibition.   

Phrase: "*"

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared to relative fluorescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of GSK3 inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.258: Discussion Top Summary Introduction Materials and Methods Results Discussion References  Disruption of ER function has been linked to the development of several disorders including Alzheimer's, Huntington's and Parkinson's diseases, type-1 diabetes mellitus and hepatic steatosis (Werstuck et al., 2001; Siman et al., 2001; Harding et al., 2001; Ryu et al., 2002; Nishitoh et al., 2002). 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Disruption of ER function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "linked to the development of several disorders"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0012634:Disorders [Disease or Syndrome]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   738   C0008073:DEVELOPMENTAL DISORDERS [Mental or Behavioral Dysfunction]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer's,"

Phrase: "Huntington's"

Phrase: "and"

Phrase: "Parkinson's diseases,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0030567:Parkinson Disease [Disease or Syndrome]
   983   C1521736:Parkinson's Disease [Functional Concept]
   983   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "type-1 diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Type 1 diabetes
  1000   C2984334:Type I diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441729:Type 1 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "hepatic steatosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015695:hepatic steatosis [Disease or Syndrome]
  1000   C2711227:Hepatic steatosis [Disease or Syndrome]
   861   C0152254:Steatosis [Pathologic Function]
   861   C0205054:Hepatic [Body Location or Region]

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: "; Siman et al.,"

Phrase: "2001"

Phrase: "; Harding et al.,"

Phrase: "2001"

Phrase: "; Ryu et al.,"

Phrase: "2002"

Phrase: "; Nishitoh et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.259: Although in most cases, a causative role has yet to be clearly demonstrated, possible mechanisms by which ER dysfunction could initiate or promote a disease state have been proposed. 

Phrase: "Although in most cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "a causative role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "clearly"

Phrase: "demonstrated"

Phrase: ","

Phrase: "possible mechanisms by which ER dysfunction"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "could"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "or"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "a disease state"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0012634:Disease [Disease or Syndrome]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "proposed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]
Processing 00000000.tx.260: For example, several independent studies have demonstrated that ER stress can promote apoptosis through caspase 7-mediated caspase 12 activation and/or through the activation of caspase 8 (Rao et al., 2001; Jimbo et al., 2003). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "several independent studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C0681367:independent study [Educational Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "apoptosis through caspase 7-mediated caspase 12 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: "and/or through the activation of caspase 8"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1706528:And/Or [Conceptual Entity]
   767   C1159825:Caspase Activation [Molecular Function]
   744   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1515981:And [Idea or Concept]
   744   C1879547:Activation [Activity]

Phrase: "(Rao et al.,"

Phrase: "2001"

Phrase: "; Jimbo et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.261: It has been postulated that ER stress promotes dopaminergic neuronal cell death in Parkinson's disease (Ryu et al., 2002), cortical neuronal cell death in Alzheimer's disease (Nakagawa et al., 2000) and in pancreatic  cell death associated with the Wolcott-Rallison syndrome of infantile diabetes (Harding et al., 2001). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "that ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "dopaminergic neuronal cell death in Parkinson's disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C2754100:neuronal cell death [Cell Function]
           neuron death
   778   C0007587:Cell Death [Cell Function]
   774   C1512035:Dopaminergic cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(Ryu et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: ","

Phrase: "cortical neuronal cell death in Alzheimer's disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C2754100:neuronal cell death [Cell Function]
           neuron death
   778   C0007587:Cell Death [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(Nakagawa et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "and in pancreatic  cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "associated with the Wolcott-Rallison syndrome of infantile diabetes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0432217:Wolcott-Rallison syndrome [Congenital Abnormality,Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0039082:Syndrome [Disease or Syndrome]
   742   C0231330:Infantile [Temporal Concept]
   742   C2939166:Infantile [Qualitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Harding et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.262: In addition to inducing apoptosis, we have demonstrated that ER stress can lead to the activation and dysregulation of the sterol-responsive element binding proteins, transcription factors that control lipid biosynthesis and uptake. 

Phrase: "In addition to inducing apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "can"

Phrase: "lead to the activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1879547:Activation [Activity]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "dysregulation of the sterol-responsive element binding proteins,"

Phrase: "transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "lipid biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1563744:lipid biosynthesis [Organism Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.263: In human aortic smooth muscle cells, HepG2 cells and in some plant cells, this can result in lipid accumulation (Werstuck et al., 2001; Shank et al., 2001). 

Phrase: "In human aortic smooth muscle cells,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   897   C0427861:Human cells [Laboratory or Test Result]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   804   C0003483:Aortic [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0086418:Human [Human]
   804   C0205357:Smooth [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and in some plant cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C3178867:Plant Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0032098:Plant [Plant]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "this"

Phrase: "can"

Phrase: "result in lipid accumulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0333574:Lipid accumulation [Finding]
   770   C0023779:Lipid [Lipid]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: "; Shank et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.264: Hepatic steatosis associated with severe hyperhomocysteinemia may represent one physiological manifestation of ER stress-induced dysregulation of lipid metabolism. 

Phrase: "Hepatic steatosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015695:hepatic steatosis [Disease or Syndrome]
  1000   C2711227:Hepatic steatosis [Disease or Syndrome]
   861   C0152254:Steatosis [Pathologic Function]
   861   C0205054:Hepatic [Body Location or Region]

Phrase: "associated with severe hyperhomocysteinemia"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205082:Severe [Qualitative Concept]
   770   C0598608:Hyperhomocysteinemia [Disease or Syndrome]
   770   C3495426:HYPERHOMOCYSTEINEMIA [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "one physiological manifestation of ER stress-induced dysregulation of lipid metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   736   C0205319:manifestation [Functional Concept]
Processing 00000000.tx.265: The potential role of ER stress in the pathogenesis of different diseases supports the therapeutic relevance of strategies that either (1) alleviate the burden of unfolded proteins in the ER, or (2) block the signaling pathways from the dysfunctional ER that trigger detrimental downstream events. 

Phrase: "The potential role of ER stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of different diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the therapeutic relevance of strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "that either"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "alleviate"

Phrase: "the burden of unfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2828008:Burden [Idea or Concept]

Phrase: "in the ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "or (2"

Phrase: ")"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the signaling pathways from the dysfunctional ER"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C0037080:pathways signaling [Molecular Function]
   754 E C0037083:signaling pathway [Cell Function]
   754 E C0086982:Signaling Pathway [Molecular Function]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "detrimental downstream events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]
Processing 00000000.tx.266: Support for the first strategy has come from experiments in which our lab, and others, have demonstrated that the overexpression of GRP78/BiP can increase the resistance of cells to ER stress-induced apoptosis and SREBP activation (Liu et al., 1997; Werstuck et al., 2001; Rao et al., 2002). 

Phrase: "Support for the first strategy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0183683:Support [Medical Device]
   760   C1521721:Support [Conceptual Entity]

Phrase: "has"

Phrase: "come from experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "in which"

Phrase: "our lab,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]

Phrase: "and"

Phrase: "others,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the overexpression of GRP78/BiP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the resistance of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "to ER stress-induced apoptosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2610698:endoplasmic reticulum stress-induced apoptosis [Cell Function]
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "SREBP activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(Liu et al.,"

Phrase: "1997"

Phrase: "; Werstuck et al.,"

Phrase: "2001"

Phrase: "; Rao et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.267: However, the transgene strategy to block ER stress is limited by our ability to stably transfect and maintain ER chaperone-overexpressing cells, especially in vivo. 

Phrase: "However,"

Phrase: "the transgene strategy to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "is"

Phrase: "limited by our ability"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0085732:Ability [Organism Attribute]
   770   C0439801:Limited [Functional Concept]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "to stably"

Phrase: "transfect"

Phrase: "and"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "ER chaperone-overexpressing cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0229606:Reticulum cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "especially in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.268: Verification of the efficacy of the second strategy, to block the signals from the ER that trigger detrimental downstream events, has been impeded by our lack of knowledge of the pathways linking ER dysfunction to specific cellular responses. 

Phrase: "Verification of the efficacy of the second strategy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237944:Verification [Research Activity]
   744   C1711411:Verification [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the signals from the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "detrimental downstream events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "has"

Phrase: "been"

Phrase: "impeded by our lack of knowledge of the pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0332268:lack [Qualitative Concept]
   742   C0376554:Knowledge [Intellectual Product]
   742   C1704259:Pathways [Molecular Function]
   742   C1705987:Pathways [Conceptual Entity]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "ER dysfunction to specific cellular responses."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031847:dysfunction [Functional Concept]
   748   C0277785:Dysfunction, NOS [Qualitative Concept]
Processing 00000000.tx.269: Valproate is a potent and widely prescribed drug that acts both as an anti-convulsant in the treatment of epilepsy and as a mood-stabilizer to control bipolar disorder (Bowden et al., 1994; Penry and Dean, 1989). 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "is"

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "widely prescribed drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "both as an anti-convulsant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0009950:convulsant [Hazardous or Poisonous Substance,Pharmacologic Substance]
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of epilepsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014544:Epilepsy [Disease or Syndrome]

Phrase: "and as a mood-stabilizer to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2917435:Mood Stabilizer [Pharmacologic Substance]
   753   C0026516:Mood [Mental Process]
   753   C0920880:Stabilizer [Organ or Tissue Function]
   753   C1515981:And [Idea or Concept]
   753   C1550603:stabilizer [Substance]
   753   C1705532:Stabilizer [Medical Device]
   753   C2713234:Mood [Clinical Attribute]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "bipolar disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005586:Bipolar Disorder [Mental or Behavioral Dysfunction]
   861   C0012634:Disorder [Disease or Syndrome]
   861   C0443156:Bipolar [Spatial Concept]

Phrase: "(Bowden et al.,"

Phrase: "1994"

Phrase: "; Penry"

Phrase: "and"

Phrase: "Dean,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.270: Exposure to valproate can induce a variety of cellular responses that may be responsible for its clinical efficacy. 

Phrase: "Exposure to valproate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a variety of cellular responses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "responsible for its clinical efficacy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.271: For example, it has been reported that valproate potentiates GABA-mediated postsynaptic inhibition, an effect that could play a direct role in the prevention of seizures (MacDonald and Bergey, 1979). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "potentiates"

Phrase: "GABA-mediated postsynaptic inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0021467:Inhibition [Mental Process]
   812   C0021469:Inhibition [Molecular Function]
   812   C1628982:% inhibition [Quantitative Concept]
   812   C3463820:Inhibition [Activity]
   741 E C0311403:Inhibited [Qualitative Concept]

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a direct role in the prevention of seizures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(MacDonald"

Phrase: "and"

Phrase: "Bergey,"

Phrase: "1979"

Phrase: ")."
Processing 00000000.tx.272: Valproate and other anti-convulsant drugs have been shown to stabilize neuronal growth cones by depleting intracellular inositol concentrations (Williams et al., 2002). 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "other anti-convulsant drugs"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0009950:convulsant [Hazardous or Poisonous Substance,Pharmacologic Substance]
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "neuronal growth cones by depleting intracellular inositol concentrations"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0596632:Growth Cones [Cell Component]
   770   C0814002:Neuronal Growth [Cell Function,Organism Function]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0206428:Cones [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   711 E C0330095:Cone [Plant]
   711 E C2350017:Cone [Spatial Concept]

Phrase: "(Williams et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.273: In addition, valproate has been shown to modulate gene expression by activating the AP-1 family of transcription factors as well as through the inhibition of histone deacetylases (HDACs) (Chen et al., 1999b; Phiel et al., 2001). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "gene expression by activating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0017262:Gene Expression [Genetic Function]
   770   C0017337:Gene [Gene or Genome]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the AP-1 family of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]

Phrase: "as well as through the inhibition of histone deacetylases (HDACs)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0019643:Histone Deacetylases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0019652:Histone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0205170:Well [Qualitative Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3146287:Well [Manufactured Object]
   742   C3463820:Inhibition [Activity]
   708   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Chen et al.,"

Phrase: "1999b"

Phrase: "; Phiel et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.274: Finally, valproate and another mood modifier, lithium, have been shown to inhibit GSK3, a kinase involved in a diverse number of signaling pathways including those controlling neuronal gene expression and survival (Chen et al., 1999a; De Sarno et al., 2002). 

Phrase: "Finally,"

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "another mood modifier,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205349:Modifier [Qualitative Concept]
   861   C1514623:Modifier [Conceptual Entity]
   861   C1516451:Modifier [Chemical Viewed Functionally]
   861   C3542952:Modifier [Intellectual Product]

Phrase: "lithium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in a diverse number of signaling pathways"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   767   C0037080:pathways signaling [Molecular Function]
   754 E C0037083:signaling pathway [Cell Function]
           Signaling
   754 E C0086982:Signaling Pathway [Molecular Function]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
   744   C1880371:Diverse [Qualitative Concept]
   744   C3537152:signaling [Biologic Function]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those controlling neuronal gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "(Chen et al.,"

Phrase: "1999a"

Phrase: "; De Sarno et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.275: It is not known which if any of these characteristics of valproate contribute to its physiological properties in the treatment of epilepsy and bipolar disorder. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "which"

Phrase: "if"

Phrase: "any of these characteristics of valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0080356:Valproate [Lipid,Pharmacologic Substance]
   753   C1521970:Characteristics [Qualitative Concept]
   753   C1552551:Any [Qualitative Concept]
   753   C3272371:ANY [Intellectual Product]

Phrase: "contribute to its physiological properties"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205463:Physiological [Functional Concept]
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   760   C1880177:Contribute [Activity]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of epilepsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014544:Epilepsy [Disease or Syndrome]

Phrase: "and"

Phrase: "bipolar disorder."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005586:Bipolar Disorder [Mental or Behavioral Dysfunction]
   861   C0012634:Disorder [Disease or Syndrome]
   861   C0443156:Bipolar [Spatial Concept]
Processing 00000000.tx.276: It has recently been demonstrated that GRP78/BiP protein and mRNA levels are increased in the cerebral cortex of rats injected with valproate as well as in rat C6 glioma cells treated with valproate (Wang et al., 1999; Brown et al., 2000). 

Phrase: "It"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that GRP78/BiP protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0063423:BiP Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in the cerebral cortex of rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1176472:Cortex [Body Part, Organ, or Organ Component]
   748   C2700441:Cortex [Plant]

Phrase: "injected with valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]
   756   C1720154:Inject [Functional Concept]

Phrase: "as well as in rat C6 glioma cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   767   C2347578:Cells/well [Quantitative Concept]
   744   C0007634:Cells [Cell]
   744   C0017638:Glioma [Neoplastic Process]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0205170:Well [Qualitative Concept]
   744   C0555198:[M]Glioma NOS [Neoplastic Process]
   744   C2984291:Glioma [Functional Concept]
   744   C3146287:Well [Manufactured Object]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "treated with valproate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(Wang et al.,"

Phrase: "1999"

Phrase: "; Brown et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.277: We have shown that in HepG2 cells, valproate increases protein levels of GRP78/BiP, GRP94, calreticulin, PDI as well as HSP70. 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in HepG2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2717940:HepG2 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "protein levels of GRP78/BiP,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0063423:BiP Protein [Amino Acid, Peptide, or Protein,Enzyme]
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "GRP94,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0120372:GRP94 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1825546:GRP94 [Gene or Genome]

Phrase: "calreticulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "PDI"

Phrase: "as well as"

Phrase: "HSP70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.278: The mechanism by which valproate enhances ER chaperone gene expression is not clear but appears to be independent of the UPR pathway of induction for two reasons. 

Phrase: "The mechanism by which valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "ER chaperone gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0017262:Gene Expression [Genetic Function]
   840   C1332924:Chaperone Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "but"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be independent of the UPR pathway of induction"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   782   C1155342:Unfolded Protein Response [Molecular Function]
   760   C0332291:Independent of [Functional Concept]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0085862:Independent [Idea or Concept]
   739   C0205263:Induction [Functional Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]
   739   C0871261:Response [Organism Attribute]
   739   C1299583:Independent [Finding]
   739   C1704259:Pathway [Molecular Function]
   739   C1704632:Response [Finding]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
   739   C2987476:Be [Conceptual Entity]

Phrase: "for two reasons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.279: First, induction of GRP78/BiP by the UPR has been shown to require PERK-dependent phosphorylation of eIF2 (Scheuner et al., 2001). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "induction of GRP78/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "require"

Phrase: "PERK-dependent phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "of eIF2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439095:Alpha [Intellectual Product]
   804   C0589507:Initiation [Mental Process]
   804   C1158830:Initiation [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1704686:Initiation [Functional Concept]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "(Scheuner et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.280: We have shown that valproate promotes the expression of GRP78/BiP and other chaperones in a manner that is independent of eIF2 phosphorylation (Fig. 4). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the expression of GRP78/BiP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "other chaperones in a manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is independent of eIF2 phosphorylation"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   818   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332291:Independent of [Functional Concept]
   762   C1979845:Alpha 2 [Qualitative Concept]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0085862:Independent [Idea or Concept]
   742   C0439095:Alpha [Intellectual Product]
   742   C0589507:Initiation [Mental Process]
   742   C1158830:Initiation [Genetic Function]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1299583:Independent [Finding]
   742   C1521761:Factor [Functional Concept]
   742   C1704686:Initiation [Functional Concept]
   742   C2003941:Alpha [Intellectual Product]
   742   C2350010:Alpha [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.281: Second, the induction of ER resident chaperones by valproate requires prolonged cellular exposure: 48 hours in HepG2 cells (Fig. 3) and up to 7 days in rat glioma cells (Brown et al., 2000). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the induction of ER resident chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "requires"

Phrase: "prolonged cellular exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: ":"

Phrase: "48 hours in HepG2 cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439586:48 hours [Temporal Concept]
   806   C1442464:48 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and up to 7 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439228:days [Temporal Concept]
   760   C1515981:And [Idea or Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "in rat glioma cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Brown et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.282: By contrast, activation of the UPR results in the rapid induction of ER chaperone expression that is evident within 4 hours of exposure to an ER stress-inducing agent (Figs 4 and 5). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "activation of the UPR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "results in the rapid induction of ER chaperone expression"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205263:Induction [Functional Concept]
   739   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439831:Rapid [Qualitative Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "that"

Phrase: "is"

Phrase: "evident within 4 hours of exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence of [Functional Concept]

Phrase: "to an ER stress-inducing agent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0450442:Agent [Chemical Viewed Functionally]
   804   C1254351:Agent [Pharmacologic Substance]
   804   C1521826:Agent [Intellectual Product]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "(Figs 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.283: The differing kinetics of ER chaperone accumulation suggest that valproate acts indirectly on gene transcription through a pathway distinct from the UPR. 

Phrase: "The differing kinetics of ER chaperone accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0022702:Kinetics [Natural Phenomenon or Process]
   744   C0220865:kinetics [Functional Concept]
   744   C2825046:Kinetics [Occupation or Discipline]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "indirectly on gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0040649:Gene Transcription [Genetic Function]
           Transcription
   770   C0017337:Gene [Gene or Genome]

Phrase: "through a pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "distinct from the UPR."
Processing 00000000.tx.284: The existence for such a pathway is supported by the ability of mitogens including interleukin 3 (IL3) and erythropoietin to activate GRP78/BiP and GRP94 expression in non-stressed myeloid FDC-P1.2 cells (Brewer et al., 1997). 

Phrase: "The existence for such"

Phrase: "a pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "supported by the ability of mitogens"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0026249:Mitogens [Pharmacologic Substance]
   753   C0085732:Ability [Organism Attribute]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0183683:Support [Medical Device]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "interleukin 3 (IL3)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021757:Interleukin-3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334117:INTERLEUKIN 3 [Gene or Genome]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "erythropoietin to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0014822:Erythropoietin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0357126:ERYTHROPOIETIN [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0376541:Erythropoietin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1755594:erythropoietin [Molecular Function]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "GRP78/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415761:BIP [Gene or Genome]

Phrase: "and"

Phrase: "GRP94 expression in non-stressed myeloid FDC-P1.2 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Brewer et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.285: The significance of this pathway with regard to cellular function and response to unfolded proteins is not known. 

Phrase: "The significance of this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "with regard to cellular function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0007613:Cellular Function [Cell Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "response to unfolded proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   991   C1155342:response to unfolded protein [Molecular Function]
           Unfolded Protein Response
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.286: Our observation that valproate could protect HepG2 cells from ER stress-induced lipid accumulation and apoptosis (Figs 1 and 2), led us to investigate the possibility that this protection was a result of the ability of valproate to increase ER chaperone levels and thereby relieve the burden of unfolded proteins in the ER. 

Phrase: "Our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "could"

Phrase: "protect"

Phrase: "HepG2 cells from ER stress-induced lipid accumulation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   764   C2717940:HepG2 Cells [Cell]
   745   C0229606:Reticulum cell [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Figs 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "this protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "a result of the ability of valproate to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "ER chaperone levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "thereby"

Phrase: "relieve"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301676:relieve [Functional Concept]
   916 E C0332303:relieving [Functional Concept]
   916 E C1301771:Relieved [Qualitative Concept]

Phrase: "the burden of unfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2828008:Burden [Idea or Concept]

Phrase: "in the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.287: However, upon further examination, this mechanism was discounted for two reasons. 

Phrase: "However,"

Phrase: "upon further examination,"

Phrase: "this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "was"

Phrase: "discounted for two reasons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205448:Two [Quantitative Concept]
   770   C0392360:reasons [Idea or Concept]
   737   C1555671:discount [Intellectual Product]
Processing 00000000.tx.288: First, valproate-conferred protection occurs at least 20 hours before the observed increase in ER chaperone levels (Figs 1, 2, 3). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "valproate-conferred protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1545588:Protection [Finding]

Phrase: "occurs at least 20 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0439227:hours [Temporal Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "before the observed increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in ER chaperone levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Figs 1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.289: Second, cells pretreated with valproate, despite exhibiting increased resistance to disrupted lipid metabolism and apoptosis, mounted a similar ER stress response when challenged with agents that cause protein misfolding (Fig. 5). 

Phrase: "Second, cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated with valproate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "despite"

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "increased resistance to disrupted lipid metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0332325:Resistant to [Functional Concept]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: "and"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "mounted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]

Phrase: "a similar ER stress response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0149784:stress response [Physiologic Function]
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "when"

Phrase: "challenged with agents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0450442:Agent [Chemical Viewed Functionally]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C1254351:Agent [Pharmacologic Substance]
   756   C1521826:Agent [Intellectual Product]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "protein misfolding"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.290: In these experiments an ER stress response was defined as the increased phosphorylation of eIF2 by activated PERK on serine52. 

Phrase: "In these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "an ER stress response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0149784:stress response [Physiologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "defined as the increased phosphorylation of eIF2"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   797   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1979845:Alpha 2 [Qualitative Concept]
   738   C0031715:Phosphorylation [Molecular Function]
   738   C0205217:Increased [Quantitative Concept]
   738   C0439095:Alpha [Intellectual Product]
   738   C0442805:Increased [Functional Concept]
   738   C0589507:Initiation [Mental Process]
   738   C1158830:Initiation [Genetic Function]
   738   C1158886:Phosphorylation [Molecular Function]
   738   C1521761:Factor [Functional Concept]
   738   C1704686:Initiation [Functional Concept]
   738   C1704788:Defined [Conceptual Entity]
   738   C2003941:Alpha [Intellectual Product]
   738   C2350010:Alpha [Qualitative Concept]
   738   C2827422:Factor [Conceptual Entity]
   738   C3539106:Defined [Intellectual Product]

Phrase: "by activated PERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on serine52."
Processing 00000000.tx.291: This has been identified as one of the earliest events in the UPR and occurs within 60 minutes of addition of an agent such as tunicamycin or A23187 (Harding et al., 2000). 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "identified as one of the earliest events"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205396:Identified [Qualitative Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0441471:Events [Event]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C3541888:Events [Classification]
   714   C1279919:Early [Temporal Concept]

Phrase: "in the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "occurs within 60 minutes of addition of an agent"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0439232:minute [Temporal Concept]
   742   C0450442:Agent [Chemical Viewed Functionally]
   742   C0700321:minute [Quantitative Concept]
   742   C0702093:/minute [Temporal Concept]
   742   C1254351:Agent [Pharmacologic Substance]
   742   C1282918:Minute [Quantitative Concept]
   742   C1521826:Agent [Intellectual Product]
   742   C1709305:Occur [Activity]
   742   C1883712:Addition [Functional Concept]
   742   C2347166:Minute [Quantitative Concept]
   742   C2745955:OCCUR [Temporal Concept]

Phrase: "such as tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "(Harding et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.292: Other indicators of ER stress including induction of GADD153 expression were also not effected by valproate pretreatment. 

Phrase: "Other indicators of ER stress"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1718172:Other indicators [Finding]
   753   C0021212:Indicators [Indicator, Reagent, or Diagnostic Aid]
   719 E C1235732:Indicator [Bird]
   719 E C1522602:Indicator [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "induction of GADD153 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "effected by valproate pretreatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0080356:Valproate [Lipid,Pharmacologic Substance]
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]
   737   C1280500:Effect [Qualitative Concept]
   737   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.293: These findings suggest that valproate does not directly protect HepG2 cells from ER stress but instead acts at some subsequent stage to block the onset of cellular complications that are induced by ER stress. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "protect"

Phrase: "HepG2 cells from ER stress"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C2717940:HepG2 Cells [Cell]
   767   C0229606:Reticulum cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "instead"

Phrase: "acts at some subsequent stage to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0205390:Stage [Temporal Concept]
   753   C0332282:Subsequent [Temporal Concept]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the onset of cellular complications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "induced by ER stress."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C0205263:Induced [Functional Concept]
Processing 00000000.tx.294: The inability of valproate-induced ER chaperone protein levels to protect cells from ER stress is probably a result of the comparatively low levels of chaperone induction observed relative to the previously utilized GRP78/BiP-overexpressing cell lines (Werstuck et al., 2001). 

Phrase: "The inability of valproate-induced ER chaperone protein levels to"

Phrase: "protect"

Phrase: "cells from ER stress"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0229606:Reticulum cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "a result of the comparatively low levels of chaperone induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "relative to the previously utilized GRP78/BiP-overexpressing cell lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "(Werstuck et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.295: It is also possible that the increase in chaperone levels observed in valproate-treated cells is offset by a corresponding increase in the load of folding proteins in the ER under the conditions tested. 

Phrase: "It"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the increase in chaperone levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "observed in valproate-treated cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0080356:Valproate [Lipid,Pharmacologic Substance]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "offset by a corresponding increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   760   C1711330:Offset [Quantitative Concept]

Phrase: "in the load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "of folding proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0162847:folding protein [Molecular Function]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.296: The ability of valproate to inhibit GSK3/ (Fig. 6B) together with the observation that lithium and a synthetic GSK3 inhibitor can mimic the ability of valproate to block cholesterol accumulation in cells exposed to ER stress (Fig. 7B,C) suggests that GSK3 plays a central role in signaling from the ER. 

Phrase: "The ability of valproate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: "together with the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "a synthetic GSK3 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "can"

Phrase: "mimic"

Phrase: "the ability of valproate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "cholesterol accumulation in cells"

Phrase: "exposed to ER stress"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]

Phrase: "(Fig. 7B,"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "from the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.297: This observation is consistent with a previous report indicating that GSK3 plays a central role in ER stress-induced apoptosis (Song et al., 2002). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "consistent with a previous report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "indicating"

Phrase: "that GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in ER stress-induced apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(Song et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.298: GSK3/ were initially identified as two homologous kinases that phosphorylate the rate-limiting enzyme in glycogen synthesis, glycogen synthase (Plyte et al., 2002). 

Phrase: "GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "identified as two homologous kinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205396:Identified [Qualitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1334043:Homologous [Gene or Genome]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "phosphorylate"

Phrase: "the rate-limiting enzyme in glycogen synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0597548:synthetic enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Plyte et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.299: Over the last 20 years the list of GSK3 substrates has grown to encompass a broad array of proteins that are involved in several important regulatory and developmental pathways including translation initiation factor eIF2, transcription factors CREB, c-Jun, c-Myc, c-Myb, HSF-1, ATP-citrate lysase and tau (Doble and Woodgett, 2003). 

Phrase: "Over the last 20 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "the list of GSK3 substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0745732:List [Conceptual Entity]
   760   C3272378:LIST [Intellectual Product]

Phrase: "has"

Phrase: "grown"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "encompass"

Phrase: "a broad array of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1136346:Protein Array [Medical Device,Research Device]
   760   C1510941:Array [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "involved in several important regulatory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220905:regulatory [Regulation or Law]
   760   C1314939:Involved [Functional Concept]
   760   C1704735:Regulatory [Conceptual Entity]

Phrase: "and"

Phrase: "developmental pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "translation initiation factor eIF2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   869   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Translational Initiation Factor 2
   861   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0439095:Alpha [Intellectual Product]
   793   C2003941:Alpha [Intellectual Product]
   793   C2350010:Alpha [Qualitative Concept]

Phrase: "transcription factors CREB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "c-Jun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "c-Myc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "c-Myb,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751993:c myb [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "HSF-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519740:HSF-1 [Cell]
  1000   C2348945:HSF 1 [Amino Acid, Peptide, or Protein]
   861   C0021760:HSF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1334122:HSF [Gene or Genome]
   861   C1527132:HSF [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "ATP-citrate lysase"

Phrase: "and"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(Doble"

Phrase: "and"

Phrase: "Woodgett,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.300: Valproate and lithium have previously been reported to inhibit GSK3 through direct (Chen et al., 1999a) and/or indirect mechanisms (De Sarno et al., 2002). 

Phrase: "Valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "have"

Phrase: "previously"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3 through direct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Chen et al.,"

Phrase: "1999a"

Phrase: ")"

Phrase: "and/or"

Phrase: "indirect mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "(De Sarno et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.301: Our results using both recombinant GSK3s as well as GSK3 immunoprecipitated from HepG2 cell lysates indicate that physiological concentrations of valproate directly inhibit GSK3 in vitro and GSK3 and - activity in vivo (Fig. 6). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both recombinant GSK3s"

Phrase: "as well as"

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "immunoprecipitated from HepG2 cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C2717940:HepG2 Cell [Cell]
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "indicate"

Phrase: "that physiological concentrations of valproate directly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.302: Together these findings indicate that in HepG2 cells ER dysfunction triggers cellular responses that can lead to lipid accumulation and/or apoptosis. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that in HepG2 cells ER dysfunction"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   778   C2717940:HepG2 Cells [Cell]
   757   C0229606:Reticulum cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0031847:dysfunction [Functional Concept]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0277785:Dysfunction, NOS [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "cellular responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "can"

Phrase: "lead to lipid accumulation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0333574:Lipid accumulation [Finding]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0023779:Lipid [Lipid]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.303: Although it is still not clear if GSK3/ activity is enhanced under conditions of ER stress, a role for GSK3/ is implied by the ability of several different inhibitors of this kinase to block both ER stress-induced lipid accumulation and apoptosis. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "still"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "if"

Phrase: "GSK3/ activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "enhanced under conditions of ER stress,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0038435:Stress [Finding]
   748   C2349975:Enhanced [Activity]
   714   C0012634:condition [Disease or Syndrome]
   714   C0348080:Condition [Qualitative Concept]
   714   C1705253:Condition [Conceptual Entity]

Phrase: "a role for GSK3/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "implied by the ability of several different inhibitors of this kinase to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   751   C1152564:Kinase Inhibitors [Molecular Function]
   751   C3537035:inhibitors kinase [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   736   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0085732:Ability [Organism Attribute]
   736   C0243077:inhibitors [Chemical Viewed Functionally]
   736   C1705242:Different [Qualitative Concept]
   734 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   734 E C3537023:kinase inhibitor [Molecular Function]
   703 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "both ER stress-induced lipid accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333574:Lipid accumulation [Finding]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.304: GSK3/ has been recognized as a therapeutic target for the treatment of cancer and neurological disorders. 

Phrase: "GSK3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "recognized as a therapeutic target"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0302350:Therapeutic [Functional Concept]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "for the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "neurological disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027765:Neurological Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.305: These results suggest that this already diverse kinase may be involved in an even broader array of conditions and may represent a point of convergence between different pathways of disease progression. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this already diverse kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "involved in an even broader array of conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C1314939:Involved [Functional Concept]
   744   C1510941:Array [Spatial Concept]
   711   C0012634:condition [Disease or Syndrome]
   711   C0332464:Broad [Spatial Concept]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a point of convergence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2924612:A point [Body Location or Region]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "between different pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "of disease progression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242656:Disease Progression [Pathologic Function]
           progression
  1000   C1947900:Disease progression NOS [Finding]
   861   C0449258:Progression [Functional Concept]
Processing 00000000.tx.306: Further studies will be required in different cell types and in animal models to explore the potential efficacy of valproate on the development and progression of conditions associated with ER stress.  

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "required in different cell types"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0332307:Types [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1514873:Required [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705242:Different [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "and in animal models to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599779:Models, Animal [Animal]
   760   C0003062:Animal [Animal]
   760   C1515981:And [Idea or Concept]
   760   C3161035:Models [Intellectual Product]

Phrase: "explore"

Phrase: "the potential efficacy of valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:Efficacy [Qualitative Concept]
   760   C1707887:EFFICACY [Research Activity]

Phrase: "on the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "progression of conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "associated with ER stress."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.307: Acknowledgments  We would like to thank Jack Hirsh and Jeffrey Weitz for helpful comments and suggestions throughout the course of these studies. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "would like to"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Jack Hirsh"

Phrase: "and"

Phrase: "Jeffrey Weitz for helpful comments"

Phrase: "and"

Phrase: "suggestions throughout the course of these studies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0038659:Suggestions [Idea or Concept]
   714 E C1705535:suggestion [Idea or Concept]
Processing 00000000.tx.308: This work was supported by a Research Grant (MOP-62910) from the Canadian Institutes of Health Research (to G.H.W.).  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a Research Grant"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0260206:research grant [Research Activity]
   797   C0035176:research supported [Quantitative Concept]
   760   C0018173:Grant [Quantitative Concept]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1521721:Supported [Conceptual Entity]
   760   C1548284:Grant [Idea or Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "(MOP-62910"

Phrase: ")"

Phrase: "from the Canadian Institutes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0021622:Institutes [Organization]
   827 E C1272753:Institute [Idea or Concept]

Phrase: "of Health Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "("

Phrase: "to G.H.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0560020:g h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.309: References Top Summary Introduction Materials and Methods Results Discussion References  Aridor, M. and Balch, W. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Aridor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Balch,"

Phrase: "W."
Processing 00000000.tx.310: E. 

Phrase: "E."
Processing 00000000.tx.311: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.312: Integration of endoplasmic reticulum signaling in health and disease. 

Phrase: "Integration of endoplasmic reticulum signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1158478:Integration [Genetic Function]
   760   C1705422:Integration [Machine Activity]

Phrase: "in health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018684:Health [Idea or Concept]
   900 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.313: Nat. 

Phrase: "Nat."
Processing 00000000.tx.314: Med. 

Phrase: "Med."
Processing 00000000.tx.315: 5, 745-751.[CrossRef][Medline] Bittigau, P., Sifringer, M., Genz, K., Reith, E., Pospischil, D., Govindarajalu, S., Dzietko, M., Pesditschek, S., Mai, I., Dikranian, K. et al. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "745-751."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bittigau,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sifringer,"

Phrase: "M."

Phrase: ","

Phrase: "Genz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Reith,"

Phrase: "E.,"

Phrase: "Pospischil,"

Phrase: "D."

Phrase: ","

Phrase: "Govindarajalu,"

Phrase: "S."

Phrase: ","

Phrase: "Dzietko,"

Phrase: "M."

Phrase: ","

Phrase: "Pesditschek,"

Phrase: "S."

Phrase: ","

Phrase: "Mai,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026914:mai [Bacterium]
  1000   C1415341:MAI [Gene or Genome]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Dikranian,"

Phrase: "K. et al."
Processing 00000000.tx.316: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.317: Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. 

Phrase: "Antiepileptic drugs"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
  1000   C0003299:Antiepileptic Drugs [Pharmacologic Substance]
           Anti-epileptic
   983 E C3537002:Anti-epileptic Drug [Pharmacologic Substance]
           Anti-epileptic
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "apoptotic neurodegeneration in the developing brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.318: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.319: Natl. 

Phrase: "Natl."
Processing 00000000.tx.320: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.321: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.322: USA 99, 15089-15094.[Abstract/Free FullText] Bowden, C. 

Phrase: "USA 99,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "15089-15094."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bowden,"

Phrase: "C."
Processing 00000000.tx.323: L., Brugger, A. 

Phrase: "L., Brugger,"

Phrase: "A."
Processing 00000000.tx.324: M., Swann, A. 

Phrase: "M."

Phrase: ","

Phrase: "Swann,"

Phrase: "A."
Processing 00000000.tx.325: C., Calabrese, J. 

Phrase: "C., Calabrese,"

Phrase: "J."
Processing 00000000.tx.326: R., Janicak, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Janicak,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.327: G., Petty, F., Dilsaver, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Petty,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Dilsaver,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.328: C., Davis, J. 

Phrase: "C., Davis,"

Phrase: "J."
Processing 00000000.tx.329: M., Rush, A. 

Phrase: "M."

Phrase: ","

Phrase: "Rush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443052:Rush [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.330: J., Small, J. 

Phrase: "J.,"

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.331: G. et al. 

Phrase: "G. et al."
Processing 00000000.tx.332: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.333: Efficacy of divalproex vs lithium and placebo in the treatment of mania. 

Phrase: "Efficacy of divalproex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280519:Efficacy [Qualitative Concept]
   790   C1707887:EFFICACY [Research Activity]

Phrase: "vs"

Phrase: "lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "placebo in the treatment of mania."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0032042:placebo [Therapeutic or Preventive Procedure]
   753   C1696465:placebo [Biomedical or Dental Material]
   753   C1706408:PLACEBO [Research Activity]
Processing 00000000.tx.334: The Depakote Mania Study Group. 

Phrase: "The Depakote Mania Study Group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0441833:Group [Idea or Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.335: J. 

Phrase: "J."
Processing 00000000.tx.336: Am. 

Phrase: "Am."
Processing 00000000.tx.337: Med. 

Phrase: "Med."
Processing 00000000.tx.338: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.339: 271, 918-924.[Abstract] Brewer, J. 

Phrase: "271,"

Phrase: "918-924."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.340: W., Cleveland, J. 

Phrase: "W., Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454845:Cleveland [Geographic Area]

Phrase: "J."
Processing 00000000.tx.341: L. and Hendershot, L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hendershot,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.342: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.343: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.344: A pathway distinct from the mammalian unfolded protein response regulates expression of endoplasmic reticulum chaperones in non-stressed cells. 

Phrase: "A pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "distinct from the mammalian unfolded protein response"

Phrase: "regulates"

Phrase: "expression of endoplasmic reticulum chaperones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in non-stressed cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.345: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.346: 16, 7207-7216.[Abstract/Free FullText] Brown, M. 

Phrase: "16,"

Phrase: "7207-7216."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.347: S. and Goldstein, J. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Goldstein,"

Phrase: "J."
Processing 00000000.tx.348: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.349: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.350: A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. 

Phrase: "A proteolytic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the cholesterol content of membranes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.351: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.352: Natl. 

Phrase: "Natl."
Processing 00000000.tx.353: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.354: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.355: USA 96, 11041-11048.[Abstract/Free FullText] Brown, C. 

Phrase: "USA 96,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "11041-11048."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "C."
Processing 00000000.tx.356: D., Wang, J. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "J."
Processing 00000000.tx.357: F. and Young, L. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Young, L."
Processing 00000000.tx.358: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.359: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.360: Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells. 

Phrase: "Increased expression of endoplasmic reticulum stress proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "chronic valproate treatment of rat C6 glioma cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.361: Neuropharmacology 39, 2162-2169.[CrossRef][Medline] Chen, G., Huang, L.-D., Jiang, Y.-M. and Manji, H. 

Phrase: "Neuropharmacology 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027896:Neuropharmacology [Biomedical Occupation or Discipline]

Phrase: "2162-2169."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Huang,"

Phrase: "L.-D.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Jiang,"

Phrase: "Y.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Manji,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.362: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.363: (1999a). 

Phrase: "(1999a"

Phrase: ")."
Processing 00000000.tx.364: The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. 

Phrase: "The mood-stabilizing agent valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0080356:Valproate [Lipid,Pharmacologic Substance]
   756   C1533054:Mood stabilizing agent [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the activity of glycogen synthase kinase-3."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   879   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   840   C2261482:glycogen synthase kinase activity [Molecular Function]
   804   C1152133:glycogen synthase activity [Molecular Function]
   774   C1150423:kinase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.365: J. 

Phrase: "J."
Processing 00000000.tx.366: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.367: 72, 1327-1330.[CrossRef][Medline] Chen, G., Yuan, P. 

Phrase: "72,"

Phrase: "1327-1330."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yuan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.368: X., Jiang, Y. 

Phrase: "X.,"

Phrase: "Jiang,"

Phrase: "Y."
Processing 00000000.tx.369: M., Huang, L. 

Phrase: "M."

Phrase: ","

Phrase: "Huang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.370: D. and Manji, H. 

Phrase: "D."

Phrase: "and"

Phrase: "Manji,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.371: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.372: (1999b). 

Phrase: "(1999b"

Phrase: ")."
Processing 00000000.tx.373: Valproate robustly enhances AP-1 mediated gene expression. 

Phrase: "Valproate robustly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "AP-1 mediated gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0017262:Gene Expression [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.374: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.375: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.376: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.377: 64, 52-58.[Medline] De Sarno, P., Li, X. and Jope, R. 

Phrase: "64,"

Phrase: "52-58."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Sarno,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X."

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.378: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.380: Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. 

Phrase: "Regulation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "glycogen synthase kinase-3 beta phosphorylation by sodium valproate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "lithium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.381: Neuropharmacology 43, 1158-1164.[CrossRef][Medline] Doble, B. 

Phrase: "Neuropharmacology 43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027896:Neuropharmacology [Biomedical Occupation or Discipline]

Phrase: "1158-1164."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Doble,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.382: W. and Woodgett, J. 

Phrase: "W."

Phrase: "and"

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.383: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.384: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.385: GSK-3: tricks of the trade for a multi-tasking kinase. 

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "tricks of the trade"

Phrase: "for a multi-tasking kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.386: J. 

Phrase: "J."
Processing 00000000.tx.387: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.388: 116, 1175-1186.[Abstract/Free FullText] Friedlander, R., Jarosch, E., Urban, J., Volkwein, C. and Sommer, T. 

Phrase: "116,"

Phrase: "1175-1186."

Phrase: "[Abstract/Free FullText"

Phrase: "] Friedlander,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jarosch,"

Phrase: "E.,"

Phrase: "Urban,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442529:Urban [Geographic Area]
  1000   C2700386:Urban [Qualitative Concept]

Phrase: "J.,"

Phrase: "Volkwein,"

Phrase: "C."

Phrase: "and"

Phrase: "Sommer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.389: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.390: A regulatory link between ER-associated protein degradation and the unfolded-protein response. 

Phrase: "A regulatory link between ER-associated protein degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1517892:Link [Intellectual Product]
   742   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the unfolded-protein response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.391: Nat. 

Phrase: "Nat."
Processing 00000000.tx.392: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.393: 2, 379-384.[CrossRef][Medline] Gething, M. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "379-384."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gething,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.394: J. and Sambrook, J. 

Phrase: "J."

Phrase: "and"

Phrase: "Sambrook,"

Phrase: "J."
Processing 00000000.tx.395: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.396: Protein folding in the cell. 

Phrase: "Protein folding in the cell."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0162847:protein folding [Molecular Function]
   760   C0185026:Folding [Therapeutic or Preventive Procedure]
Processing 00000000.tx.397: Nature 355, 33-45.[CrossRef][Medline] Harding, H., Novoa, I., Zhang, Y., Zeng, H., Schapira, M. and Ron, D. 

Phrase: "Nature 355,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "33-45."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harding,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Novoa,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Zeng,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schapira,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ron,"

Phrase: "D."
Processing 00000000.tx.398: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.399: Regulated translation initiation controls stress-induced gene expression in mammalian cells. 

Phrase: "Regulated translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1519613:Translation Initiation [Genetic Function]
   827   C0589507:Initiation [Mental Process]
   827   C1158830:Initiation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "stress-induced gene expression in mammalian cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0017262:Gene Expression [Genetic Function]
   757   C1861886:CELL Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.400: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.401: Cell 6, 1099-1108.[Medline] Harding, H. 

Phrase: "Cell 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1099-1108."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harding,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.402: P., Zeng, H., Zhang, Y., Jungries, R., Chung, P., Plesken, H., Sabatini, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zeng,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Jungries,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chung,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Plesken,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sabatini,"

Phrase: "D."
Processing 00000000.tx.403: D. and Ron, D. 

Phrase: "D."

Phrase: "and"

Phrase: "Ron,"

Phrase: "D."
Processing 00000000.tx.404: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.405: Diabetes mellitus and exocrine pancreatic dysfunction in perk/mice reveals a role for translational control in secretory cell survival. 

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "exocrine pancreatic dysfunction in perk/mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3151951:Exocrine pancreatic dysfunction [Finding]
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a role for translational control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in secretory cell survival."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007620:Cell Survival [Cell Function]
   901   C1519221:Secretory cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.406: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.407: Cell 7, 1153-1163.[CrossRef][Medline] Haze, K., Yoshida, H., Yanagi, H., Yura, T. and Mori, K. 

Phrase: "Cell 7,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1153-1163."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haze,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshida,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yanagi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yura,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.408: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.409: Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. 

Phrase: "Mammalian transcription factor ATF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412622:ATF6 [Gene or Genome]

Phrase: "is"

Phrase: "synthesized as a transmembrane protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1167322:transmembrane [Cell Component]
   760   C1883254:Synthesized [Activity]
   760   C2752508:transmembrane [Cell Component]

Phrase: "and"

Phrase: "activated by proteolysis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0597304:Proteolysis [Molecular Function]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]
   718 E C1947941:proteolytic [Enzyme]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to endoplasmic reticulum stress."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.410: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.411: Biol. 

Phrase: "Biol."
Processing 00000000.tx.412: Cell 10, 3787-3799.[Abstract/Free FullText] Helenius, A. 

Phrase: "Cell 10,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "3787-3799."

Phrase: "[Abstract/Free FullText"

Phrase: "] Helenius,"

Phrase: "A."
Processing 00000000.tx.413: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.414: How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. 

Phrase: "How N-linked oligosaccharides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028959:Oligosaccharides [Carbohydrate]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "glycoprotein folding in the endoplasmic reticulum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185026:Folding [Therapeutic or Preventive Procedure]
Processing 00000000.tx.415: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.416: Biol. 

Phrase: "Biol."
Processing 00000000.tx.417: Cell 5, 253-265.[Medline] Horton, J. 

Phrase: "Cell 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "253-265."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horton,"

Phrase: "J."
Processing 00000000.tx.418: D. and Shimomura, I. 

Phrase: "D."

Phrase: "and"

Phrase: "Shimomura,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.419: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.420: Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. 

Phrase: "Sterol regulatory element-binding proteins"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C1566548:Sterol Regulatory Element Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C2246292:sterol binding [Molecular Function]
   840   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0038323:Sterol [Steroid]
   804   C0220905:regulatory [Regulation or Law]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704735:Regulatory [Conceptual Entity]
   804   C1705248:Element [Conceptual Entity]

Phrase: ":"

Phrase: "activators of cholesterol"

Phrase: "and"

Phrase: "fatty acid biosynthesis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596562:fatty acid biosynthesis [Molecular Function]
  1000   C2981166:Fatty acid biosynthesis [Functional Concept]
   827   C0005572:biosynthesis [Functional Concept]
   827   C0220781:Biosynthesis [Biologic Function]
   734   C0015684:Fatty acid [Lipid]
Processing 00000000.tx.421: Curr. 

Phrase: "Curr."
Processing 00000000.tx.422: Opin. 

Phrase: "Opin."
Processing 00000000.tx.423: Lipidol. 

Phrase: "Lipidol."
Processing 00000000.tx.424: 10, 143-150.[CrossRef][Medline] Hossain, G. 

Phrase: "10,"

Phrase: "143-150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hossain,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.425: S., van Thienen, J. 

Phrase: "S."

Phrase: ","

Phrase: "van Thienen,"

Phrase: "J."
Processing 00000000.tx.426: V., Werstuck, G. 

Phrase: "V., Werstuck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.427: H., Zhou, J., Sood, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zhou,"

Phrase: "J.,"

Phrase: "Sood,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.428: K., Dickhout, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dickhout,"

Phrase: "J."
Processing 00000000.tx.429: G., de Koning, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "de Koning,"

Phrase: "A."
Processing 00000000.tx.430: B., Tang, D., Wu, D., Falk, E. et al. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tang,"

Phrase: "D."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "D."

Phrase: ","

Phrase: "Falk,"

Phrase: "E. et al."
Processing 00000000.tx.431: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.432: TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. 

Phrase: "TDAG51"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418540:TDAG51 [Gene or Genome]

Phrase: "is"

Phrase: "induced by homocysteine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019878:homocysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0019879:Homocystine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "detachment-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0541879:detachment [Mental Process]
  1000   C0595950:Detachment [Pathologic Function]
   928 E C0687118:Detached [Functional Concept]
   928 E C1561504:detached [Idea or Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "programmed cell death,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "contributes to the cevelopment of atherosclerosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004153:Atherosclerosis [Disease or Syndrome]
   753   C1880177:Contribute [Activity]

Phrase: "in hyperhomocysteinemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0598608:Hyperhomocysteinemia [Disease or Syndrome]
  1000   C3495426:HYPERHOMOCYSTEINEMIA [Disease or Syndrome]
Processing 00000000.tx.433: J. 

Phrase: "J."
Processing 00000000.tx.434: Biol. 

Phrase: "Biol."
Processing 00000000.tx.435: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.436: 278, 30317-30327.[Abstract/Free FullText] Jimbo, A., Fujita, E., Kouroku, Y., Ohnishi, J., Inohara, N., Kuida, K., Sakamaki, K., Yonehara, S. and Momoi, T. 

Phrase: "278,"

Phrase: "30317-30327."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jimbo,"

Phrase: "A.,"

Phrase: "Fujita,"

Phrase: "E.,"

Phrase: "Kouroku,"

Phrase: "Y.,"

Phrase: "Ohnishi,"

Phrase: "J.,"

Phrase: "Inohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kuida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakamaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yonehara,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Momoi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.437: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.438: ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. 

Phrase: "ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "caspase-8 activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "cytochrome c release"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   734   C1153524:cytochrome c [Molecular Function]
   734   C1426584:CYTOCHROME C [Gene or Genome]

Phrase: "and"

Phrase: "caspase-9 activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.439: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.440: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.441: 283, 156-166.[CrossRef][Medline] Johnson, R. 

Phrase: "283,"

Phrase: "156-166."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: J., Liu, N., Shanmugaratnam, J. and Fine, R. 

Phrase: "J.,"

Phrase: "Liu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shanmugaratnam,"

Phrase: "J."

Phrase: "and"

Phrase: "Fine, R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.443: E. 

Phrase: "E."
Processing 00000000.tx.444: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.445: Increased calreticulin stability in differentiated NG-108-15 cells correlates with resistance to apoptosis induced by antisense treatment. 

Phrase: "Increased calreticulin stability in differentiated NG-108-15 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205360:Stability [Qualitative Concept]
   742   C2347098:Stability [Qualitative Concept]

Phrase: "correlates with resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0237834:Resistance [Mental Process]
   790   C1514892:Resistance [Physiologic Function]
   718 E C0332325:Resistant [Functional Concept]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "to apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by antisense treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205263:Induced [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.446: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.447: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.448: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.449: 53, 104-111.[CrossRef][Medline] Katayama, T., Imaizumi, K., Honda, A., Yoneda, T., Kudo, T., Takeda, M., Mori, K., Rozmahel, R., Fraser, P., George-Hyslop, P. 

Phrase: "53,"

Phrase: "104-111."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katayama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Imaizumi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Honda,"

Phrase: "A.,"

Phrase: "Yoneda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kudo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takeda,"

Phrase: "M."

Phrase: ","

Phrase: "Mori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rozmahel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.450: S. and Tohyama, M. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Tohyama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.451: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.452: Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations. 

Phrase: "Disturbed activation of endoplasmic reticulum stress transducers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "by familial Alzheimer's disease-linked presenilin-1 mutations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   795   C0026882:Mutations [Genetic Function]
   762 E C1705285:Mutation [Cell or Molecular Dysfunction]
   701   C2931257:Alzheimer disease 1 [Disease or Syndrome]
Processing 00000000.tx.453: J. 

Phrase: "J."
Processing 00000000.tx.454: Biol. 

Phrase: "Biol."
Processing 00000000.tx.455: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.456: 46, 43446-43454.[CrossRef] Kaufman, R. 

Phrase: "46,"

Phrase: "43446-43454."

Phrase: "[CrossRef"

Phrase: "] Kaufman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.457: J. 

Phrase: "J."
Processing 00000000.tx.458: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.459: Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. 

Phrase: "Stress signaling from the lumen of the endoplasmic reticulum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0037083:Signaling [Cell Function]
   742   C3537152:signaling [Biologic Function]

Phrase: ":"

Phrase: "coordination of gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242414:Coordination [Physiologic Function]
   790   C0700114:Coordination [Functional Concept]

Phrase: "transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcriptional [Genetic Function]

Phrase: "and"

Phrase: "translational controls."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1519614:Translational [Genetic Function]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   789 E C0040712:Translation [Intellectual Product]
   789 E C0597295:translation [Molecular Function]
Processing 00000000.tx.460: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.461: 13, 1211-1233.[Free FullText] Kruth, H. 

Phrase: "13,"

Phrase: "1211-1233."

Phrase: "[Free FullText"

Phrase: "] Kruth,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.462: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.463: (1984). 

Phrase: "(1984"

Phrase: ")."
Processing 00000000.tx.464: Histochemical detection of esterified cholesterol within human atherosclerotic lesions using the fluorescent probe filipin. 

Phrase: "Histochemical detection of esterified cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "within human atherosclerotic lesions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0221198:lesions [Finding]
   827   C0333482:Atherosclerotic [Functional Concept]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the fluorescent probe filipin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0016095:Filipin [Antibiotic,Organic Chemical]
   734   C0016321:fluorescent probe [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.465: Atherosclerosis 51, 281-292.[Medline] Kuznetsov, G., Chen, L. 

Phrase: "Atherosclerosis 51,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004153:Atherosclerosis [Disease or Syndrome]
   789 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "281-292."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuznetsov,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.466: B. and Nigam, S. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Nigam,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.467: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.468: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.469: Multiple molecular chaperones complex with misfolded large oligomeric glycoproteins in the endoplasmic reticulum. 

Phrase: "Multiple molecular chaperones complex with misfolded large oligomeric glycoproteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in the endoplasmic reticulum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.470: J. 

Phrase: "J."
Processing 00000000.tx.471: Biol. 

Phrase: "Biol."
Processing 00000000.tx.472: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.473: 272, 3057-3063.[Abstract/Free FullText] Lee, A. 

Phrase: "272,"

Phrase: "3057-3063."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "A."
Processing 00000000.tx.474: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.476: The glucose-regulated proteins: stress induction and clinical applications. 

Phrase: "The glucose-regulated proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0061421:glucose-regulated proteins [Amino Acid, Peptide, or Protein,Receptor]
   896   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ":"

Phrase: "stress induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "clinical applications."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0185125:applications [Health Care Activity]
   827 E C1947919:Application [Intellectual Product]
   827 E C2347934:Application [Intellectual Product]
   827 E C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.477: Trends Biol. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biol."
Processing 00000000.tx.478: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.479: 26, 504-510.[CrossRef] Lee, A.-H., Iwakoshi, N. 

Phrase: "26,"

Phrase: "504-510."

Phrase: "[CrossRef"

Phrase: "] Lee,"

Phrase: "A.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Iwakoshi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.480: N. and Glimcher, L. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Glimcher,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.481: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.482: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.483: XBP-1 regulates a subset of endoplasmic reticulum resident chaperone gene in the unfolded protein response. 

Phrase: "XBP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825104:XBP-1 [Amino Acid, Peptide, or Protein]

Phrase: "regulates"

Phrase: "a subset of endoplasmic reticulum resident chaperone gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1515021:Subset [Classification]

Phrase: "in the unfolded protein response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.484: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.485: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.486: Biol. 

Phrase: "Biol."
Processing 00000000.tx.487: 23, 7448-7459.[Abstract/Free FullText] Liu, H., Bowes, R. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "7448-7459."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bowes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.488: C., III, van de Water, B., Sillence, C., Nagelkerke, J. 

Phrase: "C., III,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1547548:C-III [Regulation or Law]
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "van de Water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Sillence,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nagelkerke,"

Phrase: "J."
Processing 00000000.tx.489: F. and Stevens, J. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "J."
Processing 00000000.tx.490: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.491: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.492: Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. 

Phrase: "Endoplasmic reticulum chaperones GRP78"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0063423:GRP78 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1415761:GRP78 [Gene or Genome]
   812   C1708295:GRP78 [Gene or Genome]

Phrase: "and"

Phrase: "calreticulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "Ca2+ disturbances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699787:Disturbance [Qualitative Concept]

Phrase: "and"

Phrase: "cell death in renal epithelial cells."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007587:Cell Death [Cell Function]
           cells death
   783   C0553257:Renal cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.493: J. 

Phrase: "J."
Processing 00000000.tx.494: Biol. 

Phrase: "Biol."
Processing 00000000.tx.495: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.496: 272, 21751-21759.[Abstract/Free FullText] MacDonald, R. 

Phrase: "272,"

Phrase: "21751-21759."

Phrase: "[Abstract/Free FullText"

Phrase: "] MacDonald,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.497: L. and Bergey, G. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Bergey,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.498: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.499: (1979). 

Phrase: "(1979"

Phrase: ")."
Processing 00000000.tx.500: Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurons. 

Phrase: "Valproic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042291:Valproic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "GABA-mediated postsynaptic inhibition in cultured mammalian neurons."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
   725   C0234074:Neuronal inhibition [Organ or Tissue Function]
Processing 00000000.tx.501: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.502: 170, 558-562.[CrossRef][Medline] McElroy, S. 

Phrase: "170,"

Phrase: "558-562."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McElroy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.503: L. and Keck, P. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Keck,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.504: E., Jr (1995). 

Phrase: "E.,"

Phrase: "Jr (1995"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.505: Textbook of Psychopharmacology (ed. A. F. Schatzberg and C. B. Nemeroff), pp. 

Phrase: "Textbook of Psychopharmacology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0039712:textbook [Intellectual Product,Manufactured Object]

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: "A. F. Schatzberg"

Phrase: "and"

Phrase: "C. B. Nemeroff"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.506: 351-375. 

Phrase: "351-375."
Processing 00000000.tx.507: Washington, DC: American Psychiatric Press. 

Phrase: "Washington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:Washington [Geographic Area]

Phrase: "DC"

Phrase: ":"

Phrase: "American Psychiatric Press."
Processing 00000000.tx.508: Mora, A., Gonzalez-Polo, R. 

Phrase: "Mora,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1077713:Mora [Plant]
  1000   C1460829:Mora [Fish]

Phrase: "A.,"

Phrase: "Gonzalez-Polo,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.509: A., Fuentes, J. 

Phrase: "A.,"

Phrase: "Fuentes,"

Phrase: "J."
Processing 00000000.tx.510: M., Soler, G. and Centeno, F. 

Phrase: "M."

Phrase: ","

Phrase: "Soler,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Centeno,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.511: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.512: Different mechanisms of protection against apoptosis by valproate and Li+. 

Phrase: "Different mechanisms of protection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "against apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "by valproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080356:Valproate [Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "Li+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]
Processing 00000000.tx.513: Eur. 

Phrase: "Eur."
Processing 00000000.tx.514: J. 

Phrase: "J."
Processing 00000000.tx.515: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.516: 266, 886-891.[Abstract/Free FullText] Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. 

Phrase: "266,"

Phrase: "886-891."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakagawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Zhu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Morishima,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "J.,"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.517: A. and Yuan, J. 

Phrase: "A."

Phrase: "and"

Phrase: "Yuan,"

Phrase: "J."
Processing 00000000.tx.518: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.519: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. 

Phrase: "Caspase-12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0911469:Caspase 12 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "endoplasmic-reticulum-specific apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "cytotoxicity by amyloid-beta."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
Processing 00000000.tx.520: Nature 403, 98-103.[CrossRef][Medline] Ng, D. 

Phrase: "Nature 403,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "98-103."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ng,"

Phrase: "D."
Processing 00000000.tx.521: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.522: W., Spear, E. 

Phrase: "W., Spear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336708:Spear [Manufactured Object]

Phrase: "E."
Processing 00000000.tx.523: D. and Walter, P. 

Phrase: "D."

Phrase: "and"

Phrase: "Walter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.524: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.525: The unfolded protein response regulates multiple aspects of secretory and membrane protein biogenesis and endoplasmic reticulum quality control. 

Phrase: "The unfolded protein response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "regulates"

Phrase: "multiple aspects of secretory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547011:Aspect [Quantitative Concept]
   737   C1879746:Aspect [Qualitative Concept]

Phrase: "and"

Phrase: "membrane protein biogenesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0596898:membrane biogenesis [Cell Function]
   827   C0005495:Biogenesis [Natural Phenomenon or Process]
   827   C0220781:Biogenesis [Biologic Function]
   734   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "endoplasmic reticulum quality control."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0034378:quality control [Functional Concept]
   861   C1561524:Quality Control [Intellectual Product]
   861   C1610034:Quality Control [Intellectual Product]
   812   C0243148:control [Qualitative Concept]
   812   C0332306:Quality [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.526: J. 

Phrase: "J."
Processing 00000000.tx.527: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.528: 150, 77-88.[Abstract/Free FullText] Nishitoh, H., Matsuzawa, A., Tobiume, K., Saegusa, K., Takeda, K., Inoue, K., Hori, S., Kakizuka, A. and Ichijo, H. 

Phrase: "150,"

Phrase: "77-88."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsuzawa,"

Phrase: "A.,"

Phrase: "Tobiume,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saegusa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Inoue,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hori,"

Phrase: "S."

Phrase: ","

Phrase: "Kakizuka,"

Phrase: "A."

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.529: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.530: ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. 

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "is"

Phrase: "essential for endoplasmic reticulum stress-induced neuronal cell death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205224:Essential [Qualitative Concept]

Phrase: "triggered by expanded polyglutamine repeats."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1444748:Triggered by [Qualitative Concept]
           Trigger
   760   C0205229:expanded [Spatial Concept]
   760   C0205341:repeats [Functional Concept]
   760   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   760   C1705914:Repeats [Conceptual Entity]
   726   C0032930:Trigger [Clinical Attribute]
   726 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.531: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.532: 16, 1345-1355.[Abstract/Free FullText] Outinen, P. 

Phrase: "16,"

Phrase: "1345-1355."

Phrase: "[Abstract/Free FullText"

Phrase: "] Outinen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.533: A., Sood, S. 

Phrase: "A.,"

Phrase: "Sood,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.534: K., Pfeifer, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pfeifer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.535: I., Pamidi, S., Podor, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pamidi,"

Phrase: "S."

Phrase: ","

Phrase: "Podor,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.536: J., Li, J., Weitz, J. 

Phrase: "J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Weitz,"

Phrase: "J."
Processing 00000000.tx.537: I. and Austin, R. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.538: C. 

Phrase: "C."
Processing 00000000.tx.539: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.540: Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. 

Phrase: "Homocysteine-induced endoplasmic reticulum stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   840   C0014239:Endoplasmic Reticulum [Cell Component]
   804   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   804   C0038435:Stress [Finding]
   733 E C0231297:Stressful [Functional Concept]
   733   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "growth arrest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333951:Growth arrest [Pathologic Function]
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "leads to specific changes"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0205369:Specific [Qualitative Concept]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1552740:specific [Intellectual Product]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in human vascular endothelial cells."
Meta Candidates (Total=22; Excluded=11; Pruned=0; Remaining=11)
   923   C1257792:Vascular Endothelial Cells [Cell]
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   825   C0005773:Blood Cells [Cell]
   825   C0014261:Endothelium, Vascular [Tissue]
   816 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.541: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.542: 94, 959-967.[Abstract/Free FullText] Oyadomari, S., Araki, E. and Mori, M. 

Phrase: "94,"

Phrase: "959-967."

Phrase: "[Abstract/Free FullText"

Phrase: "] Oyadomari,"

Phrase: "S."

Phrase: ","

Phrase: "Araki,"

Phrase: "E."

Phrase: "and"

Phrase: "Mori,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: (2002a). 

Phrase: "(2002a"

Phrase: ")."
Processing 00000000.tx.544: Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. 

Phrase: "Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C3157088:pancreatic beta cell apoptosis [Cell Function]
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.545: Apoptosis 7, 335-345.[CrossRef][Medline] Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E. and Mori, M. 

Phrase: "Apoptosis 7,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "335-345."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Oyadomari,"

Phrase: "S."

Phrase: ","

Phrase: "Koizumi,"

Phrase: "A.,"

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gotoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Akira,"

Phrase: "S."

Phrase: ","

Phrase: "Araki,"

Phrase: "E."

Phrase: "and"

Phrase: "Mori,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.546: (2002b). 

Phrase: "(2002b"

Phrase: ")."
Processing 00000000.tx.547: Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. 

Phrase: "Targeted disruption of the Chop gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "delays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "endoplasmic reticulum stress-mediated diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   717   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
Processing 00000000.tx.548: J. 

Phrase: "J."
Processing 00000000.tx.549: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.550: Invest. 

Phrase: "Invest."
Processing 00000000.tx.551: 109, 525-532.[Abstract/Free FullText] Pahl, H. 

Phrase: "109,"

Phrase: "525-532."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pahl,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.552: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.553: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.554: Signal transduction from the endoplasmic reticulum to the cell nucleus. 

Phrase: "Signal transduction from the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0037083:Signal Transduction [Cell Function]
   753   C1160185:transduction [Organism Function]
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "to the cell nucleus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007610:Cell Nucleus [Cell Component]
           Nucleus
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.555: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.556: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.557: 79, 683-701.[Abstract/Free FullText] Penry, J. 

Phrase: "79,"

Phrase: "683-701."

Phrase: "[Abstract/Free FullText"

Phrase: "] Penry,"

Phrase: "J."
Processing 00000000.tx.558: K. and Dean, J. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Dean,"

Phrase: "J."
Processing 00000000.tx.559: C. 

Phrase: "C."
Processing 00000000.tx.560: (1989). 

Phrase: "(1989"

Phrase: ")."
Processing 00000000.tx.561: The scope and use of valproate in epilepsy. 

Phrase: "The scope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710028:Scope [Conceptual Entity]

Phrase: "and"

Phrase: "use of valproate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1524063:Use of [Functional Concept]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "in epilepsy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014544:Epilepsy [Disease or Syndrome]
Processing 00000000.tx.562: J. 

Phrase: "J."
Processing 00000000.tx.563: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.564: Psychol. 

Phrase: "Psychol."
Processing 00000000.tx.565: 50, 17-22. 

Phrase: "50,"

Phrase: "17-22."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450332:17/22 [Quantitative Concept]
Processing 00000000.tx.566: Phiel, C. 

Phrase: "Phiel,"

Phrase: "C."
Processing 00000000.tx.567: J., Zhang, F., Huang, E. 

Phrase: "J.,"

Phrase: "Zhang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Huang,"

Phrase: "E."
Processing 00000000.tx.568: Y., Guenther, M. 

Phrase: "Y.,"

Phrase: "Guenther,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.569: G., Lazar, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazar,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.570: A. and Klein, P. 

Phrase: "A."

Phrase: "and"

Phrase: "Klein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.571: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.572: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.573: Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. 

Phrase: "Histone deacetylase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019643:Histone Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0019652:Histone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a direct target of valproic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1550500:direct target [Idea or Concept]
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "a potent anticonvulsant, mood stabilizer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C2917435:Mood Stabilizer [Pharmacologic Substance]
   812   C0920880:Stabilizer [Organ or Tissue Function]
   812   C1550603:stabilizer [Substance]
   812   C1705532:Stabilizer [Medical Device]

Phrase: "and"

Phrase: "teratogen."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039536:Teratogen [Hazardous or Poisonous Substance]
   900 E C0232910:Teratogenicity [Pathologic Function]
Processing 00000000.tx.574: J. 

Phrase: "J."
Processing 00000000.tx.575: Biol. 

Phrase: "Biol."
Processing 00000000.tx.576: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.577: 276, 36734-36741.[Abstract/Free FullText] Plyte, S. 

Phrase: "276,"

Phrase: "36734-36741."

Phrase: "[Abstract/Free FullText"

Phrase: "] Plyte,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.578: E., Hughes, K., Nikolakaki, E., Pulverer, B. 

Phrase: "E.,"

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nikolakaki,"

Phrase: "E.,"

Phrase: "Pulverer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.579: J. and Woodgett, J. 

Phrase: "J."

Phrase: "and"

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.580: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.581: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.582: Glycogen synthase kinase-3: functions in oncogenesis and development. 

Phrase: "Glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "functions in oncogenesis"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0542341:Functions [Functional Concept]
   756 E C0031843:function [Physiologic Function]
   756 E C0700205:FUNCTION [Classification]
   756 E C1705273:Function [Intellectual Product]
   706 E C0205245:Functional [Functional Concept]
   706 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.583: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.584: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.585: Acta 1114, 147-162.[CrossRef][Medline] Rao, R. 

Phrase: "Acta 1114,"

Phrase: "147-162."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.586: V., Hermel, E., Castro-Obregon, S., del Rio, G., Ellerby, L. 

Phrase: "V., Hermel,"

Phrase: "E.,"

Phrase: "Castro-Obregon,"

Phrase: "S."

Phrase: ","

Phrase: "del Rio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008628:del [Cell or Molecular Dysfunction]
   861   C0445581:Rio [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ellerby,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.587: M., Ellerby, H. 

Phrase: "M."

Phrase: ","

Phrase: "Ellerby,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.588: M. and Bredesen, D. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bredesen,"

Phrase: "D."
Processing 00000000.tx.589: E. 

Phrase: "E."
Processing 00000000.tx.590: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.591: Coupling endoplasmic reticulum stress to the cell death program. 

Phrase: "Coupling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "endoplasmic reticulum stress to the cell death program."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   767   C0229606:Reticulum cell [Cell]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0038435:Stress [Finding]
Processing 00000000.tx.592: Mechanism of caspase activation. 

Phrase: "Mechanism of caspase activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.593: J. 

Phrase: "J."
Processing 00000000.tx.594: Biol. 

Phrase: "Biol."
Processing 00000000.tx.595: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.596: 276, 33869-33874.[Abstract/Free FullText] Ryu, E. 

Phrase: "276,"

Phrase: "33869-33874."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ryu,"

Phrase: "E."
Processing 00000000.tx.597: J., Harding, H. 

Phrase: "J.,"

Phrase: "Harding,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.598: P., Angelastro, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Angelastro,"

Phrase: "J."
Processing 00000000.tx.599: M., Vitolo, O. 

Phrase: "M."

Phrase: ","

Phrase: "Vitolo,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.600: V., Ron, D. and Greene, L. 

Phrase: "V., Ron,"

Phrase: "D."

Phrase: "and"

Phrase: "Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.601: A. 

Phrase: "A."
Processing 00000000.tx.602: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.603: Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. 

Phrase: "Endoplasmic reticulum stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "the unfolded protein response in cellular models of Parkinson's disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   782   C1155342:Unfolded Protein Response [Molecular Function]
   757   C1704632:Disease Response [Finding]
           Response
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0871261:Response [Organism Attribute]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
Processing 00000000.tx.604: J. 

Phrase: "J."
Processing 00000000.tx.605: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.606: 22, 10690-10698.[Abstract/Free FullText] Ruddon, R. 

Phrase: "22,"

Phrase: "10690-10698."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ruddon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.607: W. and Bedows, E. 

Phrase: "W."

Phrase: "and"

Phrase: "Bedows,"

Phrase: "E."
Processing 00000000.tx.608: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.609: Assisted protein folding. 

Phrase: "Assisted protein folding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0162847:protein folding [Molecular Function]
   827   C0185026:Folding [Therapeutic or Preventive Procedure]
Processing 00000000.tx.610: J. 

Phrase: "J."
Processing 00000000.tx.611: Biol. 

Phrase: "Biol."
Processing 00000000.tx.612: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.613: 272, 3125-3128.[Free FullText] Scheuner, D., Song, B., McEwen, E., Liu, C., Laybutt, R., Gillespie, P., Saunders, T., Bonner-Weir, S. and Kaufman, R. 

Phrase: "272,"

Phrase: "3125-3128."

Phrase: "[Free FullText"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McEwen,"

Phrase: "E.,"

Phrase: "Liu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Laybutt,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gillespie,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saunders,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bonner-Weir,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kaufman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.614: J. 

Phrase: "J."
Processing 00000000.tx.615: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.616: Translational control is required for the unfolded protein response and in vivo glucose homeostasis. 

Phrase: "Translational control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C1519614:Translational [Genetic Function]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   789 E C0040712:Translation [Intellectual Product]
   789 E C0597295:translation [Molecular Function]

Phrase: "is"

Phrase: "required for the unfolded protein response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   783   C2985857:Required Response [Idea or Concept]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0871261:Response [Organism Attribute]
   753   C1514873:Required [Functional Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "in vivo glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1326961:glucose homeostasis [Physiologic Function]
   812   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.617: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.618: Cell 7, 1165-1176.[CrossRef][Medline] Shank, K. 

Phrase: "Cell 7,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1165-1176."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shank,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444675:Shank [Body Location or Region]
  1000   C1422551:SHANK [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.619: J., Su, P., Brglez, I., Boss, W. 

Phrase: "J.,"

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brglez,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Boss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "W."
Processing 00000000.tx.620: F., Dewey, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Dewey,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.621: E. and Boston, R. 

Phrase: "E."

Phrase: "and"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.622: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.623: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.624: Induction of lipid metabolic enzymes during the endoplasmic reticulum stress response in plants. 

Phrase: "Induction of lipid metabolic enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0025513:Metabolic induction [Molecular Function]
   781   C0014431:Enzyme Induction [Genetic Function]
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "during the endoplasmic reticulum stress response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0149784:stress response [Physiologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "in plants."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plants [Plant]
   900 E C0006038:Botany [Occupation or Discipline]
   884 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.625: Plant Physiol. 

Phrase: "Plant Physiol."
Processing 00000000.tx.626: 126, 267-277.[Abstract/Free FullText] Siman, R., Flood, D. 

Phrase: "126,"

Phrase: "267-277."

Phrase: "[Abstract/Free FullText"

Phrase: "] Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Flood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016248:Flood [Natural Phenomenon or Process]
  1000   C0375741:Flood [Injury or Poisoning]

Phrase: "D."
Processing 00000000.tx.627: G., Thinakaran, G. and Neumar, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Neumar,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.628: W. 

Phrase: "W."
Processing 00000000.tx.629: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.630: Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation. 

Phrase: "Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]

Phrase: ":"

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "of an Alzheimer's disease-linked presenilin-1 knock-in mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0026882:Mutation [Genetic Function]
   793   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.631: J. 

Phrase: "J."
Processing 00000000.tx.632: Biol. 

Phrase: "Biol."
Processing 00000000.tx.633: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.634: 276, 44736-44743.[Abstract/Free FullText] Song, L., de Sarno, P. and Jope, R. 

Phrase: "276,"

Phrase: "44736-44743."

Phrase: "[Abstract/Free FullText"

Phrase: "] Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "de Sarno,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.635: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.636: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.637: Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. 

Phrase: "Central role of glycogen synthase kinase-3beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in endoplasmic reticulum stress-induced caspase-3 activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C1159825:Caspase Activation [Molecular Function]
   795   C1879547:Activation [Activity]
Processing 00000000.tx.638: J. 

Phrase: "J."
Processing 00000000.tx.639: Biol. 

Phrase: "Biol."
Processing 00000000.tx.640: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.641: 277, 44701-44708.[Abstract/Free FullText] Stambolic, V., Ruel, L. and Woodgett, J. 

Phrase: "277,"

Phrase: "44701-44708."

Phrase: "[Abstract/Free FullText"

Phrase: "] Stambolic,"

Phrase: "V.,"

Phrase: "Ruel,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.642: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.643: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.644: Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. 

Phrase: "Lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glycogen synthase kinase-3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "wingless"

Phrase: "signalling in intact cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   816   C0682538:intact cell [Cell]
   786   C0037083:signal cell [Cell Function]
   770   C0007634:Cells [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C3282337:Cells [Cell]
   770   C3537152:signalling [Biologic Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1710082:Signal [Phenomenon or Process]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.645: Curr. 

Phrase: "Curr."
Processing 00000000.tx.646: Biol. 

Phrase: "Biol."
Processing 00000000.tx.647: 6, 1664-1668.[Medline] Suchy, F. 

Phrase: "6,"

Phrase: "1664-1668."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Suchy,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.648: J., Balistreri, W. 

Phrase: "J.,"

Phrase: "Balistreri,"

Phrase: "W."
Processing 00000000.tx.649: F., Buchino, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Buchino,"

Phrase: "J."
Processing 00000000.tx.650: J., Sondheimer, J. 

Phrase: "J.,"

Phrase: "Sondheimer,"

Phrase: "J."
Processing 00000000.tx.651: M., Bates, S. 

Phrase: "M."

Phrase: ","

Phrase: "Bates"

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.652: R., Kearns, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kearns,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.653: L., Stull, J. 

Phrase: "L., Stull,"

Phrase: "J."
Processing 00000000.tx.654: D. and Bove, K. 

Phrase: "D."

Phrase: "and"

Phrase: "Bove,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.655: E. 

Phrase: "E."
Processing 00000000.tx.656: (1979). 

Phrase: "(1979"

Phrase: ")."
Processing 00000000.tx.657: Acute hepatic failure associated with the use of sodium valproate. 

Phrase: "Acute hepatic failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162557:Hepatic Failure, Acute [Disease or Syndrome]
   913   C0231176:Acute failure [Pathologic Function]
   901   C0085605:Hepatic Failure [Disease or Syndrome]
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "associated with the use of sodium valproate."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0037567:Sodium Valproate [Lipid,Pharmacologic Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1524063:Use of [Functional Concept]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0042153:use [Functional Concept]
   748   C0080356:Valproate [Lipid,Pharmacologic Substance]
   748   C0457083:Use [Functional Concept]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1947944:Use [Intellectual Product]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.658: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.659: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.660: J. 

Phrase: "J."
Processing 00000000.tx.661: Med. 

Phrase: "Med."
Processing 00000000.tx.662: 300, 962-966.[Medline] Tatebayashi, Y., Haque, N., Tung, Y.-C., Iqbal, K. and Grundke-Iqbal, I. 

Phrase: "300,"

Phrase: "962-966."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tatebayashi,"

Phrase: "Y.,"

Phrase: "Haque,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tung,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330603:Tung [Plant]

Phrase: "Y.-C., Iqbal,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Grundke-Iqbal,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.663: (2004). 

Phrase: "(2004"

Phrase: ")."
Processing 00000000.tx.664: Role of tau phosphorylation by glycogen synthase kinase-3 in the regulation of organelle transport. 

Phrase: "Role of tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "by glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of organelle transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
Processing 00000000.tx.665: J. 

Phrase: "J."
Processing 00000000.tx.666: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.667: 117, 1653-1663.[Abstract/Free FullText] Travers, K. 

Phrase: "117,"

Phrase: "1653-1663."

Phrase: "[Abstract/Free FullText"

Phrase: "] Travers,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.668: J., Patil, C. 

Phrase: "J.,"

Phrase: "Patil,"

Phrase: "C."
Processing 00000000.tx.669: K., Wodicka, L., Lockhart, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wodicka,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "D."
Processing 00000000.tx.670: J., Weissman, J. 

Phrase: "J.,"

Phrase: "Weissman,"

Phrase: "J."
Processing 00000000.tx.671: S. and Walter, P. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Walter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.672: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.673: Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. 

Phrase: "Functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "genomic analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "an essential coordination between the unfolded protein response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0242414:Coordination [Physiologic Function]
   744   C0700114:Coordination [Functional Concept]

Phrase: "and"

Phrase: "ER-associated degradation."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C3178997:Endoplasmic Reticulum-Associated Degradation [Molecular Function]
   861   C0014239:Endoplasmic Reticulum [Cell Component]
   812   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   812   C0243125:degradation [Functional Concept]
   812   C0332281:Associated [Qualitative Concept]
   812   C0699900:Degradation [Organism Function]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
   741   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.674: Cell 101, 249-258.[Medline] Wang, X. 

Phrase: "Cell 101,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "249-258."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wang,"

Phrase: "X."
Processing 00000000.tx.675: Z., Harding, H. 

Phrase: "Z.,"

Phrase: "Harding,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.676: P., Zhang, Y., Jolicoeur, E. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Jolicoeur,"

Phrase: "E."
Processing 00000000.tx.677: M., Kuroda, M. and Ron, D. 

Phrase: "M."

Phrase: ","

Phrase: "Kuroda,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ron,"

Phrase: "D."
Processing 00000000.tx.678: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.679: Cloning of mammalian Ire1 reveals diversity in the ER stress responses. 

Phrase: "Cloning of mammalian Ire1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009015:Cloning [Research Activity]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "diversity in the ER stress responses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.680: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.681: 17, 5708-5717.[Abstract/Free FullText] Wang, J.-F., Brown, C. and Young, L. 

Phrase: "17,"

Phrase: "5708-5717."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "J.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "C."

Phrase: "and"

Phrase: "Young, L."
Processing 00000000.tx.682: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.683: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.684: Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78. 

Phrase: "Differential display PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "novel targets for the mood-stabilizing drug valproate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0085104:drug targets [Medical Device]
   711   C1521840:Target [Functional Concept]
   711   C2986546:TARGET [Diagnostic Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the molecular chaperone GRP78."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0063423:molecular chaperone GRP78 [Amino Acid, Peptide, or Protein,Enzyme]
           GRP78
   827   C1415761:GRP78 [Gene or Genome]
   827   C1708295:GRP78 [Gene or Genome]
   734   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.685: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.686: Pharm. 

Phrase: "Pharm."
Processing 00000000.tx.687: 55, 521-527.[Abstract/Free FullText] Werstuck, G. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "521-527."

Phrase: "[Abstract/Free FullText"

Phrase: "] Werstuck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.688: H., Lentz, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lentz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.689: R., Dayal, S., Shi, Y., Hossain, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dayal,"

Phrase: "S."

Phrase: ","

Phrase: "Shi,"

Phrase: "Y.,"

Phrase: "Hossain,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.690: S., Sood, S. 

Phrase: "S."

Phrase: ","

Phrase: "Sood,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.691: K., Krisans, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Krisans,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.692: K. and Austin, R. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.693: C. 

Phrase: "C."
Processing 00000000.tx.694: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.695: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. 

Phrase: "Homocysteine-induced endoplasmic reticulum stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   840   C0014239:Endoplasmic Reticulum [Cell Component]
   804   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   804   C0038435:Stress [Finding]
   733 E C0231297:Stressful [Functional Concept]
   733   C0598268:Endoplasm [Cell Component]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "dysregulation of the cholesterol"

Phrase: "and"

Phrase: "triglyceride biosynthetic pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1721101:Biosynthetic Pathways [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.696: J. 

Phrase: "J."
Processing 00000000.tx.697: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.698: Invest. 

Phrase: "Invest."
Processing 00000000.tx.699: 107, 1263-1273.[Abstract/Free FullText] Williams, R. 

Phrase: "107,"

Phrase: "1263-1273."

Phrase: "[Abstract/Free FullText"

Phrase: "] Williams,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.700: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.701: B., Cheng, L., Mudge, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cheng,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mudge,"

Phrase: "A."
Processing 00000000.tx.702: W. and Harwood, A. 

Phrase: "W."

Phrase: "and"

Phrase: "Harwood,"

Phrase: "A."
Processing 00000000.tx.703: J. 

Phrase: "J."
Processing 00000000.tx.704: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.705: A common mechanism of action for three mood-stabilizing drugs. 

Phrase: "A common mechanism of action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0031327:mechanism of action [Physiologic Function]
   862   C1524059:mechanism of action [Functional Concept]
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "for three mood-stabilizing drugs."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   912   C1276998:Mood stabilizing drug [Pharmacologic Substance]
   812   C0013227:Drugs [Pharmacologic Substance]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.706: Nature 417, 292-295.[CrossRef][Medline] Zinszner, H., Kuroda, M., Wang, X. 

Phrase: "Nature 417,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "292-295."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zinszner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kuroda,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "X."
Processing 00000000.tx.707: Z., Batchvarova, N., Lightfoot, R. 

Phrase: "Z.,"

Phrase: "Batchvarova,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lightfoot,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.708: T., Remotti, H., Stevens, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Remotti,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "J."
Processing 00000000.tx.709: L. and Ron, D. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Ron,"

Phrase: "D."
Processing 00000000.tx.710: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.711: CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. 

Phrase: "CHOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945739:chop [Activity]

Phrase: "is"

Phrase: "implicated in programmed cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0162638:Programmed Cell Death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to impaired function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "of the endoplasmic reticulum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.712: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.713: 12, 982-995.[Abstract/Free FullText] Related articles in JCS: ER stress relief JCS 2005 118: 101. 

Phrase: "12,"

Phrase: "982-995."

Phrase: "[Abstract/Free FullText"

Phrase: "] Related articles in JCS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1706852:Article [Intellectual Product]

Phrase: ":"

Phrase: "ER stress relief JCS 2005 118"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   845   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   818   C0014239:Endoplasmic Reticulum [Cell Component]
   795   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   795   C0038435:Stress [Finding]
   795   C0564405:Relief [Finding]
   724 E C0231297:Stressful [Functional Concept]
   724   C0598268:Endoplasm [Cell Component]

Phrase: ":"

Phrase: "101."
Processing 00000000.tx.714: [Full Text]

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]"

